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1. Introduction 
1.1 Introduction. 
The extreme growth of global economy has led to a massive exploitation of fossil 
reserves both for energy need end for the production of chemicals. Nowadays these 
requests are partially provided from renewable sources. The passage form fossil-
based economy to a more sustainable economy has become a top priority. This 
transition from fossil economy to a sustainable economy is necessary to meet the 
urgent environmental concerns in favour to a sustainable development, preserving the 
integrity, stability and beauty of natural biotic system. The use of renewable 
alternatives and sustainable sources has a number of advantages in comparison with 
the use of fossil sources, for example, reduction of air pollution, global warming, and 
dependence from petroleum.1 Chemists, scientists, and engineers have a key role in 
the developing processes that exploit renewable sources. In recent years, there is an 
enormous interest in the usage of alcohols as starting materials, as they are readily 
available by a variety of industrial processes, inexpensive because they can be 
obtained renewably via fermentation or catalytic conversion of lignocellulosic 
biomass, relatively nontoxic, and easy to use.2 The work presented in this thesis is 
focused on the use of alcohols as alkylating agents to develop new synthetic 
methodology exploiting the borrowing hydrogen process, as activation strategy that 
allow the preparation of valuable classes of molecules of industrial and 
pharmaceutical interest according to the guide lines of green chemistry.   
1.2 Alcohols in alkylation reactions.  
Alcohols are versatile, organic compounds since they undergo a wide variety of 
transformations. Considering the use of alcohols in alkylation reactions, they are able 
to react only prior activation. Conventionally the activation consists in the conversion 
of OH group into a good leaving group. To increase the electrophilicity at C1 of the 
alcohol and generate a good leaving group allowing the reactivity toward the 
nucleophilic attack the simplest method would be the protonation. Despite the 
protonation looks attractive as it produces only water as byproduct, this method can 
deactivate the nucleophile as occur in acid conditions, reducing drastically the scope 
and efficiencies of the reaction. Therefore, alcohol activation as alkylating agent is 
afforded by the interconversion of OH into alkyl halide, tosylate or mesylate. These 
kind of activations from a green metrics point of view does not respect the 
sustainability and the efficiency of the reaction. Not only an extra step is required but 
also both for the activation and the subsequent reaction a stoichiometric amount of 
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chemical waste is produced, reducing the safety due to the intrinsic mutagenicity and 
toxicity of the halide. Alternatively, also the in situ nucleophilic substitution of 
alcohols operated through a Mitsunobu reaction, has the problem of the 
stoichiometric use of the derivatizing reagents. Dialkyl azodicarboxylate (e. g. diethyl 
azodicarboxylate, DEAD) and triphenylphosphine, are also unsafe and toxic (Scheme 
1). 
 
 
Scheme 1 Traditional activation of alcohols. 
Despite these facts, the direct substitution/alkylation of alcohols has been developed. 
Through the use of Lewis acids and Bronsted acids, π-activated alcohol such as 
allylic and benzylic can undergo the direct substitution of the hydroxyl group, via 
formation of a carbocation.3 However, many of these methods have some drawbacks, 
even if the problem of the stoichiometric use of Lewis acids or Bronsted acids is 
bypassed by the catalytic variation/form. Low yields of the products, long reaction 
times, harsh reaction conditions, tedious work-ups and relatively expensive reagents, 
the requirement for an inert atmosphere, and formation of a significant amount of 
side products, are still present. Only one example of the use of less-activated alcohols 
was reported, nevertheless the scope continues to be mainly restricted to π-activated 
alcohol.4 For all these reasons aforementioned, the development of efficient and 
sustainable methodologies for the activation of alcohols is needed. Among the 
strategy developed for the direct use of alcohols as alkylating agents, the catalytic 
activation of alcohols by hydrogen borrowing has attracted significant attention in 
recent years as a powerful and sustainable solution for addressing some of the 
contemporary goals of pharmaceutical and chemical industries. As highlighted during 
the ACS GCI Pharmaceutical Roundtable the direct nucleophilic substitution of 
alcohols is one of the most important and challenging priorities both for academia 
and industry.5 
1.3 The Borrowing Hydrogen Strategy 
The increasing demand to have more green processes in chemistry has focused the 
attention to bond construction strategies that promote atom economy and avoid 
mutagenic reagents.6 The borrowing hydrogen or hydrogen autotransfer is a catalytic 
fashion way to exploit the potential of alcohols to be ideal green substitute of halides 
or (pseudo)halides. Alcohols are ideal candidates for green chemistry because they 
have low-molecular-weight leaving group (HO, 17 u.m.a.), low environmental impact 
factor of the leaving group (H2O), they are inexpensive and sustainable (most of them 
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come from biomasses and renewable sources1) and they are easy to handle and store 
(safely).7 The more general description of the borrowing hydrogen process can be 
given as follow: an inert substrate after the dehydrogenation operated by a metal 
catalyst become reactive (oxidized species), this new reactive oxidized substrate will 
form the reacted substrate, and finally the metal catalyst makes the hydrogenation to 
form the final product. In this cycle, the catalyst act both as oxidant 
(dehydrogenation) and as reductant (hydrogenation) – Globally no net oxidation or 
reduction takes place in the catalytic cycle itself (Scheme 2). 
 
 
Scheme 2 General scheme of Borrowing Hydrogen Process. 
The substrates involved in the borrowing hydrogen activation are alkanes,8 alcohols,9 
and amines.10 Regarding the catalytic cycle of borrowing hydrogen for alcohol 
activation mainly consists of two or three steps: The first step is the alcohol 
dehydrogenation run by the catalyst, then the correspondent carbonyl compounds 
derived from the dehydrogenation of alcohol can carry out its typical reactivity, and 
lastly in the third step the abstracted hydrogen is usually returned back to the 
intermediate. It is also possible to intercept the intermediate for a further 
functionalization or block the reaction and have the hydrogenation of the sacrificial 
intermediate or that the intermediate can react again with additional reagents or the 
abstracted hydrogen is further returned and incorporated to the final product, hence 
the reaction name (Scheme 3). In other words in some specific cases, the borrowing 
process can be truncated to the reactive intermediate using a hydrogen acceptor or H2 
gas removal. The result in these cases is a reactive final compound that might be 
ready for further functionalization/ additional cascade transformation. 
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Scheme 3 General Borrowing Hydrogen Process for Alcohols Activation.  
 
From a mechanistic point of view the borrowing hydrogen process (activation via 
dehydrogenation) operated by homogenous catalyst depends from the type of the 
complex, the substrates as well as the conditions of reaction. Considering that the 
catalytic cycle is based on three steps. (i) Dehydrogenation (ii) functionalization and 
(iii) hydrogenation and since functionalization in step (ii) is usually a classical 
organic transformation such us a nucleophilic addition and there is no catalyst needed 
as it can act probably coordinating the carbonyl compound enhancing the 
electrophilicit, it is possible to assume no participation of the catalyst in this step. The 
more significant and central steps are the first (i) and the third (iii), assuming 
reversibility between they are possible to discuss only the first (i). The mechanistic 
possibilities for the step (i) of transfer hydrogenation are mainly classified as: Inner 
sphere, intermediate sphere, outer sphere.11 In the inner sphere, after the alcohol 
coordination to the metal centre trough an insertion, the correspondent carbonyl 
compound is formed via -hydride elimination both for dihydride and monohydride 
mechanisms (Scheme 4). 
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Scheme 4 Inner Sphere Transfer Hydrogenation Mechanisms. 
The intermediate sphere mechanism consists in a transfer of the hydride from the 
donor to the acceptor where the metal hold together the two species like in the 
Meerwein-Ponndorf-Verley (Scheme 5). 
 
Scheme 5 Intermediate Sphere - Mechanism of the Meerwein-Pondorf-Verley Reduction and 
Oppenauer Oxidation. 
 
The outer sphere mechanism is plausible when the metal complex have no open site 
for binding the substrate. This kind of mechanism is for all the catalysts that have a 
hydride in position cis respect to the protonic hydrogen, typically in a form 
coordinating R2NH ligand, like in the Noyori’s Catalyst (Scheme 6). 
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Scheme 6 Outer sphere transfer Hydrogenation of Noyori’s Catalyst.    
The mechanism of dehydrogenative activation via homogeneous transition-metal 
complexes varies greatly, depending on the substrate and catalyst employed as well 
as the conditions chosen. The two H atoms extruded can be delivered to the metal 
complex or directly to a hydrogen acceptor. The pathways for stepwise mechanisms 
generally consist of two separate components: association of the substrate with the 
catalyst followed by cleavage of a C-H bond. A saturated molecule must first 
coordinate in some manner to a transition-metal complex. This step often requires 
direct activation of a C-H bond for alkanes, or an O-H bond for alcohols, or an N-H 
bond for amines. Alcohol or amine binding to the metal catalyst is typically followed 
by a deprotonation event. The resulting metal alkoxide or amine complex then 
undergoes to a C-H bond cleavage, resulting in a metal hydride and a dehydrogenated 
organic species. Following the dehydrogenative step, a functionalization occurs. This 
process can be catalyzed by the same catalyst employed for dehydrogenation, 
catalyzed by a different species added to the reaction mixture for this purpose, or 
simply occurs without the need for a catalyst. Once generated, the resulting 
intermediate can react with additional reagents and be oxidized or reduced depending 
on the specific reaction sequence. 
 
1.4 General Activation pathway via Borrowing Hydrogen. 
The general reactivity of alcohols both as nucleophiles and as electrophiles is very 
limited and some kind of activation results necessary. As describe before, OH group 
is transformed to alkoxide to enhance the nucleophilicity, on the other end, 
electrophilicity is ideally enhanced adding an acid. This description involves the 
classical activation of alcohols. Another possibility is to convert alcohols transiently 
in to the correspondent carbonyl compound. In this way is possible to exploit the 
reactivity of carbonyls that in comparison to the alcohol, as functional groups, allow 
more transformation, and lastly, after the reaction, the intermediate product is 
reduced to the original oxidation state of the alcohol. This process become catalytic, 
when, after the oxidation of the alcohol (activation), the formation and the reaction of 
the  carbonyl compound, the intermediate is reduced under the reaction conditions. 
Now a detailed discussion on the reactivity of the carbonyl compound follows. After 
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the oxidation, we can have aldehyde or ketone respectively from primary and 
secondary alcohol, that in term of reactivity they show almost the same reactivity. As 
shown in (Scheme 7) carbonyl compound reacts at C1 in nucleophilic addition 
reactions, and in C2 with electrophile exploiting the possible enol-enolate chemistry, 
and alkene formation in Wittig type reaction (ylide addition to C1).  
 
Scheme 7 Alcohol Activation Pathways via Borrowing Hydrogen.  
 
1.4.1 C-N Bond Formation-Amination of Alcohol: alcohol amination is 
traditionally achieved using alkyl halide agents. The alkyl halide strategy for the 
formation of amine by alkylation may have control limitation like the over alkylation. 
For example, the alkylation of a primary amine could results in the formation of a 
mixture of mono, di-alkylated amine and also the quaternary ammonium salt. This 
over alkylation simply happens because the more the amine is substituted, the more it 
becomes nucleophilic and reactive in the substitution reaction with alkyl halides. 
Methods for the controlled alkylation of primary amine have been reported, and in 
some instances, is possible to have mono alkylation under appropriate conditions. At 
the beginning Gabriel synthesis was introduced for the synthesis of primary amines12 
and many other methods was developed. For examples, more recently a potassium 
iodide catalyzed method for the selective N-monoalkylation of amines with alkyl 
halides and alkyl tosylate under microwave irradiation has been described. A simple 
method for the N-alkylation of primary amines was developed using ionic liquids as 
solvent in order to prepare secondary amines selectively. However, these approaches 
have some drawbacks even if they are selective they continue to employ mutagenic 
and toxic reagents. The direct amination via borrowing hydrogen resolve both the 
problems, over alkylation and the use of mutagenic and toxic reagents. The sequence 
of alcohol amination consists in: alcohol dehydrogenation operated by the metal 
catalyst, the resulting carbonyl compound react in an addition reaction with the 
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ammine generating an imine fially is reduced to amine by the catalyst, with the 
hydrogen borrowed from the alcohol in the dehydrogenation step. In this alcohol 
activation process the over alkylation is controlled, due to the initial secondary amine 
formed by alkylation of primary amine, the intermediate doesn’t tend to react further 
because this would require the unfavorable formation of an iminium cation. The 
borrowing hydrogen activation process is a good alternative to the reductive 
amination. In other words, it could be considered the catalytic version of reductive 
amination employing alcohols rather than aldehydes that in some case result instable 
like -amino aldehyde13 that can react itself or lose the optical purity/stability. These 
problems are overcome with the borrowing hydrogen because the aldehyde is 
transiently formed and consumed soon after. Several examples of C-N bond 
formation via borrowing hydrogen have been reported, and among them, a selection 
of examples follows. The first alkylation of amine using alcohols via the borrowing 
hydrogen route date back to 1932 with a work where a heterogeneous nickel catalyst 
was employed.14 The first report of N-alkylation with alcohols of primary and 
secondary amine via homogeneous catalysis was by Grigg and co-workers in 1981.15 
A screening with different catalysts based on rhodium, iridium and ruthenium was 
presented (Scheme 8). 
 
 
Scheme 8 N-alkylation via Borrowing Hydrogen with Rh Ir Ru Catalyst.  
 
Watanabe has reported a study about the selectivity for N-alkylation of primary 
amine demonstrating that different ruthenium catalysts and adopted conditions show 
different selectivity between mono and di-alkylation for the same substrates (Scheme 
9). 16 
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Scheme 9 Selectivity: Mono-Alkylation vs Di-Alkylation of Amines. 
 
A method for converting primary alcohols in primary amines using a PNP pincer 
complex of ruthenium and reasonable pressure of ammonia has been reported by 
Milstein and co-workers (Scheme 10).17  
 
 
Scheme 10 Direct Formation of Primary Amine from Ammonia and Alcohol via Borrowing 
Hydrogen. 
 
Alkylation of primary amines with primary alcohols has been accomplished by 
Williams and co-workers, an alternative combination of phenylethanol and 
tryptamine or tryptophol and phenylethanamine give the secondary amine product in 
good yields (Scheme 11).18 
 
Scheme 11 Formation of Alkylated Tryptamine. 
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Taddei and co-workers reported an interesting example of C-N bond formation at low 
temperature, via borrowing hydrogen. The alkylation of arylamines has been achived 
using stoichiometric amounts of aliphatic and benzylic alcohols in the presence of 
tBuOK, the reaction was carried out at 55 °C using ruthenium with low catalyst 
loading. (Scheme 12).19  
 
 
 
Scheme 12 Alkylation of different aniline under mild condition. 
 
The catalytic enantioselective synthesis of chiral amines via borrowing hydrogen is 
possible and represents a highly efficient way to prepare chiral amines from simple 
alcohols. Zhao reported the cooperative catalysis by iridium and a chiral phosphoric 
acid where different amines and alcohols have been employed for the enatioselective 
synthesis of chiral amines (Scheme 13).20  
 
 
Scheme 13  Catalytic Enantioselective Synthesis of Chiral Amine. 
 
Enantioselective version of C-N formation has been used for the formation of -
amino-alcohols from different diols and secondary amines. The reaction is catalyzed 
by ruthenium complex/JOSHIPHOS and proceeds mainly through amino ketone 
intermediates that are converted into the corresponding optically active β-amino 
alcohols (Scheme 14). 21 
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Scheme 14 Enantioselective Synthesis of β-Amino Alcohols. 
Dynamic kinetic resolution (DKR) for the amination of alcohols was recently 
presented by Zhao.22 Applying the borrowing hydrogen concept, a cooperative 
catalysis by an iridium complex end chiral phosphoric acid, -substituted alcohol that 
exist as a mixture of four isomers was converted in disastero- and enantio-pure 
amine. More precisely as shown in (Scheme 15) the initial racemic alcohol is 
converted in to the enantioenriched amine through a borrowing hydrogen pathway 
where a DKR take place. Dehydrogenation of the alcohol to ketone, condensation of 
ketone to form imine followed by transfer hydrogenation of amine and 
tautomerization /racemization of the two imines allow the formation into the amine 
that come from the fastest asymmetric hydrogenation. 
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Scheme 15 Dynamic Kinetic Asymmetric Amination of Alcohols and Mechanism.  
 
A recent related work has been presented by the same group, an acid-assisted Ru-
catalyzed enantioselective amination of 1,2-diols through borrowing hydrogen. In this 
reaction, the involved mechanism is borrowing hydrogen combined with dynamic 
kinetic resolution, and from a preliminary mechanistic study the beneficial effect of 
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achiral Brønsted acids on the enantioselectivity of the reaction may come from an 
accelerated tautomerization/racemization. Several β-amino alcohols have been 
prepared through monoamination of readily available racemic diols (Scheme 16). 
   
 
Scheme 16 Enantioselective Amination of Alcohols with Secondary Amine. 
 
Nitrogen containing heterocycles are target of great interest in organic synthesis due 
to the common occurrence in natural products and pharmaceutical active compounds. 
The amination via borrowing hydrogen has been extended with success to the 
formation of nitrogen containing heterocycles. As strategy, amino alcohol cyclisation 
has been employed as shown in (Scheme 17), ruthenium and rhodium complexes are 
able to provide the reaction in good yield. 23 
 
 
Scheme 17 Cyclization Reaction of Aminalcohols. 
  
Annulation reaction employing diols and primary ammines is another disconnection 
affordable via borrowing hydrogen strategy for the preparation of nitrogen containing 
heterocycles. With a suitable catalyst is possible to promote a double alkylation of the 
primary amine, with the second step being an intramolecular alkylation (Scheme 18). 
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Scheme 18 Annulation Disconnection for the Formation of N-heterocycles from Primary Amine. 
 
With this strategy Koten and co-workers have prepared piperazine (4) which is a 
potent serotonin agonist from aniline (1) and diol (2) using a ruthenium pincer 
complex (3).24 Watanabe and co-workers have converted primary amine into 
piperidines (5) morpholines (6) and piperazines (7) by condensation with suitable 
diols in presence of ruthenium phosphine complex (Scheme 19).25 
 
 
Scheme 19 N-Heterocyclization from Primary Amine via Borrowing Hydrogen. 
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Iridium complex [IrCp*Cl2]2 has been used for this heterocyclization process. 
Representative examples include as primary amine the use of aliphatic amine, 
benzylamine, and aniline with different diols in good yields (Scheme 20).26  
 
 
Scheme 20 Nitrogen Heterocycles Formation Catalyzed by [IrCp*Cl2]2. 
 
Moreover, an efficient method for the formation of 5-, 6-, and 7-membered cyclic 
amines from tryptamine and suitable diols has been presented employing an iridium 
complexes show in (Scheme 21).27  
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Scheme 21 Cyclic Amines from Tryptamine.  
 
Another interesting N-heterocycles construction has been reported by Taddei and co-
workers. In particular starting from 2-aminobenzyl alcohols and 1,2-aminoalcohols, 
2,3,4,5-tetrahydro-1H-1,4-benzodiazepines (THBDZ) can be prepared through a one-
pot ruthenium-catalyzed reaction encompassing two consecutive borrowing hydrogen 
cycles (Scheme 22).28  
 
Scheme 22 Ru Catalyzed Benzodiazepine Derivatives Synthesis Reported by Taddei.  
Stereoselective version of N-heterocycle construction has been reported by Fujita and 
Yamaguchi for the preparation of 2-substituted piperidines. Starting from racemic 
diols and enantioenriched amine the major diastereoisomer was formed in 92 % de. 
via reduction of the iminium intermediate, and 86% ee. The slight loss of 
enantiopurity is explained by the isomerization of intermediate (Scheme 23).29  
 
 
Scheme 23 Stereoselective Formation of a Cyclic Amine. 
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Zhao reported the stereoselective construction of 2-methyl-tetrahydroquinolin, using 
iridium complex as catalyst and chiral phosphoric acid as additive (Scheme 24).19 
 
 
Scheme 24 Stereoselective Intramolecular Amination of Alcohols. 
   
Urea motifs with glycol as diol can form the correspondent cyclic product 
dihydroimidazolone,30 whereas employing the same catalytic system based on 
ruthenium and still using ethylene glycol with a primary amine, symmetric formation 
of piperazine has been reported (Scheme 25).31  
 
 
Scheme 25 Cyclisation of 1,2 Diols to Form Dihydroimidazolone and Piperazine. 
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1.4.2 C-C Bond Formation: In general, the carbon-carbon bond formation via 
borrowing hydrogen is affordable in two different manners. After the 
dehydrogenation of alcohol and formation of correspondent carbonyl compound, one 
is the attack of C1 of the carbonyl with a carbon nucleophile, usually methylene 
active compounds, electron rich aromatic compounds, and stabilized or non-stabilized 
phosphorus ylides. The other possibility is the -functionalization with an 
electrophile, or a mixed case where the alcohol act as electrophile and nucleophile in 
the same reaction. Indirect Wittig reaction of alcohols via borrowing hydrogen has 
been described by Williams employing [Ir(cod)Cl]2. After the dehydrogenation step 
of the benzylic alcohol the correspondent carbonyl compound readily undergo 
olefination with the ylide and then alkane is formed by hydrogenation completing the 
catalytic cycle (Scheme 26).  
 
 
Scheme 26 Indirect Wittig Reaction of Alcohols by Borrowing Hydrogen Activation. 
 
Moreover, Williams and co-worker uses a Ru-NHC complex with great result in term 
of yields and more mild conditions in the Wittig Type process with alcohols 
activation (Scheme 27).32   
 
Scheme 27 Improved Indirect Wittig Reaction via Borrowing Hydrogen. 
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Stereoselective version of indirect Wittig has been developed by Williams using 
[IrCp*Cl2]2 and a chiral phosphine BINAP, in the overall process the stereo-selection 
is introduced during the hydrogenation step (Scheme 28).33 
 
 
Scheme 28 Stereoselective Wittig Reaction Via Borrowing Hydrogen. 
 
In the realm of C-C bond formation through borrowing hydrogen several 
nucleophiles has been employed, an overview follows in (Table 1). 
 
 
Table 1 Representative Nucleophile used in Browning Hydrogen. 
                                                           
Grigg published seminal work on C-C bond formation via hydrogen borrowing with 
the monoalkylation of arylacetonitriles by alcohols, where the catalyst was prepared 
in situ from rhodium trichloride triphenylphosphine and sodium carbonate (Scheme 
29).34  
 
 
Scheme 29 First Example of Homogeneous Transition Metal Catalysed C-C Bond Formation via 
Borrowing Hydrogen. 
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More recently Grigg reported this transformation using [IrCp*Cl2]2 as catalyst and 
catalytic amount of KOH as base. With this convenient and highly effective catalytic 
system has been achieved selective monoalkylation of arylacetonitriles with a wide 
range of aromatic, heteroaromatic, and aliphatic alcohols (Scheme 30).35 
 
 
Scheme 30 Monoalkylation of Arylacetonitriles with Primary Alcohols. 
 
Another methylene active compound studied, cyanoacetate, was reported by Grigg 
and Hisii in two distinct work. Grigg reported in his work the alkylation of T-butyl 
cyanoacetate with a variety of substituted benzyl and heteroaryl alcohols affording 
the corresponding -alkylated products from moderate to high yield.36 While Hisii 
with different cyanoacetate as methylene active compound reported the iridium 
catalyzed alkylation with different primary aliphatic alcohols (Scheme 31).37   
 
 
Scheme 31 Monoalkylation of Cyanoacetates Via Borrowing Hydrogen. 
 
Catalytic alkylation of 1,3-dimethylbarbituric acid as methylene active compound 
with various alcohols under solvent-free microwave irradiation (MWI) conditions and 
[IrCp*Cl2]2 has been reported by Grigg (Scheme 32).
38 
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Scheme 32 Alklyaltion of 1,3-dimethylbarbituric acid. 
Indole is not a proper methylene active compound but can be considered an activated 
nucleophile. In particular, its electron rich system has been employed as nucleophile 
in C3, his behaviour is quite similar to enamine, and the resulting C3-nucleophilicity 
can be easily justified by resonance forms as shown in (Figure1).  
 
Figure 1  
Grigg reported the formation of substituted indoles with benzylic alcohol catalyzed 
by [IrCp*Cl2]2 (Scheme 33). 
 
 
Scheme 33 Synthesis of Substituted Indoles Via Borrowing Hydrogen. 
 
Inspired by the work of Grigg, Piersanti and co-workers reported the first iridium-
catalyzed direct synthesis of tryptamines. Different substituted indoles (position 2, 4, 
5, 6 and 7) were alkylated with different N-protected aminoles (Bn, dimethyl) using 
[IrCp*Cl2]2 as catalyst end Cs2CO3 as base (Scheme 34).
 39  
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Scheme 34  Selective C3-Alkylation of Indoles with N-Protected Ethanolamines Involving the 
“Borrowing Hydrogen” 
 
Since oxindole showns a pKa value of 18.2, and it is an interesting methylene active 
compound, has been exploited as nucleophile by Madsen. The use of RuCl3 · H2O, 
PPh3, and NaOH has been proved as a very effective catalytic system for the site 
selective mono 3-alkylation of unprotected and protected oxindoles with a range of 
aromatic, heteroaromatic, and aliphatic alcohols (Scheme 35).40  
 
Scheme 35 Selective C3 alkylation o oxindoles with different alcohols. 
 
Other interesting nucleophiles are ketones, as they are nucleophile in C2 and they 
undergo to indirect -alkylation with alcohols via borrowing hydrogen following the 
aldol reaction pathway as depicted in (Scheme 36). 
 
Scheme 36 Oxidation/ Aldol Condensation/ Reduction Pathway. 
 
In this reaction, the intermediate is the -unsaturated ketone, that can be 
transformed either in statured ketone or in the complete reduced form (alcohol) using 
an additional source of hydrogen or a high amount of alcohol (hydrogen source). For 
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example, ruthenium-catalyzed borrowing hydrogen of ketones and primary alcohols 
involving carbon-carbon bond formation has been developed by Cho and co-workers, 
acetophenone was alkylated with benzyl alcohol and butanol to obtain the 
correspondent alcohol, this when 3 equivalents of alcohol are used (Scheme 37).41  
 
 
Scheme 37 Alkylation of Acetophenone with Benzylic Alcohol and Butanol. 
 
The same ruthenium catalyst allows the formation of the correspondent carbonyl 
compound when only one equivalent of alcohol is used in a presence of dodecane as 
hydrogen acceptor (Scheme 38).42  
 
 
Scheme 38 Alkylation of Acetophenone with Benzylic Alcohol. 
 
Yus and co-workers used a related approach employing a catalyst system based on 
ruthenium, employing 1 equivalent of alcohol is possible to obtain the final product 
as alcohol while exploiting the same catalyst system in presence of 2 equivalents of 
alcohol and a triphenylphosphine the ketone was obtained (Scheme 39).43 
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Scheme 39 -Alkylation and Formation of Relative Ketone and Alcohol. 
 
A one pot procedure was used by Nishibayashi to perform the condensation of an 
alcohol and a ketone in asymmetric way, where after the activation of alcohol 
operated by [Ir(COD)Cl]2 and subsequent aldol reaction the reduction of -
unsaturated intermediate is operated by an asymmetric complex of ruthenium 
(Scheme 40).44 
 
 
Scheme 40 Asymmetric Alkylation of Ketone with Alcohols.  
 
More recently asymmetric tandem α-alkylation via borrowing hydrogen of 
acetophenone with primary alcohols was demonstrated using ruthenium and 
enantioenriched amino acid as chiral ligand (Scheme 41).45  
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Scheme 41 Tandem α-Alkylation of Acetophenone with Primary Alcohols, and Relative Schematic 
Mechanism. 
 
Finally, as methylene active nucleophile nitro alkane has been employed by Williams 
in nitro aldol reaction in the context of hydrogen borrowing with alcohols as 
electrophiles (Scheme 42).  
 
 
Scheme 42 Indirect Nitro Aldol Reaction via Borrowing Hydrogen. 
 
Still in the realm of enantioselective formation of C-C bond with the borrowing 
hydrogen strategy, enzymes were used as catalyst. -cyano-ketones were alkylated 
with different alcohols in the presence of Baker’s Yeast or C. Lunata as enzyme. In 
this biocatalysis example, the followed pathway is the borrowing hydrogen process 
(Scheme 43). 
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Scheme 43 Biocatalysis example of Borrowing Hydrogen. 
 
-alkylation of Alcohols: When carbonyls compounds are formed transiently form 
alcohols they can undergo to enol-enolate chemistry as shown in (Scheme 44). 
 
 
Scheme 44 - Functionalization of Alcohol via Borrowing Hydrogen. 
 
In this reaction, different electrophiles can be employed, if the electrophile is a 
carbonyl compound, it can be directly added as regent in the reaction or can be 
formed in situ from another alcohol. Another possibility is that the initial alcohol can 
react with itself according to a Geurbet aldol pathway (Scheme 45).  
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Scheme 45 Guerbet Product Formation 
 
Considering the reaction stoichiometry during an alcohol-alcohol coupling the 
product is an alcohol, except when the hydrogen is transferred to another spices or is 
liberated in atmosphere, otherwise results in -unsaturated carbonyl. While 
carbonyl and alcohol react together is possible to obtain an alcohol or a carbonyl, 
based on the amount of alcohol (hydrogen donor). In particular in the presence of an 
excess of alcohol (hydrogen donor) is possible to reduce the intermediate -
unsaturated carbonyl all the way down to alcohol. Examples of the aforementioned 
chemistry follow. Indirect -bromination of alcohol has been presented by Williams, 
using aluminium alkoxide as catalyst and pyridinium tribromide as brominating 
agent. The reaction via temporary oxidation of the alcohol to a ketone, giving the -
brominated product in good yield (Scheme 46).46 
 
 
Scheme 46 Indirect Bromination of Alcohol via Borrowing Hydrogen Activation. 
 
Self-condensation of alcohol (Guerbet Reaction) of primary alcohols leading to -
alkylated dimer alcohols catalyzed by iridium complexes has been reported by Ishii 
in good yields (Scheme 47).47 
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Scheme 47 Guerbet Reaction of Primary Alcohols. 
 
Two alcohols can react together forming a new C-C bond, usually a primary alcohol 
and a secondary alcohol are coupled. From a mechanistic point of view, both alcohols 
are oxidized to the correspondent carbonyl compounds (ketone, and aldehyde). These 
react together in aldol condensation giving an -unsaturated ketone, which 
undergoes reduction to give the saturated corresponding alcohol (Scheme 48).  
 
 
Scheme 48 General Mechanism for Alcohol Indirect Aldol Condensation. 
 
For example, butanol and methanol has been proved to react together employing 
different catalyst systems producing isobutyl alcohol. Ru(PPh3)3Cl2 has been used for 
the coupling of a secondary alcohol with primary alcohols, using1-dodecene as 
hydrogen source. Yamguchi for the same reaction has reported a different catalyst 
system, based on iridium, enhancing the yield (Scheme 49). 
 
 
 29 
 
 
Scheme 49 Examples of Alcohol-Alcohol Coupling.  
 
As extension in the C-C bond formation, we can consider the functionalization of 
allylic alcohol, as they can be considered as homo version -functionalization of 
alcohols. Quintard and Rodriguez reported a dual catalyst system based on iron 
catalyst and an organocatalysts, for the enantioselective functionalization of allylic 
alcohol with Keto-ester as nucleophile (Scheme 50). 48 
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Scheme 50 Enantioselective Addition of Ketoester to Allylic Alcohols, and Relative Concept of 
Dual Catalysis.  
 
Interestingly, the chiral linear alcohols obtained in this transformation are in 
equilibrium with the closed lactol form. Building on this initial report, the same team 
reported the use of the same catalytic system for diketones instead of ketoesters 
leading directly to a linear 3-alkyl-pentanol scaffolds.49 This dual catalyst system 
allows the preparation of important synthetic intermediates that otherwise require 
long and tedious synthesis (Scheme 51).50 
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Scheme 51 Dual Catalysis: Enantioselective Addition of Diketones to Allylic Alcohols.  
 
1.4.3 Consecutive C-C, C-N bond formation. 
 
In the field of borrowing hydrogen, the last past year’s investigations have focused on 
the development of new catalytic systems more and more efficient with the goal to 
reach mild condition and low catalyst loading for the formation of C-C and C-N 
bonds. More recently considering the raising interest in the construction of complex 
structure motif in the most efficient  possible way, and the interest in the formation of 
N-containing heterocycle due to their relevance from a medicinal point of view, the 
focus of borrowing hydrogen is addressed to the synthesis of sustainable consecutive 
formation of C-C and C-N bond for the preparation of N-heterocycles and more 
general to the combination of C-C and C-N bond formation in one pot process51.  
Kempe and Co Worker reported the use of a PNP-type iridium-based catalyst for an 
efficient synthesis of pyrroles. They presented the formation of several substituted 
pyrroles, in particular: the formation of 2,5 and 2,3,5 di-and tri-substituted pyrroles, 
bicyclic pyrroles from cyclic secondary alcohols, dipyrroles from diols, and 
substituted pyrroles form amines and diols (Scheme 52).52  
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Scheme 52 Synthesis of Pyrroles via Borrowing Hydrogen. 
 
Soon after Milstein presented another efficient, atom-economical, one-step synthesis 
of pyrroles, based on dehydrogenative coupling of -aminoalcohols with secondary 
alcohols, catalyzed by a ruthenium pincer catalyst. Alfa amino aldehyde is generated 
from the corresponding -aminoalcohols, and the ketone is generated from the 
secondary alcohol, these two activated species can undergo to coupling to form the 
correspondent pyrroles in the presence of base. Therefore, formation of pyrroles 
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through selective and consecutive C-C and C-N bond formations take place (Scheme 
53) .53 
 
 
Scheme 53 Ruthenium Catalyzed Pyrroles Synthesis via Browning Hydrogen. 
 
Saito reported the direct formation of pyrroles form 1, 2 amino alcohols and ketones 
instead useing the secondary alcohols as above described by Milstein, employing a 
ruthenium catalyst. In his work Saito demonstrated the preparation of 2, 5 and 2, 3, 5 
di-and tri-substituted pyrroles and the synthesis of the core pyrrole of Lipitor 
(Scheme 54).54 
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Scheme 54 Saito Strategy for the Synthesis of Diverse Substituted Pyrroles via Borrowing 
Hydrogen. 
 
In the panorama of one pot multiple formation, an extra example outside the C-C and 
C-N bond follows. Beller reported the enantioselective synthesis of oxazolidin-2-ones 
from urea and diols.  The synthesis of this heterocycle experiences the sequential 
formation of two different C-O and C-N bonds, in a domino process consisting of 
nucleophilic substitution and alcohol amination (Scheme 55).55 
 35 
 
 
Scheme 55 Ruthenium-Catalyzed Synthesis of Oxazolidin-2-ones from Urea and Vicinal Diols. 
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2. Aim of the Thesis   
 
The work presented in this thesis is focused on the use of alcohol as green alkylating 
agents to develop novel synthetic routes using borrowing hydrogen methodology to 
synthesize small molecules and biologically active natural products. Initially, based 
on the recently reported protocol for the direct Ir-catalyzed alkylation of indoles with 
N-substituted ethanolamines (Scheme 1),37 the synthesis of substituted tryptamine 
derivatives starting from indoles and amino alcohols via the borrowing hydrogen 
process were considered. / Initially was considered the synthesis of substituted 
tryptamine derivatives starting from indoles and amino alcohols via the borrowing 
hydrogen process based on the recently reported protocol for the direct Ir-catalyzed 
alkylation of indoles with N-substituted ethanolamines (Scheme 1).37 
 
 
 
Scheme 1 C3-Alkylation of Indoles with N-substituted Tryptamine.  
 
Tryptamine is commercially available through a variety of suppliers; however, when 
the indole ring of tryptamine is functionally substituted, the commercial availability 
of the resulting derivatives decreases while their cost increases, especially with 4 or 
6-substituted tryptamine derivatives. Tryptamine motif occurs in a wide range of 
biologically active molecules, pharmaceuticals and naturally occurring compounds, 
such as those outlined in (Figure 1). 
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Figure 1 Synthesis of Biologically Interesting Tryptamine. 
 
Tryptamine derivatives have attracted comprehensive and continuous interest from 
the chemical community.56 Moreover, tryptamine represent the basis for some 
condensed ring alkaloids, and it is a key starting building block for many intents and 
purposes, such as the total synthesis of polycyclic tryptamine-derived indole 
alkaloids.57 Simple synthetic approaches tryptamine derivatives are highly desirable 
considering their practical importance and because they avoid the lees sustainable 
approach.58 For this purpose efficient formation via borrowing hydrogen of N-acetyl-
protected branched tryptamines and homotryptamine derivatives, as well as N-
methylated tryptamine cores of biological importance such as psilocin, bufotenin and 
serotonin, were taken in consideration. 
 
 
Scheme 2 Synthesis of Tryptamine Derivatives by the Use of Borrowing Hydrogen Method. 
Further oxindole, another scaffold that characterizes a large number of natural59 and 
synthetic compounds with important biological activities,60 will be explored in order 
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to show the importance and versatility of ethanolamines as alkylating agents in a 
different context and the power of iridium catalyst system already developed. 
Oxindoles have a wide range of applications and they show an extensive range of 
biological effects. Moreover, the biological activity of the oxindoles and their 
derivatives has made them very important in synthetic organic and medicinal 
chemistry. These characteristics of oxindoles prompt chemist to provide various 
applications of oxindoles and their derivatives. In particular using the already 
developed iridium catalyst37 it has been planned to present a divergent synthesis 
employing diversely substituted oxindoles: when N-acetyl-ethanolamine is used the 
C3-alkylation via borrowing hydrogen methodology has been expected, alternatively 
when N-benzyl ethanolamine is used a sequential/domino process, consisting of 
alkylation and transamidation processes, should took place providing α-substituted γ-
lactams. When N-aryl oxindoles will be employed with N-benzyl ethanolamine, 
substituted diarylamines could be obtained, which represent an important class of 
compounds due to their wide applications and special pharmacological activities 
(Scheme 3).61 
 
 
Scheme 3 Divergent Borrowing Hydrogen Approach from Oxindoles end Ethanolamines: Synthesis 
of C3-Substituted Oxindoles and Substituted Diarylamines. 
 
Though, in terms of sustainability, the use of precious transition metals should be 
substituted by more eco-friendly, inexpensive and earth-abundant metals. Among 
these metals, iron attracts significant attention and is considered as a valuable 
alternative.62 In the last decades, iron catalysts have increasingly been used in organic 
synthesis in a number of reactions.63 Feringa and Barta, Wills and Zhao have reported 
the alkylation of primary amines with alcohols to give secondary and tertiary amines 
by utilizing iron catalysts featuring functionalized cyclopentadienone or hydroxy 
cyclopentadienyl ligands based on Knölker’s complex or derivatives thereof.64 
However, the borrowing hydrogen methodology using iron with alcohol in C-C- bond 
formation has been reported in few publications.65 Therefore, the focus was placed on 
the search for an iron catalyst able to afford the selective iron C3-alkylation of 
indoles with different substituted benzylic alcohol. After a search for a suitable 
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catalyst system based on a commercial available iron complex, the reaction scope 
will be tested with different substituted primary and secondary benzyl alcohol and 
eterobenzylic alchol (Scheme 4).   
 
 
Scheme 4 Iron Catalyzed Direct C3-Benzylation of Indoles with Benzyl Alcohols. 
 
Mechanistic studies were expected to ensure that the catalytic process involves the 
borrowing hydrogen mechanism. 
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3. Results and Discussion 
 
3.1 Observations concerning the synthesis of tryptamine homologues and 
branched tryptamine derivatives via the borrowing hydrogen process: synthesis 
of psilocin, bufotenin, and serotonin. 
 
Initial studies were carried out using N-acetyl-protected propanolamine (2a) and 
butanolamine (2b) as representative suitable three-carbon and four-carbon nitrogen-
containing electrophiles. Pleasingly, complete indole consumption and good yields of 
homotryptamine (3a) and dihomotryptamine (3b) were observed after 48 h at 150°C 
when powdered Cs2CO3 was used as the base and [Cp*IrCl2]2 was used as the 
catalyst (Table 1, entries 1 and 2). We succeeded in carrying out the alkylation 
reaction even with longer carbon chain N-acetylated primary amino alcohols; for 
example, using (2c), (3c) has isolated in modest yield (Table 1, entry 3). 
 
 
Entry N-Acetylamino Alcohol Product Yield (%)b 
1 
 
 
54 
2 
 
 
76 
3 
 
 
57 
aReactions were carried out in a sealed vial at 150 °C for 48 h with indole (1 equiv.), N-
acetylamino alcohol (3 equiv.), [Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1 equiv.). 
bIsolated yield. 
 41 
 
Table 1 Synthesis of N-Actyltryptamine Homologuesa. 
Lower conversions and increased byproduct formation were generally observed when 
solvents such as toulene, tert-amylalcohol, and trifluoroethanol were employed. Apart 
from tryptamine analogues and homologues with linear side chains, derivatives with 
branched side chains, both in the - and -positions, are becoming increasingly 
studied in medicinal chemistry due to their ability to discriminate between the 
serotonin/melatonin receptor family subtypes. Recently, the first examples of 
branched tryptamines possessing pharmacologically interesting properties have been 
developed.66 Thus, we then turned our attention to more sophisticated substituted N-
acetylethanol-amines, such as the homochiral primary N-acetyl-L-alaninol (4a) and 
N-acetyl-L-serine (4b), knowing their sensitivity toward racemization, once oxidised 
to the transient aldehyde. Interestingly, the methyl-substituted amino alcohol 
derivative (4a) performed poorly in this reaction, possibly due to the increased steric 
hindrance around the nitrogen atom that precludes effective ligand dissociation from 
the iridium centre. Notably, we did not observe any products that could arise from the 
potentially competitive four- membered ring cycloiridation pathway. Strong electron- 
withdrawing groups adjacent to the amine motif also failed to produce the desired 
product tryptophans in acceptable yields. In addition, the small amounts of products 
(5a) and (5b) obtained were racemic, as expected (Table 2, entries 1 and 2). A 
different outcome was obtained when we examined the applicability of the borrowing 
hydrogen reaction of indoles with racemic secondary N-acetyl ethanolamines, which 
proceeds via generally less electrophilic ketones (Table 2, entries 3 and 4). Therefore, 
we elected to examine the behaviour of indole in a borrowing hydrogen alkylation 
with N-acetyl-2-propanolamine (4c) and 2-acetamido-1-phenylethanol (4d). We 
found that iridium- catalyzed indole alkylation with branched alcohol (4c) afforded a 
superior yield to the parent linear congeners, and we ascribe this reactivity to the 
relatively lower energetic demand of secondary alcohol dehydrogenation compared to 
primary alcohols, as well as the faster elimination of water from the adduct-formed 
alcohol- containing products of ketone addition. Unsatisfactory results were obtained 
when chiral Ir complexes and/or chiral ligands were employed to attempt an 
enantioselective version of this approach, although good yields were confirmed.67 On 
the contrary, the secondary alcohol (4d) gave a complex mixture of unidentified 
compounds, containing only trace quantities of a compound identified as the desired 
protected tryptamine by LC/MS. This latter result was quite surprising because 
secondary benzyl alcohols are known to be good substrates in redox-neutral 
alkylations, reflecting their more favourable oxidation relative to higher alcohols68. 
Therefore, we suspected that the initial alcohol oxidation step had occurred but that 
alternative pathways (aldol-type reactions) prevented condensation (the resulting 
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conjugated ketone is notably less electrophilic) and the return of the hydrogen back to 
the desired indolenium intermediate, thus stalling the reaction. 
 
 
 
 
 
 
 
 
Entry Amino alcohol Product Yield (%)b 
1 
 
 
37 
2 
 
 
15 
3 
 
 
78 
4 
 
 
Traces 
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5 
 
 
72 
aReactions were carried out in a sealed vial at 150 °C for 48 h with indole (1 equiv.), amino alcohol (3 equiv.), 
[Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1 equiv.). 
bIsolated yield. 
Table 2 Synthesis of α- and β-branched tryptamines and branched homotryptamines from indole 
and amino alcohols.a 
 
To confirm this hypothesis, we tested the viability of N-methyl-4-piperidinol (4e) as a 
secondary alcoholic substrate for hydrogen borrowing alkylation with indole, which 
allowed us to extend the methodology to branched homotryptamines (Table 2, entry 
5). The reaction of indole with piperidine alcohol (4) under the same reaction 
conditions gave a good yield of 3-(N-methylpiperidyl) indole (5e), which is an 
important structural element of clinical candidates such as the antimigraine 
compound LY334370 and naratriptan (Fig. 1).69 Since most indole-based central 
nervous system drugs used in the treatment of migraines and cluster headaches, as 
well as some psychoactive natural product tryptamines, are tryptamine-based 
dimethylated amines,70 we used the commercially available and highly interesting 
amino alcohol N,N-dimethylethanolamine (7a) to further demonstrate the application 
of this methodology. We adopted this chemistry for the total syntheses of psilocin 
and bufotenin in a straightforward manner (Table 3). Thus, the reaction of known 4-
benzyloxyindole (6a) and 5-benzyloxyindole (6b) with N,N-dimethylethanolamine 
(7a) provided the desired products, which were debenzylated under hydrogenolysis 
conditions to afford psilocin and bufotenin in 61% and 67% overall yields, 
respectively. The salient features of this method include the single step preparation of 
the tryptamine core through displacement of the alcohol without the need for prior 
activation and without resorting to a high dilution or the use of a protected amine or 
final reductive alkylation for the tertiary amine. Among the biologically important 
hydroxytryptamines, serotonin is perhaps the most important and best known as a 
neurotransmitter that modulates neural activity and a wide range of 
neuropsychological processes.71 Despite the fact that several syntheses and 
biosynthesis of serotonin have been described,72 none seem practical or economical; 
thus, serotonin is still quite expensive on the market. Using our procedure of treating 
5-benzyloxyindole with N-benzylethanolamine under Ir-catalyzed borrowing 
hydrogen conditions, followed by double debenzylation by catalytic reduction with 
palladium on carbon as the catalyst, serotonin was obtained in good overall yield. 
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Entry R1 N-Akylamino alcohol Product Yield (%)b 
1 4-OBn 
 
 
61 
2 5-OBn 
 
 
67 
3 5-OBn 
 
 
62 
aReactions were carried out in a sealed vial at 150 °C for 48 h with indole (1 equiv.), N-alkylamino 
alcohol (3 equiv.), [Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1 equiv.), followed by hydrogenolysis with 
NH4HCO2 (4.5 equiv.) and Pd/C (10%) in MeOH at 70 °C for 45 min. bIsolated overall yield. 
Table 3 Syntheses of psilocin, bufotenin, and serotonin from N-alkylated                                                                     
ethanolaminesa 
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3.2 Divergent Borrowing Hydrogen Approach from Oxindoles and 
Ethanolamine: Synthesis of C3-Substituted Oxindoles and -Lactams. 
 
Herein, we describe a convenient iridium-catalyzed process for the alkylation of 2-
oxindoles with ethanolamines. The studies began with the investigation of the direct 
C3 catalytic alkylation of oxindole (1) with two aminoles (2) and (3). As catalytic 
system we used the commercially available trivalent iridium complex [Cp*IrCl2]2 in 
the conditions previously developed in our laboratories.37 Essentially, we found that 
when the N-acetyl ethanolamine (2) reacts with oxindole (1) a direct alkylation of C-
3 occurs giving the oxindole ethyl acetamide (4) in 61% yield. Unexpected result was 
obtained with aminol (3). Instead, to obtain the simply alkylated oxindoles in C-3, -
substituted -lactam (5) was formed in 54% yield (Scheme 1).  
 
 
Scheme 1 Divergent Reaction of Oxindoles with Ethanolamines Via Borrowing Hydrogen. 
 
Therefore, we speculate on a possible pathway for the formation of -substituted -
lactam. Sequential/domino process consisting of alkylation and intramolecular 
secondary amide transamidation process could take place as shown in (Figure 1). 
 
 
Figure 1 Proposed Opening Ring Mechanism. 
 
We can justify the different behaviour of ethanolamines considering the different 
availability of the lone pair on the ethanolamines nitrogen atom. In the case of the 
ethanolamine (2), the lone pair is delocalized due to the resonance with the acetyl 
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group resulting not enough nucleophilic to give the intermolecular 
addition/elimination.  Instead, ethanolamine (3) have a strong nucleophilic nitrogen 
and could give the intramolecular addition/elimination on the carbonyl of oxindole 
(1). After this finding, we have extended the scope of this divergent reaction studying 
different substituted oxindoles. First, we investigated the reactivity of N-acetyl 
ethanolamine (2), with different substituted 2-oxindoles (Table 1). Through the 
treatment of 2-oxindoles (6), (8), (10) end (12) with N-acetylethanolamine (2) under 
the above-mentioned conditions, C3-amidoethyl oxindoles (7), (9), (11) and (13) 
were selectively achieved in 54–88% yield (Table 1, entries 1–4).73 High yields were 
also achieved using N-methyl and N-phenyloxindoles (14) and (16) (Table 1, entries 
5–6). Given the enormous effort that has already been dedicated to the catalytic 
asymmetric construction of oxindoles bearing a C3-quaternary stereocenter from 
simple C3-monoalkylated oxindoles,74 which are then often converted into 2-oxindole 
containing a 2-aminoethyl side chain (and subsequently cyclized under reductive 
conditions to generate the tricyclic pyrrolidinoindoline ring system), the C3-
amidoethylated 2-oxindoles (7), (9), (11), (13), (15), and (17) can be considered as 
advanced starting materials for the more direct asymmetric synthesis of enantio-
enriched 3,3-disubstituted oxindoles and some related natural products/drug 
candidates. Furthermore in this series, compound (4) can be readily converted to the 
natural product (±)-N-[2-(3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-
yl)ethyl]acetamide, which is an antiproliferative compound from Selaginella 
pulvinata, using a previously developed cobalt-catalyzed peroxidation reaction with 
hydroperoxide and a hydrogenation reaction,75 whereas 2-oxo-2,3-dihydromelatonin 
(9), an oxidized analog of the neurohormone melatonin, is a valuable precursor for 2-
substituted melatonin.76  
 
 
 
 
 
 
Entry Substrate Product Yield (%)b 
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1 
  
57 
2 
 
 
54 
3 
 
 
70 
4 
 
 
88 
5 
 
 
99 
6 
 
 
54 
aReactions were carried out in a sealed vial at 150 °C for 24 h with oxindole (1 equiv.), 
N-Ac ethanolamine (3 equiv.), [Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1) equivalent 
bIsolated yield. 
Table 1 Scope for the Direct C3-Alkylation of Substituted Oxindoles 
respect to Acetyl ethanolaminea. 
Then we investigated the reactivity of N-benzylethanolamine (3) with different 
substituted oxindoles (Table 2). In particular, this method was compatible with 
modification of the benzyl moiety of the 2-oxindole core, and substitution (e.g., Cl, 
OMe, and Me) was readily tolerated on the aromatic ring (Table 2, entries 1–6). 
Finally, we studied the domino alkylation/annulation of N-substituted 2-oxindoles 
such as N-methyl and N-phenyl oxindole (14, 16) with N-benzylethanolamine (3), 
and a decent yield was achieved with substrate 16 to afford ortho-substituted 
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diarylaniline 28 (Table 2, entry 8). Importantly, the diarylamine products of the type 
generated from the reactions described herein are highly valued motifs with important 
structural, electronic, and mechanical properties suitable for therapeutic applications. 
In addition, the amide of the γ-lactams can be cleaved to provide access to a variety 
of 2-(2-phenylamino)phenyl)ethanoic acid nonsteroidal anti-inflammatory agent 
derivatives, such as Lumiracoxib and Diclofenac.59  
 
 
Entry Substrate Product Yield (%)b 
1 
  
37 
2 
  
42 
3 
  
35 
4 
  
48 
5 
  
46 
6 
  
72 
7 
  
35 
 49 
 
8 
 
 
68 
aReactions were carried out in a sealed vial at 150 °C for 24 h with indole (1 equiv.), N-
Benzyl ethanolamine (3 equiv.), [Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1) equivalent 
bIsolated yield. 
Table 2 Scope for the Direct C3-Alkylation of Substituted Oxindoles 
respect to Benzyl ethanolaminea. 
 
Since the importance of pharmaceutical and biological activity of the diaryl amines, 
obtained with the strategy described above, where oxindoles are N-substituted with 
aril group, we extended and explore more structure with different substitution on aryl 
and heteroaryl group (Table 3).  
 
 
Entry Substrate Product Yield (%)b 
1 
 
 
69 
2 
 
 
64 
 50 
 
3 
 
 
60 
4 
 
 
49 
5 
 
 
70 
aReactions were carried out in a sealed vial at 150 °C for 24 h with indole (1 equiv.), N-
Acetyl ethanolamine (3 equiv.), [Cp*IrCl2]2 (2.5 mol%), and Cs2CO3 (1.1) equivalent 
bIsolated yield. 
Table 3 Scope for the Direct C3-Alkylation of N-Aryl Substituted 
Oxindoles respect to Benzyl ethanolaminea. 
. 
Transformations of N-aryloxindoles bearing a halogen atom, such as fluorine (29), 
afforded the corresponding product 30 in 69% yield (Table 3, entry 1). For N-
aryloxindoles bearing an even stronger electron-withdrawing substituent, such as 
pyridil (36, 38), the reaction proceeded smoothly to afford the desired products 37, 39 
in 49% and 70% yield, respectively (Table 3, entries 4, 5). Furthermore, when the 
alkylation/annulation was applied to N-aryloxindoles bearing an electron-donating 
substituent, such as a methoxy or dimethylamine group (31, 33), the corresponding 
products 32, 35 were afforded in 64% and 60% yield, respectively (Table 3, entries 2, 
3). 
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3.3 Iron-Catalyzed Direct C3-Benzylaion of Indoles with Benzyl Alcohols 
through Borrowing Hydrogen 
Inspired by the recent studies to use the metals of first row as catalysts, we report 
herein a green, economical, and efficient iron-catalyzed C3-selective alkylation of 
indole. This reaction employs iron(II) phthalocyanine (Fe(II)Pc), an inexpensive 
commercially available compound that is typically used as an industrial additive for 
ink as well as photonic and optical material manufacturing. Of note, to date, Fe(II)Pc 
complexes have not been applied as catalysts for the formation of new carbon−carbon 
bonds via the borrowing hydrogen process.77 The reaction of unsubstituted indole 
(1a) with benzyl alcohol (2a) was selected as the model reaction to establish the best 
reaction conditions. Initially, the effect of various iron based catalysts was 
investigated (Table 1).  
 
 
Entrya Catalyst Yield of 3b (%) 
1 - - 
2 FeSO4 c - 
3 FeCl2d - 
4 Fe(acac)3 - 
5 Fe(II)Pc 99 
6 Fe(II)Pc e 8 
7 Fe(II)Pc f Trace 
8 Fe-Knölker - 
9 Fe-Knölker with PPh3 - 
10 Fe-Knölker with Me3NO - 
11 Fe(II)Pc in the dark 97 
12 Fe(II)Pc with BHT 98 
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aReaction conditions: indole (0.5 mmol), benzyl alcohol (1 mmol), Cs2CO3 (0.55 mmol), catalyst (1 mol%) at 140 °C 
for 16 h. bIsolated yield. cOnly 4 was isolated in 13% yield.  dOnly 4 was isolated in 21% yield eCs2CO3 (0.05 mmol). 
fWithout base. 
 
Table 1 Optimization of the Reaction Conditions for C3-Alkylation of Indole with Benzyl Alcohol. 
The reaction did not proceed without catalyst in the presence of Cs2CO3, which 
excluded the contribution of the base itself as a catalyst (Table 1, entry 1).78 The 
highest activity was observed with Fe(II)Pc and a stoichiometric amount of Cs2CO3 
(Table 1, entries 5−7). Other iron salts were found to be ineffective and, not 
surprisingly, led to the formation of bis(indolyl)methane (4) in poor yields (Table 1, 
entries 2−4).79 Due to its inherent redox properties, the iron(0)tricarbonyl complex 
such as the Knölker-type catalyst is widely known to activate inert substrates via 
dehydrogenation/hydrogenation reactions and has been reported previously for C−C 
bond formation.80 Neither alone (Table 1, entry 8) nor in the presence of 10 mol % 
Me3NO oxidant (to form active catalyst) and PPh3 ligand did the alkylated product 
form (Table 1, entries 9 and 10). This solvent-free reaction with Fe(II)Pc as the 
catalyst was excellent in terms of both yield and selectivity as compared with the 
corresponding reaction in toluene (1.0 M, 54% yield; 0.5 M, 10% yield) or tert-amyl 
alcohol (at reflux under air atmosphere for 16 h afforded the desired alkylated 
product 3a in 31% yield). The desired coupling product was also obtained in the 
absence of light as well as in the presence of radical scavengers such butylated 
hydroxytoluene (BHT), thus discarding the involvement of radical species in the 
reaction pathway, more precisely using TEMPO as a radical scavenger, only 
oxidative degradation of indole was observed. (Table 1, entries 11 and 12). Once the 
optimal reaction conditions were achieved, we examined the scope of the alkylation 
with respect to alcohols catalyzed by Fe(II)Pc, and these results are outlined in 
(Table2). 
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a Reaction conditions: indole (0.5 mmol), alcohol (1 mmol), Cs2CO3 (0.55 mmol), Fe(II)Pc (0.055 mmol) at 140 °C for 
16 h. bIndole (1mmol), alcohol (0.5 mmol). c1H-indole (0.5 mmol), 6-fluoro-1H-indole (0.5 mm0l), 2-
(hydroxymethyl)phenol (0.5 mmol). d 140 °C for 36h. 
Table 2 Scope of C3-Alkylation of Indole with Benzyl Alcohola 
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The C3-alkylation of indole with primary benzylic alcohols bearing an electron-
donating substituent such as methyl, phenyl, and methoxy groups afforded the 
corresponding products (3b−f) in 46−98% yields. Also, (2-aminophenyl)- methanol 
and 2-(hydroxymethyl)phenol provided the products (3g−h) in good yield, 56% and 
42%, respectively. Similarly, electronically deactivated benzylic alcohols, which are 
very poor substrates in Lewis- or Brønsted acid-catalyzed Friedel−Crafts reactions81, 
bearing an electron-withdrawing group such as chloro, fluoro, cyano and 
trifluoromethyl groups were converted to the desired products (3i−m) in 37−71% 
yields. A trisubstituted benzyl alcohol, such as 3,4,5-trimethoxybenzyl alcohol, was 
successfully transformed to 3-(3,4,5-trimethox- ybenzyl)-1H-indole in 62% yield. A 
naphthyl alcohol (naphthalen-2-ylmethanol), (3,5-dichlorophenyl)methanol, and 
benzo[1,3]dioxonyl were converted to give the corresponding alkylated indole 
products (3o−q) in good yields. Heteroaromatic alcohols with furanyl and thienyl 
groups were also tolerated, and the corresponding indoles (3r−s) were obtained in 
95% and 78% yields, respectively. This reaction sequence was demonstrated for the 
preparation of symmetrical bisindole compound (3t), whereby indole, used in excess, 
was double alkylated with 1,3-phenylenedimethanol through a one-pot process in 
satisfactory yield. Moreover, sequential functionalization of diols is undoubtedly a 
valuable synthetic tool to obtain compounds with great diversity. We explored a 
selective iron-catalyzed method that allows for the preparation of nonsymmetrical, 
functionalized bisindoles. This reaction sequence was demonstrated for the 
preparation of compound (3u), whereby 1,3-phenylenedimethanol was selectively 
monoalkylated with indole to form (3-((1H-indol-3-yl)methyl)phenyl)methanol and 
subsequently treated with 6-fluoroindole to provide (3u). Next, secondary benzylic 
alcohols, which are less prone to the condensation and hydrogenation step in 
comparison to primary ones, were used as the substrate. 1-Phenylethanol, 
diphenylmethanol, and 2-acetamido-1-phenylethanol reacted smoothly with indole, 
and the corresponding products (3v−x) were obtained in moderate to good yields. 
When cinnamyl alcohol was utilized, the desired product was obtained in poor yield 
due to large contamination of saturated derivatives; whereas with aliphatic alcohols 
such as cyclo- hexanol, cyclopropyl methanol, and 1-octanol, the reaction failed. 
Next, we examined some representative substituted indoles to explore the generality 
of this novel reaction. For example, the electron-rich and sterically hindered 4-
methoxyindole was converted to the desired product (3x) in a very good yield and 
selectivity. The 6-methyl-, 5-fluoro-, and 6-chloroindole- benzylated derivatives (3z) 
and (3aa−3ab) were also obtained in decent yields, although the yields were lower 
than those of the 4-OMe analogue. Pleasingly, the presence of a substituent at C2 did 
not influence the reaction, despite the potential steric crowding around the reaction 
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site. Thus, 2-phenylindole reacted efficiently with benzyl alcohol to give the 
corresponding product (3ac). Not surprisingly, N-methylindole proved to be inert, 
suggesting the involvement of the indole N−H in a key interaction with the base 
during the rate-determining step. However, nearly complete recovery of the starting 
material was observed when C3-substituted indole, such as 3-methyl or 3- 
benzylindole, was allowed to react with benzyl alcohol under the reaction conditions 
reported above. Neither dearomatization of the indole nucleus to 3-benzylindolenine 
products nor C3- to C2-benzyl migration and rearomatization to afford 2,3- 
disubstituted indoles were detected, in spite of recent reports.82 To highlight the 
synthetic utility of the present protocol, a gram-scale reaction with indole (1a) and 
benzylic alcohol (2a) was performed, and the efficiency of the small-scale reaction 
was retained upon scale-up, delivering 3a in 92% yield. To obtain insight into the 
reaction mechanism of the catalytic process, other experiments were carried out, thus 
providing significant evidence for a plausible borrowing hydrogen mechanism rather 
than a general acidic strategy involving the formation of a stabilized benzylic cation. 
The reaction of indole with benzyl bromide (2 equiv.) under the optimized reaction 
conditions gave a mixture of 1-benzyl-1H- indole (45%) and 1,3-dibenzyl-1H-indole 
(28%). Then, we repeated the reaction using triphenylmethanol, and the starting 
unchanged indole was recovered, which is another indirect proof that the cationic 
benzyl intermediate is not involved. When benzylic alcohol was heated in the 
presence of Fe(II)Pc and cesium carbonate at 140 °C in a sealed tube for 16 h, 
formation of a small amount of benzaldehyde (11% according to GC-analysis of the 
crude mixture) was observed. Finally, the competitive reaction of indole with 
benzaldehyde and (4-methoxyphenyl)methanol (Scheme 2) gave a mixture 6:1 of 3- 
benzylated compounds (based on 1H NMR spectra), in which the main product was 
that arising from the condensation with benzaldehyde followed by reduction of 
benzylideneindolenine (obviously, large formation of p-methoxybenzaldehyde was 
also observed).  
 
 
 
Scheme 2 Competitive Experiment between an Aldehyde and an Alcohol. 
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All of these data together with the presence of bisindole side product 4, obtainable 
only in the presence of aldehyde in the reaction mixture, and the good yields obtained 
with electron poor benzylic alcohols (compounds 3l, 3m) are confirming our initial 
borrowing hydrogen mechanistic hypothesis. 
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4. Conclusions 
 
In summary during my research project, I extended the selective indole alkylation 
reaction using [Cp*IrCl2]2 catalyzed-borrowing hydrogen methodology
37 for the 
synthesis of novel branched and nonbranched tryptamines and tryptamine 
homologues using amino alcohols as suitable nitrogen-containing electrophiles. In 
addition, the short alternative and expedient syntheses of psilocin, bufotenin and 
serotonin were achieved by employing this chemistry. The subtle factors influencing 
the competing pathways in the critical borrowing hydrogen reaction of indoles with 
complex amino alcohols,83 as well as some limitations on the broad applicability of 
the chemistry, were discussed. Nevertheless, encouraged by some key examples of 
this methodology, I believe that it has the potential to deliver improved processes for 
pharmaceutical manufacturing. This catalytic and modular approach tolerates the 
presence of substituents at C3 of the indole core, variations in the amine moiety, and 
the distance of the amine moiety to the indole core to the final synthetic step to be 
easily defined for a quick access to tryptamine derivatives. Then, the same catalyst 
system [Cp*IrCl2]2 was explored in the alkylation of oxindole with N-protected 
ethanolamines to provides a potential ‘green’ route to the formation C-3-substituted 
oxindole derivatives and more complex derivatives. In particular, a divergent 
synthesis has been presented: when N-acetyl-ethanol amine was used simply C3-
alkylation via borrowing hydrogen methodology occurs, alternatively employing N-
benzyl-ethanolamine diversely functionalized -substituited -lactams from 
oxindoles via the modern borrowing hydrogen methodology were obtained. A 
sequential/domino process was proposed to elucidate the formation of these products.  
In both cases were also tested N-methyl and N-phenyl group as substituent on 
oxindoles, demonstrating that the reaction does not suffer the presence of a 
substituent on oxindole N-H. With N-benzyl-ethanolamine and different N-aryl and 
N-heteroaryl substituted oxindoles different diaryl amines, representing important 
class of compound due to their wide application and special pharmacological 
activates, were obtained with this synthetic challenging route. Finally, considering the 
recent and high interest on first- row, heart-abundant metals, to enable the state of the 
art, the use of iron as catalyst in the borrowing hydrogen process has been take in 
consideration. So, for the first time, a general methodology for the catalytic formation 
of value-added 3-benzylindoles has been established through the use of indole and 
primary, secondary and heteroaromatic benzyl alcohols using an easily handled, air- 
and moisture-stable earth-abundant iron complex catalyst (iron phthalocyanine). This 
operates through a hydrogen-borrowing mechanism, demonstrated by experimental 
evidence and competitive studies. Many synthetically challenging routes were 
systematically explored, starting from readily accessible substrates that do not require 
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prior alcohol activation by stoichiometric methods. This included the one-pot 
synthesis of symmetrical bisindoles, the sequential functionalization of diols and the 
use of a secondary alcohol coupling partner under the catalytic conditions, which then 
enabled the formation of the desired branched alkylated indole. 
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5. Experimental Data  
5.1 Materials and Methods 
All reactions were run in air unless otherwise noted. Column chromatography 
purifications were performed in flash chromatography conditions using 230−400 
mesh silica gel. Analytical thin-layer chromatography (TLC) was carried out on silica 
gel plates (Silica Gel 60 F254) that were visualized by exposure to ultraviolet light 
and an aqueous solution of KMnO4, cerium ammonium molybdate (CAM), p-
anisaldehyde, or ninhydrin. 1H NMR and 13C NMR spectra were recorded on a 400 
spectrometer, using CDCl3 or CD3OD, [D6]-acetone or [D6]-DMSO. Chemical shifts 
(δ scale) are reported in parts per million (ppm) relative to the central peak of the 
solvent. Coupling constants (J values) are given in hertz (Hz). ESI-MS spectra were 
taken on a Waters Micromass ZQ instrument, only molecular ions (M + 1 or M − 1) 
are given. IR spectra were obtained on Nicolet Avatar 360 FT-IR spectrometer, and 
absorbance is reported in cm−1. Melting points were determined on a capillary 
melting point a Buchi SMP-510 apparatus and are uncorrected. HRMS analysis was 
performed using a Q-TOF microTM mass spectrometer. Elemental analyses were 
performed on a Carlo Erba analyzer and the results are within ±0.4 of the theoretical 
values (C, H, N). 4-(Benzyloxy)-1H-indole (6a) was synthesized according to the 
literature procedure84. 5-(Benzyloxy)-1H-indole (6b) was purchased from Apollo 
Scientific and was used without further purification. The aminoalcohols (2a-b) and 
(4c-d) were synthesized according to the literature procedure85. The aminoalcohol 
(2c) and (4a-b) were synthesized as described below. The aminoalcohol (7a) and (4e) 
were purchased from SigmaeAldrich, (7b) from Alfa Aesar and were all used without 
further purification. Ethanolamines (2), (3) and Oxindoles (8), (10), (12), (14), (16), 
(20), (22), (24), are commercial available. 1H-indole, 6-fluoro-1H-indole, 4-
methoxy-1H- indole, 6-methyl-1H-indole, 5-fluoro 1H-indole, 6-chloro-1H-indole, 2-
phenyl-1H-indole, benzyl alcohol, p-tolylmethanol, m-tolylmethanol, o-
tolylmethanol, biphenyl-3-ylmethanol, (N-(2-hydroxy-2-phenylethyl)acetamide, 4-
methoxyphenyl)methanol, (2-aminophenyl)methanol, 2 (hydroxymethyl)phenol, (4-
chlorophenyl)- methanol, (2-chlorophenyl)methanol, (4 fluorophenyl)methanol, (4-
(trifluoromethyl)phenyl)methanol, 4-(hydroxymethyl)benzonitrile, (3,4,5-
trimethoxyphenyl)methanol, naphthalen-2-ylmethanol, (3,5-
dichlorophenyl)methanol, furan-2-ylmethanol, thiophen-2ylmethanol, 
benzo[d][1,3]dioxol-5-ylmethanol, 1-phenylethanol, and diphenylmethanol are 
commercially available.  
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5.2 Compound Characterization and Synthetic Methods    
 
5.2.1 Observations concerning the synthesis of tryptamine homologues and 
branched tryptamine derivatives via the borrowing hydrogen process: synthesis 
of psilocin, bufotenin, and serotonin.  
 
General procedure for the synthesis of N-Acetylaminols (2c) and (4a-b). To a 
solution of aminol (2 mmol) and TEA (585 mL, 4.2 mmol) in CH2Cl2 dry (6 mL) was 
added acetyl chloride (149 mL, 2.1 mmol) at 0°C. The reaction mixture was stirred 
vigorously at 0°C under N2 until TLC analysis shows complete conversion of the 
starting materials. The solvent was removed under reduce pressure and the residue 
was purified by flash column chromatography on silica gel to afford the desired 
product. 
 N-(8-Hydroxyoctyl)acetamide (2c). (224 mg, 
60%), white solid. MS(ESI): 188 [M+H]+. 1H 
NMR(400 MHz, CDCl3):  1.25-1.29 (m, 8H), 
1.43-1.51 (m, 4H), 1.53 (s, 3H), 3.15-3.20 (m, 2H), 
3.56-3.60 (m, 2H), 6.14 (brs, 1H). 13C NMR (100 MHz, CDCl3):  23.2, 25.6, 26.7, 
29.1, 29.2, 29.5, 32.6, 39.6, 62.6, 76.7, 77.1, 77.4, 170.4. FTIR (film, cm-1): 1640, 
3385; Anal. Calcd. For C10H21NO2 (187.16): C, 64.13; H, 11.30; N, 7.48; Found: C 
64.21; H, 11.41; N, 7.45. 
 (S)-N-(1-Hydroxypropan-2-yl)acetamide (4a). (201 mg, 86%), 
colorless oil. 1H NMR (400 MHz, CDCl3):  1.07 (d, 3H, J=6.5 
Hz), 1.90 (s, 3H), 3.37-3.58 (m, 2H), 3.86-3.98 (m, 1H), 4.39 (brs, 
1H), 6.87 (brs, 1H, J=7.5 Hz). 13C NMR (100 MHz, CDCl3):  16.8, 
23.1, 47.5, 65.9, 171.1. FTIR (film, cm-1): 1653; Anal. Calcd. For C5H11NO2 
(117.08): C 51.26; H, 9.46; N, 11.96; Found: C, 51.20; H, 11.52; N, 11.92.  
 (S)-Methyl 2-acetamido-3-hydroxypropanoate (4b). (251 mg, 
78%), colorless oil. 1H NMR (400 MHz, CDCl3): d 2.09 (s, 3H), 
3.81 (s, 3H), 3.95-3.99 (m, 2H), 4.66-4.73 (m,1H), 6.46 (brs, 1H). 
The chemical-physical data are according to those published the      
literature86. 
General procedure for the synthesis of N-Substituted tryptamines. A mixture of 
the suitable indole (1a) or (6a-b) (0.25 mmol), Cs2CO3 (90 mg, 0.275 mmol), 
[Cp*IrCl2]2 (5 mg, 0.00625 mmol) and the appropriate N-protected ethanolamine 2a-
c, (4a-e) or (7a-b) (0.75 mmol) was stirred under N2 atmosphere at 150 °C for 48 h in 
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a sealed vial. After cooling to room temperature, the reaction mixture was dissolved 
in EtOAc/MeOH 9:1 (1 mL) and filtered through a silica gel pad. The filtrate was 
concentrated in vacuo and the residue was purified by flash column chromatography 
on silica gel. 
 N-(3-(1H-Indol-3-yl)propyl)acetamide (3a). Prepared 
according to the general procedure from 1H-indole and N-
(3-hydroxypropyl)acetamide (2a). Flash chromatography 
(EtOAc) gave (3a) (29 mg, 54%) as a light oil. MS (ESI): 
217 [M+H]+. 1H NMR (400 MHz, CDCl3):  1.88-1.98 (m, 
2H), 1.92 (s, 3H), 2.80 (t, 2H, J=7.5 Hz), 3.31 (dt, 2H, 
J1≈J2=7.5 Hz), 5.62 (brs, 1H), 6.70 (d, 1H, J01.5 Hz), 7.12 
(ddd, 1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.20 (ddd, 1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.36 
(dd, 1H, J=8.0 Hz), 7.59 (dd, 1H, J=8.0 Hz), 8.26 (brs, 1H). 13C NMR (100 MHz, 
CDCl3):  22.6, 23.3, 29.7, 39.5, 111.2, 115.3, 118.7, 119.1, 121.6, 121.9, 127.3, 
136.4, 170.3. The chemical-physical data are according to those published the 
literature87. 
 N-(4-(1H-Indol-3-yl)butyl)acetamide (3b). Prepared 
according to the general procedure from 1H-indole and N-
(4-hydroxybutyl)acetamide (2b). Flash chromatography 
(EtOAc) gave (3b) (44 mg, 76%) as a light oil. MS (ESI): 
231 [M+H]+. 1H NMR (400 MHz, CDCl3):  1.53-1.61 
(m, 2H), 1.70-1.77 (m, 2H), 1.93 (s, 3H), 2.78 (t, 2H, 
J=7.0 Hz), 3.23-3.28 (m, 2H), 5.57 (brs, 1H), 6.96 (d, 1H, 
J=1.5 Hz), 7.12 (ddd, 1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.19 (ddd, 1H, J1=1.0, J2=7.0, 
J3=8.0 Hz), 7.35 (ddd, 1H, J1≈J2=1.0 and J3=8.0 Hz), 7.59 (d, 1H, J=8.0 Hz), 8.20 
(brs, 1H). 13C NMR (100 MHz, CDCl3):  23.3, 24.7, 27.4, 29.3, 39.6, 111.2, 116.1, 
118.8, 119.1, 121.4, 121.8, 127.4, 136.4, 170.2; FTIR (Nujol, cm-1): 1626, 3285; 
Anal. Calcd. For C14H18N2O (230.14): C, 73.01; H, 7.88; N, 12.16; Found: C, 73.12; 
H, 7.85; N, 12.19. 
 N-(8-(1H-Indol-3-yl)octyl)acetamide (3c). 
Prepared according to the general procedure 
from 1H-indole and N-(8-
hydroxyoctyl)acetamide (2c). Flash 
chromatography (EtOAc) gave (3c) (41 mg, 57%) as a light oil. MS (ESI): 287 
[M+H]+. 1H NMR (400 MHz, CDCl3):  1.27-1.39 (m, 8H), 1.43-1.49 (m, 2H), 1.68-
1.74 (m, 2H), 1.97 (s, 3H), 2.76 (t, 2H, J=7.5 Hz), 3.19-3.24 (m, 2H), 5.74 (brs, 1H), 
6.96 (s, 1H, J¼2.0 Hz), 7.12 (ddd, 1H, J1¼1.0, J2¼7.0, J3¼8.0 Hz), 7.19 (ddd, 1H, 
J1¼1.0, J2¼7.0, J3¼8.0 Hz), 7.35 (ddd, 1H, J1¼J2¼1.0 and J3¼8.0 Hz), 7.63 (d, 1H, 
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J¼8.0 Hz), 8.31 (brs, 1H); 13C NMR (100 MHz, CDCl3): d 23.3, 25.1, 26.9, 29.3, 
29.4, 29.5, 29.6, 30.1, 39.8, 111.2, 116.8, 118.9, 119.0, 121.3, 121.7, 127.6, 136.4, 
170.3; FTIR (film, cm-1): 1642, 3391; Anal. Calcd. For C18H26N2O (286.20): C, 
75.48; H, 9.15; N, 9.78; Found: C, 75.66; H, 9.24; N, 9.91. 
 N-(1-(1H-Indol-3-yl)propan-2-yl)acetamide (5a). Prepared 
according to the general procedure from 1H-indole and (S)-N-(1-
hydroxypropan-2-yl)acetamide (4a). Flash chromatography 
(EtOAc) gave (5a) (20 mg, 37%) as a light oil. MS (ESI): 217 
[M+H]+. 1H NMR (400 MHz, CDCl3): 1.17 (d, 3H, J¼6.5 
Hz),1.92 (s, 3H), 2.95 (d, 2H, J=6.0 Hz), 4.35-4.42 (m,1H), 5.39 
(brs,1H), 7.04 (d, 1H, J=2.0 Hz), 7.14 (ddd, 1H, J1=1.0, J2=7.0, 
J3=8.0 Hz), 7.21 (ddd,
1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.38 (d, 1H, J=8.0 Hz), 7.64 (d, 
1H, J=8.0 Hz), 8.20 (brs, 1H). 13C NMR (100 MHz, CDCl3): 20.3, 23.5, 31.7, 45.6, 
111.1, 111.9, 119.0, 119.6, 122.1, 122.7, 128.0, 136.2, 169.5; FTIR (Nujol, cm-1): 
1740, 3398; Anal. Calcd. For C13H16N2O (216.13): C, 72.19; H, 7.46; N, 12.95; 
Found: C, 72.28; H, 7.52; N, 12.90. 
 Methyl 2-acetamido-3-(1H-indol-3-yl)propanoate (5b). 
Prepared according to the general procedure from 1H-indole and 
methyl 2-acetamido-3-hydroxypropanoate (4b). Flash chroma- 
tography (cyclohexane:EtOAc 4:6 to EtOAc) gave 5b (20 
mg,15%) as a white solid. MS (ESI): 261 [M+H]+. 1H NMR 
(400 MHz, CDCl3):  1.96 (s, 3H), 3.31 (dd, 1H, J1=5.5, J2=15.0 
Hz), 3.36 (dd, 1H, J1=5.5, J2=15.0 Hz), 3.71 (s, 3H), 4.97 (ddd, 
1H, J1≈J2=5.5, J3=8.0 Hz), 6.03 (brs, 1H), 6.98 (s, 1H), 7.13 (ddd, 1H, J1=1.0, J2=7.0, 
J3=8.0 Hz), 7.20 (ddd,1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.37 (d, 1H, J=8.0 Hz), 7.54 (d, 
1H, J=8.0 Hz), 8.29 (brs, 1H). 13C NMR (100 MHz, CDCl3):  23.2, 27.6, 52.3, 53.1, 
110.0, 111.3, 118.5, 119.7, 122.3, 122.7, 127.7, 136.1, 169.8, 172.4. The 
chemicalephysical data are according to those published the literature88. 
 N-(2-(1H-Indol-3-yl)propyl)acetamide (5c). Prepared 
according to the general procedure from 1H-indole and N-(2-
hydroxypropyl)acetamide (4c). Flash chromatography (EtOAc) 
gave (5c) (42 mg, 78%) as a light oil. MS (ESI): 217 [M+H]+. 1H 
NMR (400 MHz, CDCl3):  1.38 (d, 3H, J=7.0 Hz), 1.89 (s, 3H), 
3.25-3.34 (m, 1H), 3.42-3.49 (m, 1H), 3.64-3.71 (m, 1H), 5.57 
(brs, 1H), 7.03 (d, 1H, J=2.0 Hz), 7.13 (ddd, 1H, J1=1.0, J2=7.0, 
J3=8.0 Hz), 7.22 (ddd, 1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.39 (d, 1H, J=8.0 Hz), 7.66 (d, 
1H, J=8.0 Hz), 8.50 (brs, 1H). 13C NMR (100 MHz, CDCl3):  18.9, 23.4, 31.2, 45.7, 
111.4, 118.7, 119.1, 119.4, 120.8, 122.2, 126.7, 136.6, 170.2; FTIR (Nujol, cm-1): 
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1650, 3407; Anal. Calcd. For C13H16N2O (216.13): C, 72.19; H, 7.46; N, 12.95; 
Found: C, 72.25; H, 7.41; N, 12.98. 
 3-(1-Methylpiperidin-4-yl)-1H-indole (5e). Prepared according to 
the general procedure from 1H-indole and 1-methylpiperidin-4-ol 
(4e). Flash chromatography (DCM:MeOH 9:1 and 1% of TEA) gave 
5e (39 mg, 72%) as a light oil. MS (ESI): 215 [M+H]+. 1H NMR (400 
MHz, CDCl3):  1.87 (ddd, 2H, J1=3.5, J2=12.0, J3=25.0 Hz), 2.07-
2.10 (m, 2H), 2.17 (ddd, 2H, J1=2.5, J2=J312.0 Hz), 2.38 (s, 3H), 2.84 
(dddd, 1H, J1=J2=3.5, J3=J4=12.0 Hz), 3.00-3.03 (m, 2H), 6.97 (d, 1H, 
J=2.0 Hz), 7.12 (ddd, 1H, J1=1.0, J2=7.0, J3=8.0 Hz), 7.20 (ddd, 1H, J1=1.0, J2=7.0, 
J3=8.0 Hz), 7.36 (ddd, 1H, J1=J2=1.0, J3=8.0 Hz), 7.67 (d, 1H, J=8.0 Hz), 8.35 (brs, 
1H). 13C NMR (100 MHz, CDCl3):  32.9, 33.1, 46.6, 56.5, 111.2, 119.0, 119.1, 
119.7, 121.3, 121.9, 126.7, 136.6. The chemical-physical data are according to the 
literature89. 
 2-(4-(Benzyloxy)-1H-indol-3-yl)-N,N-dimethylethan-1-
amine. Prepared according to the general procedure from 4-
(benzyloxy)-1H-indole (6a) and 2-(dimethylamino)ethan-1-ol 
(7a).Flash chromatography (DCM:MeOH 9:1 and 1% of TEA) 
gave the product (45mg, 61%) as a light yellowsolid. MS (ESI): 
295 [M+H]+. 1HNMR (400 MHz, CDCl3): d 2.18 (s, 6H), 2.67 
(t, 2H, J 8.0 Hz), 3.09 (t, 2H, J 8.0Hz), 5.19 (s, 2H), 6.56 (d,1H, 
J 8.0Hz), 6.83 (s,1H), 6.95 (d,1H, J 8.0Hz), 7.06 (dd,1H, J1 J2 
8.0 Hz), 7.32e7.42 (m, 3H), 7.52 (d,1H, J 7.5Hz),8.78(br 
s,1H).13CNMR(100MHz,CDCl3): d22.8,42.5,59.6, 70.3, 100.0, 105.6, 110.1, 116.7, 
122.3, 122.7, 128.6, 128.8, 129.0, 137.1, 138.3, 153.2. FTIR (film, cm-1): 3108. Anal. 
Calcd. For C19H22N2O (294.17): C, 77.52; H, 7.53; N, 9.52; Found: C, 77.71; H, 7.45; 
N, 9.31.  
 2-(5-(Benzyloxy)-1H-indol-3-yl)-N,N-
dimethylethan-1-amine. Prepared according to the 
general procedure from 5-(ben- zyloxy)-1H-indole 
(6b) and 2-(dimethylamino)ethan-1-ol (7a). Flash 
chromatography (DCM:MeOH 9:1 and 1% of TEA) 
gave the product (49 mg, 67%) as a light red solid. 
MS (ESI): 295 [M+H]+. 1H NMR (400 MHz, CDCl3): 
 2.40 (s, 6H), 2.68 (t, 2H, J=8.0 Hz), 2.95 (t, 2H, J=8.0 Hz), 5.13 (s, 2H), 6.94 (dd, 
1H, J1=2.5, J2=8.5 Hz), 7.02 (s, 1H), 7.14 (d, 1H, J=2.5 Hz), 7.26 (d, 1H, J=8.5 Hz), 
7.31-7.36 (m, 1H), 7.38-7.42 (m, 2H), 7.49 (d, 2H, J=7.5 Hz), 7.96 (brs, 1H). 13C 
NMR (100 MHz, CDCl3):  23.4, 45.2, 59.9, 71.0, 102.5, 111.8, 112.9, 113.6, 122.4, 
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127.6, 127.7, 127.8, 128.5, 131.6, 137.7, 153.1. FTIR (film, cm-1): 3235. Anal. 
Calcd. For C19H22N2O (294.17): C, 77.52; H, 7.53; N, 9.52; Found: C, 77.63; H, 7.48; 
N, 9.39. 
 N-Benzyl-2-(5-(benzyloxy)-1H-indol-3-
yl)ethan-1-amine. Prepared according to the 
general procedure from 5-(ben-zyloxy)-1H-
indole (6b) and 2-(benzylamino)ethan-1-ol (7b). 
Flash chromatography (DCM:MeOH 9:1 and 1% 
of TEA) gave the product (55 mg, 62%) as a 
yellow oil. MS (ESI): 357 [M+H]+. 1H NMR 
(400 MHz, CDCl3): d 1.94 (brs, 1H), 2.95 (s, 
4H), 3.79 (s, 2H), 5.04 (s,2H), 6.90 (dd, 1H, 
J1=2.5, J2=9.0 Hz), 6.93 (d, 1H, J=1.5 Hz), 7.10 (d, 1H, J=2.5 Hz), 7.18-7.23 (m, 2H), 
7.26-7.31 (m, 5H), 7.34-7.38 (m, 2H), 7.44-7.46 (m, 2H), 8.05 (brs, 1H). 13C NMR 
(100 MHz, CDCl3):  25.3, 48.8, 53.4, 71.0, 102.4, 111.9, 112.9, 113.1, 123.0, 127.3, 
127.6, 127.7, 127.8, 128.4, 128.5, 128.6, 131.7, 137.7, 138.8, 153.1. The chemical-
physical data are according to those published the literature90. 
General procedure for the hydrogenolysis for the synthesis of the natural 
products. Psilocin, Bufotenin and Serotonin. To a stirred suspension of the suitable 
tryptamine (0.25 mmol) and an equal weight of 10% Pd-C in dry methanol (7 mL), 
anhydrous ammonium formate (71 mg, 1.125 mmol) was added in a single portion 
under N2. The resulting reaction mixture was stirred at 70 °C for 45 min. The solution 
was filtered through a pad of Celite, the solvent was removed under reduce pressure 
and the residue was purified by flash column chromatography on silica gel 
(DCM:MeOH 9:1 and 1% of TEA) to give the corresponding natural product in 
quantitative yield.  
Psilocin. Prepared according to the general procedurefrom2-
(4-(benzyloxy)-1H-indol-3-yl)-N,N-dimethylethan-1-amine. 
Yellowish solid (51 mg, 100%). MS (ESI): 205 [M+H]+. 1H NMR 
(400 MHz, CDCl3):  2.39 (s, 6H), 2.71-2.73 (m, 2H), 2.95-2.97 
(m, 2H), 6.58 (dd, 1H, J1=0.5, J2=7.5 Hz), 6.84 (d, 1H, J=2.0 Hz), 
6.87 (dd, 1H, J1=0.5, J2=8.0 Hz), 7.04-7.08 (m, 1H), 8.03 (brs, 
1H). 13C NMR (100 MHz, CDCl3):  25.1, 45.3, 61.6, 102.5, 106.4, 114.4, 117.5, 
120.9, 123.5, 139.1, 152.1. The chemical-physical data are according to those 
published the literature91. 
Bufotenin. Prepared according to the general procedure 
from 2-(5-(benzyloxy)-1H-indol-3-yl)-N,N-
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dimethylethan-1-amine. White solid (51 mg, 100%). MS (ESI): 205 [M+H]+. 1H 
NMR (400 MHz, MeOD):  2.38 (s, 6H), 2.65-2.70 (m, 2H), 2.86-2.90 (m, 2H), 6.65 
(dd, 1H, J1=2.5, J2=8.5 Hz) 6.90 (dd, 1H, J1=0.5, J2=2.5 Hz), 7.00 (s, 1H), 7.15 (dd, 
1H, J1=0.5, J2=8.5 Hz). 
13C NMR (100 MHz, MeOD):  23.5, 44.7, 60.6, 103.3, 
111.4, 112.5, 112.8, 124.3, 129.1, 133.1, 151.3. The chemical-physical data are 
according to those published the literature70d. 
Serotonin. Prepared according to the general procedure 
from N-benzyl-2-(5-(benzyloxy)-1H-indol-3-yl)ethan-1-
amine. White solid (44 mg, 100%). MS (ESI): 177 [M+H]+; 
1H NMR (400 MHz, MeOD):  2.90 (t, 2H, J=6.5 Hz), 3.00 (t, 
2H, J=6.5 Hz), 6.69 (dd, 1H, J1=1.5, J2=8.5 Hz), 6.95 (d, 1H, 
J=1.5 Hz), 7.04 (s, 1H), 7.18 (d, 1H, J=8.5 Hz). 13C NMR 
(100 MHz, MeOD): 27.0, 41.1, 102.0 110.4, 111.1, 111.4, 123.1, 127.9, 131.8, 
149.8. The chemical-physical data are according to those published the literature92. 
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5.2.2 Divergent Borrowing Hydrogen Approach from Oxindoles and 
Ethanolamine: Synthesis of C3-Substituted Oxindoles and Diarylamine. 
 
General procedure for the synthesis of C3-Substituted Oxindoles and -
substituted -lactams. A mixture of the suitable oxindole, (0.5 mmol), Cs2CO3 (180 
mg, 0.55 mmol), [Cp*IrCl2]2 (10 mg, 0.00125 mmol) and N-acetyl-ethanolamine (2) 
or N-benzyl-ethanolamine (3), (1,5 mmol) was stirred under N2 atmosphere at 150 °C 
for 24 h in a sealed vial. After cooling to room temperature, the reaction mixture was 
dissolved in EtOAc/MeOH 9:1 (1 mL) and filtered through a silica gel pad. The 
filtrate was concentrated in vacuo and the residue was purified by flash column 
chromatography on silica gel to afford the desired product. 
General procedure (2): preparation of N-aryl oxindoles: A dried vial was charged 
with CuI (0.10 mmol), oxindole (1.00 mmol), aryl halide (1.20 mmol, if solid), 
K2CO3 (2.0 mmol), and a magnetic stir bar. The reaction vessel was fitted with a 
rubber septum. The test tube was evacuated and back-filled with dry argon. Aryl 
halide (1.20 mmol, if liquid), rac-trans-N,N’-dimethylcyclohexane-1,2-diamine (0.20 
mmol) and 1,4-dioxane (1.0 mL) were then added successively. The rubber septum 
was removed and the reaction tube was quickly sealed with a Teflon-lined septum. 
The vessel was immersed in a pre-heated oil bath and stirred vigorously until TLC 
analysis of the crude reaction mixture indicated that the limiting reagent had been 
completely consumed. The reaction mixture was cooled to room temperature, diluted 
with ethyl acetate (15 mL), and filtered through a plug of silica, eluting with 
additional ethyl acetate (50mL). The filtrate was concentrated and the resulting 
residue was purified by flash chromatography (hexanes/ethyl acetate) to provide the 
desired product. 
 N-(2-(2-oxoindolin-3-yl)ethyl)acetamide (4) The titled 
compound was prepared according to the general procedure 
using indolin-2-one (1) and N-acetylethanolamine (2). The 
product was purified by flash chromatography (gradient from 
EtOAc to EtOAc/MeOH 95:5) to give 4 (67 mg, 61%) as white 
solid. 1H NMR (400 MHz, CDCl3)  δ 8.55 (br s, 1H), 7.28 (t, J = 
8.0 Hz, 1H), 7.21 (t, J = 8.0 Hz, 1H), 7.04 (t, J = 8.0 Hz, 1H), 
6.88 (d, J = 8.0 Hz, 1H), 6.39 (br s, 1H), 3.53 – 3.45 (m, 3H), 
2.28 – 2.20 (m, 1H), 2.10 – 2.02 (m, 1H), 1.95 (s, 3H); 13C NMR (101 MHz, CDCl3) 
δ 180.1, 170.4, 141.1, 129.2, 128.2, 124.2, 122.7, 109.8, 44.4, 37.2, 30.0, 23.2; mp: 
138−140 °C; IR (film): 3280, 1740 cm−1; HRMS (ESI) m/z calcd for C12H15N2O2 
[M+H]+ 219.1128; found 219.1113. The chemical-physical data are in accordance 
whit the literature93. 
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 3-(2-aminophenyl)-1-benzylpyrrolidin-2-one (5) The titled 
compound was prepared according to the general procedure 
using indolin-2-one (1) and N-benzylethanolamine (2). The 
product was purified by flash chromatography 
(cyclohexane/EtOAc 1:1) to give 5 (72 mg, 54%) as 
yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.43 (m, 2H), 7.37 – 7.29 (m, 
4H), 7.22 – 7.20 (m, 1H), 7.17 – 7.12 (m, 1H), 6.78 – 6.73 (m, 1H), 4.49 (d, J = 15.0 
Hz, 1H), 4.42 (d, J = 15.0 Hz, 1H), 4.40 (br s, 2H), 4.04 (dd, J = 9.0 and 6.0 Hz, 1H), 
3.52 – 3.43 (m, 1H), 3.38 – 3.32(m, 1H), 2.49 – 2.36 (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ 175.4, 145.9, 136.2, 128.7, 128.0, 127.9, 127.6, 126.1, 124.6, 119.0, 117.4, 
46.8, 45.4, 43.4, 24.1; IR (film) 1755 cm−1; HRMS (ESI) m/z calcd for C17H19N2O 
[M+H]+ 267.1492; found 267.1495. 
One-pot C-H Activation/Borylation/Oxidation Sequence for the synthesis 4-
phenylindolin-2-one (6): A flame dried vial was charged with (1,5-
cyclooctadiene)(methoxy)iridium(I) dimer (10.5 mg, 15.5 µmol), 4,4'-di-tert-butyl-
2,2'-dipyridyl (8.33 mg, 31.1 µmol), bis(pinacolato)diboron (409 mg, 2.07 mmol), 4-
phenyl-1H-indole (prepared as reported in literature94) (200 mg, 1.03 mmol), and a 
stirring bar and sealed with a septum under an atmosphere of argon. Anhydrous 
dichloromethane (3.0 mL) was added via syringe to give a colorless suspension. The 
septum was replaced with the stopper vial’s and sealed with Teflon. The entire 
mixture was heated in an oil bath set to 65 °C. The reaction mixture gradually turned 
into a clear dark amber solution. After 3 h, the mixture was allowed to cool to 23 °C 
and the volatiles were removed under reduced pressure. The reaction mixtrure was 
dissolved in THF (17 ml) and cooled to 0 °C. H2O2 (1 mL, 30% in H2O) and NaOH 
(0.5 mL, 1M) were added and the mixture stirred at 0 °C for 1.5 h. EtOAc (30 mL) 
was added and the organic layer was washed with H2O (20 mL) and brine (20 mL). 
The solvent was removed under vacuum and the resulting mixture was purified by 
flash chromatography (cyclohexane/ EtOAc 1:1) to give (6) (120  mg, 55%) as off- 
white solid. 1H NMR (400 MHz, CDCl3) δ 8.90 (s, 4H), 7.50 – 7.44 (m, 1H), 7.42 – 
7.36 (m, 1H), 7.32 (tt, J = 7.8, 0.8 Hz, 1H), 7.10 (dd, J = 7.9, 1.0 Hz, 1H), 6.91 (dt, J 
= 7.8, 0.9 Hz, 1H), 3.64 (s, 2H). 13C (101 MHz, CDCl3): 177.5, 142.8, 139.6, 138.7, 
128.9, 128.7, 128.4, 128.3, 128.0, 127.7, 122.9, 122.9, 108.7, 36.3. Mp:192-194°C IR 
(film): 1745 cm−1; HRMS (ESI) m/z calcd. for C14H12NO (M+H)
+ 210.0913; found 
210.0909. 
 N-(2-(2-oxo-4-phenylindolin-3-yl)ethyl)acetamide (7) The 
titled compound was prepared according to the general procedure 
using 4-phenylindolin-2-one (6) and N-acetylethanolamine (2). 
The product was purified by flash chromatography (gradient 
from EtOAc to EtOAc/ MeOH 99:1) to give 7 (84 mg, 57%) as 
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off-white solid. 1H NMR (400 MHz, CD3OD) δ 7.63 (br s, 1H), 7.49 – 7.35 (m, 5H), 
7.29 (t, J = 8.0 Hz, 1H), 6.98 (d, J = 7.5 Hz, 1H), 6.89 (d, J = 7.5 Hz, 1H), 3.96 (dd, J 
= 7.0 and 3.5 Hz, 1H), 2.88 – 2.83 (m, 2H), 1.91 – 1.82 (m, 1H), 1.77 (s, 3H), 1.54 – 
1.47 (m, 1H); 13C NMR (101 MHz, CD3OD) δ 182.2, 173.1, 144.5, 141.4, 140.7, 
130.1, 129.9, 129.4, 129.1, 127.5, 124.6, 110.3, 45.5, 37.1, 28.8, 22.7; mp: 145−148 
°C; IR (film): 1743, 1758 cm−1; HRMS (ESI) m/z calcd for C18H19N2O2 [M+H]+ 
295.1441; found 295.1451. 
 
 N-(2-(5-methoxy-2-oxoindolin-3-yl)ethyl)acetamide (9) 
The titled compound was prepared according to the general 
procedure using 5-methoxyindolin-2-one (8) and N-
acetylethanolamine (2). The product was purified by flash 
chromatography (gradient from EtOAc to EtOAc/MeOH 
99:1) to give 9 (67 mg, 54%) as white solid. 1H NMR (400 
MHz, CDCl3) δ 7.62 (br s, 1H), 6.90 (s, 1H), 6.77 – 6.76 
(m, 2H), 6.38 (br s, 1H), 3.78 (s, 3H), 3.50 – 3.47 (m, 3H), 2.27 – 2.22 (m, 1H), 2.08 
– 2.01 (m, 1H), 1.97 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 180.0, 170.5, 156.0, 
134.4, 130.5, 112.9, 111.2, 110.2, 55.8, 44.8, 37.2, 30.0, 23.2; mp: 127−130 °C; IR 
(film): 1760, 1748 cm−1; HRMS (ESI) m/z calcd for C13H17N2O3 [M+H]+ 249.1234; 
found 249.1242. The chemical-physical data are in accordance whit the literature.95 
 
 N-(2-(6-methoxy-2-oxoindolin-3-yl)ethyl)acetamide (11) 
The titled compound was prepared according to the general 
procedure using 6-methoxyindolin-2-one (10) and N-
acetylethanolamine (2). The product was purified by flash 
chromatography (gradient from EtOAc to EtOAc/MeOH 
99:1) to give 11 (87 mg, 70%) as white solid. 1H NMR (400 
MHz, CDCl3) δ 7.99 (br s, 1H), 7.18 (d, J = 8.0 Hz, 1H), 
6.56 (dd, J = 8.0 and 2.5 Hz, 1H), 6.48 (d, J = 2.5 Hz, 1H), 6.40 (br s, 1H), 3.80 (s, 
3H), 3.51 – 3.44 (m, 3H), 2.23 – 2.18 (m, 1H), 2.06 – 1.99 (m, 1H), 1.98 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 180.6, 170.4, 160.1, 142.1, 124.8, 121.0, 107.2, 97.3, 
55.5, 43.8, 37.2, 30.2, 23.2; mp: 145−148 °C; IR (film): 1770, 1758 cm−1; HRMS 
(ESI) m/z calcd. for C13H17N2O3 [M+H]+ 249.1234; found 249.1211. 
 
 N-(2-(7-methyl-2-oxoindolin-3-yl)ethyl)acetamide (13) The 
titled compound was prepared according to the general procedure 
using 7-methylindolin-2-onee (12) and N-acetylethanolamine (2). 
The product was purified by flash chromatography (gradient 
from EtOAc to EtOAc/MeOH 99:1) to give 13 (102 mg, 88%) as 
off-white solid. 1H NMR (400 MHz, CDCl3) δ 8.70 (br s, 1H), 
7.11 (d, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.99 (t, J = 7.5 
Hz, 1H), 6.34 (br s, 1H), 3.53 – 3.46 (m, 3H), 2.28 (s, 3H), 2.27 – 
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2.23 (m, 1H), 2.22 – 2.00 (m, 1H), 1.94  (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
180.4, 170.2, 139.7, 129.5, 128.8, 122.7, 121.5, 119.0, 44.9, 37.4, 30.1, 23.2, 16.4; 
mp: 132−136 °C; IR (film): 1777, 1788 cm−1; HRMS (ESI) m/z calcd. for 
C13H17N2O2 [M+H]+ 233.1285; found 233.1294. 
 
 N-(2-(1-methyl-2-oxoindolin-3-yl)ethyl)acetamide (15) The 
titled compound was prepared according to the general procedure 
using 1-methylindolin-2-one (14) and N-acetylethanolamine (2). 
The product was purified by flash chromatography (gradient 
from EtOAc to EtOAc/MeOH 99:1) to give 15 (116 mg, 99%) as 
off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.29 – 7.23 (m, 
2H), 7.06 – 7.02 (m, 1H), 6.81 – 6.79 (m, 2H), 3.46 – 3.40 (m, 
3.H), 3.17 (s, 3H), 2.18 – 2.13 (m, 1H), 2.03 – 1.89 (m, 1H), 1.86 (s, 3H); 13C NMR 
(101 MHz, CDCl3) δ 178.0, 170.4, 143.8, 128.5, 128.2, 123.9, 122.8, 108.2, 44.0, 
37.3, 30.1, 26.2, 23.2; mp: 142−146 °C; IR (film): 1767 cm−1; HRMS (ESI) m/z 
calcd. for C13H17N2O2 [M+H]+ 233.1285; found 233.1273. 
 N-(2-(2-oxo-1-phenylindolin-3-yl)ethyl)acetamide (17) The 
titled compound was prepared according to the general procedure 
using 1-phenylindolin-2-one (16) and N-acetylethanolamine (2). 
The product was purified by flash chromatography 
(cyclohexane/EtOAc 6:4) to give 17 (79 mg, 54%) as off-white 
solid. 1H NMR (400 MHz, CDCl3) δ 7.54 (t, J = 8.0 Hz, 2H), 
7.44 – 7.37 (m, 4H), 7.22 (t, J = 7.5 Hz, 1H), 7.12 (t, J = 7.5 Hz, 
1H), 6.80 (d, J = 8.0 Hz, 1H), 6.53 (br s, 1H), 3.69 – 3.65 (m, 
1H), 3.61 – 3.42 (m, 2H), 2.38 – 2.30 (m, 1H), 2.17 – 2.08 (m, 
1H), 1.92 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 177.6, 170.4, 143.9, 134.3, 129.7, 
128.4, 128.3, 128.1, 126.6, 124.2, 123.3, 109.5, 44.2, 37.4, 30.3, 23.2; mp: 135−138 
°C; IR (film): 1757 cm−1; HRMS (ESI) m/z calcd. for C18H19N2O2 [M+H]+ 
295.1441; found 295.1431. 
 
3-(2-amino-5-methoxyphenyl)-1-benzylpyrrolidin-2-one 
(18). The titled compound was prepared according to the 
general procedure using 5-methoxyindolin-2-one (8) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 9:1) to give 18 (55 mg, 
37%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.23 (m, 8H), 6.74 – 
6.68 (m, 2H), 4.48 (s, 2H), 3.99 – 3.96 (m, 1H), 3.74 (s, 3H), 3.49 – 3.43 (m, 1H), 
3.38 – 3.32 (m, 1H), 2.44 – 2.31 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 175.1, 
153.2, 139.5, 136.3, 128.7, 128.1, 127.7, 126.5, 118.4, 113.2, 112.6, 55.8, 46.9, 45.4, 
43.6, 24.1;. IR (film): 3459, 3390, 1760 cm−1; HRMS (ESI) m/z calcd for 
C18H21N2O2 [M+H]+ 297.1598; found 297.1571. 
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 3-(2-amino-4-methoxyphenyl)-1-benzylpyrrolidin-2-
one (19). The titled compound was prepared according 
to the general procedure using oxindole (10) and N-
benzylethanolamine (3). The product was purified by 
flash chromatography (AcOEt:MeOH 98:2) to give 19 
(62mg, 42%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.06 (m, 5H), 
6.90 (d, J = 9.2 Hz, 1H), 6.33 – 6.20 (m, 2H), 4.39 (s, 2H), 3.92 – 3.77 (m, 1H), 3.68 
(s, 3H), 3.41 – 3.33 (m, 1H), 3.31 – 3.21 (m, 1H), 2.39 – 2.19 (m, 2H).13C NMR (101 
MHz, CDCl3) 172.6, 158.7, 146.5, 136.3, 129.7, 128.1, 127.7, 126.5, 122.4, 104.2, 
103.6, 55.8, 48.9, 45.4, 43.5, 24.2. IR (film): 3447, 3395, 1780cm−1; HRMS (ESI) 
m/z calcd. for C18H21N2O2 (M+H)
+ 297.3775; found 297.3772. 
 
 3-(2-amino-4-chlorophenyl)-1-benzylpyrrolidin-2-one 
(21). The titled compound was prepared according to the 
general procedure using 6-chloroindolin-2-one (20) and 
N-benzylethanolamine (3). The product was purified by 
flash chromatography (cyclohexane/EtOAc 1:1) to give 
21 (52 mg, 35%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.30 (m, 3H), 
7.23 – 7.21 (m, 2H), 6.98 (d, J = 8.0 Hz, 1H), 6.75 – 6.72 (m, 2H), 4.51 (br s, 2H), 
4.47 (s, 2H), 3.89 (dd, J = 9.0 and 6.5 Hz, 1H), 3.48 – 3.32 (m, 2H), 2.46 – 2.28 (m, 
2H); 13C NMR (101 MHz, CDCl3) 175.0, 147.4, 136.1, 133.3, 128.8, 128.0, 127.7, 
127.3, 122.9, 118.7, 116.9, 46.9, 45.4, 43.0, 24.1; IR (film): 3457, 3385, 1769 cm−1; 
HRMS (ESI) m/z calcd. for C17H18ClN2O [M+H]+ 301.1102; found 301.1107. 
 
 3-(2-amino-5-methylphenyl)-1-benzylpyrrolidin-2-one 
(23). The titled compound was prepared according to the 
general procedure using 5-methylindolin-2-one (22) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 6:4) to give 23 (67 
mg, 48%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.28 – 7.15 (m, 5H), 6.82 
(d, J = 8.0 Hz, 1H), 6.79 (s, 1H), 6.60 (d, J = 8.0 Hz, 1H), 4.41 (d, J = 15.0 Hz, 1H), 
4.36 (d, J = 15.0 Hz, 1H), 3.86 (dd, J = 15.0 and 7.0 Hz, 1H) 3.44 – 3.32 (m, 1H), 
3.31 – 3.20 (m, 1H), 2.47 – 2.18 (m, 2H), 2.16 (s, 3H); 13C NMR (101 MHz, CDCl3) 
δ 175.4, 143.3, 136.4, 128.7, 128.5, 128.2, 128.1, 127.6, 127.0, 124.8, 117.5, 46.9, 
45.4, 43.5, 24.2, 20.7; IR (film): 3497, 3385, 1743 cm−1; HRMS (ESI) m/z calcd. for 
C18H21N2O [M+H]+ 281.1648; found 281.1654. 
 
 3-(2-amino-4-methylphenyl)-1-benzylpyrrolidin-2-one 
(25). The titled compound was prepared according to the 
general procedure using 6-methylindolin-2-one (24) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 6:4) to give 25 (64 
 71 
 
mg, 46%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.29 (m, 4H), 7.24 – 
7.22 (m, 2H), 6.96 (d, J = 8.0 Hz, 1H), 6.61 – 7.60 (m, 1H), 4.50 (d, J = 14.5 Hz, 1H), 
4.44 (d, J = 14.5 Hz, 1H), 3.92 (dd, J = 9.5 and 5.5 Hz, 1H), 3.49 – 3.43 (m, 1H), 3.37 
– 3.31 (m, 1H), 2.42 – 2.33 (m, 2H), 2.27 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
175.5, 145.9, 137.8, 136.3, 128.7, 128.1, 127.6, 126.1, 121.7, 119.8, 118.1, 46.8, 
45.4, 43.1, 24.2, 21.0; IR (film): 3490, 3380, 1753 cm−1; HRMS (ESI) m/z calcd for 
C18H21N2O [M+H]+ 281.1648; found 281.1654. 
 
 3-(2-amino-3-methylphenyl)-1-benzylpyrrolidin-2-one 
(26). The titled compound was prepared according to the 
general procedure using 7-methylindolin-2-one (12) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 7:3) to give 3e (100 
mg, 72%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.28 (m, 5H), 7.25 – 
7.23 (m, 2H), 7.01 (d, J = 7.5 Hz, 1H), 6.98 (d, J = 7.5 Hz, 1H), 6.72 (t, J = 7.5 Hz, 
1H), 4.52 (d, J = 14.5 Hz, 1H), 4.35 (d, J = 14.5 Hz, 1H), 3.97 (dd, J = 9.0 and 6.0 
Hz, 1H), 3.53 – 3.47 (m, 1H), 3.39 – 3.33 (m, 1H), 2.46 – 2.38 (m, 2H), 2.24 (s, 3H);  
13C NMR (101 MHz, CDCl3) δ 175.6, 144.3, 136.3, 129.3, 128.7, 128.0, 127.6, 
124.0, 123.9, 123.5, 118.2, 46.8, 45.5, 43.4, 24.4, 17.9; IR (film): 3475, 3362, 1763 
cm−1; HRMS (ESI) m/z calcd for C18H21N2O [M+H]+ 281.1648; found 281.1647. 
 
 1-benzyl-3-(2-(methylamino)phenyl)pyrrolidin-2-one (27). 
The titled compound was prepared according to the general 
procedure using 1-methylindolin-2-one (14) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give 27 (60 mg, 
35%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.29 (m, 3H), 7.25 – 
7.20 (m, 3H), 7.10 (dd, J = 8.0 and 1.5 Hz, 1H), 6.77 – 6.74 (m, 2H),  4.49 (d, J = 
14.5 Hz, 1H), 4.43 (d, J = 14.5 Hz, 1H), 3.95 (dd, J = 9.0 and 6.0 Hz, 1H), 3.53 – 
3.45 (m, 1H), 3.39 – 3.33 (m, 1H), 2.87 (s, 3H), 2.44 – 2.28 (m, 2H); 13C NMR (101 
MHz, CDCl3) δ 175.5, 148.6, 136.3, 128.8, 128.2, 128.0, 127.6, 125.6, 124.5, 117.4, 
111.3, 46.8, 45.6, 43.1, 30.8, 24.4; IR (film): 3465, 1753 cm−1; HRMS (ESI) m/z 
calcd for C18H21N2O [M+H]+ 281.1648; found 281.1635. 
 
 1-benzyl-3-(2-(phenylamino)phenyl)pyrrolidin-2-one (28). 
The titled compound was prepared according to the general 
procedure using 1-phenylindolin-2-one (16) and N-
benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give 28 (116 
mg, 68%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 
7.73 (br s, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.36 – 7.32 (m, 3H), 
7.29 – 7.22 (m, 6H), 7.06 – 7.02 (m, 3H), 6.88 (t, J = 7.5 Hz, 1H), 4.53 (d, J = 15.0 
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Hz, 1H), 4.49 (d, J = 15.0 Hz, 1H), 4.17 (t, J = 8.0 Hz, 1H), 3.51 – 3.48 (m, 1H), 3.39 
– 3.37 (m, 1H), 2.47 – 2.41 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 175.8, 144.6, 
142.9, 136.2, 130.3, 129.3, 128.8, 128.0, 127.9, 127.7, 126.6, 122.3, 120.9, 119.6, 
116.9, 46.9, 45.5, 43.8, 24.3;  IR (film): 3455, 1784 cm−1; HRMS (ESI) m/z calcd for 
C23H23N2O [M+H]
+ 343.1805; found 343.1826.  
 
 1-(3-fluorophenyl)indolin-2-one (29). The titled compound was 
prepared according to the general procedure 2, using indolin-2-one 
(1) and 1-bromo-3-fluorobenzene to give 29 (177 mg, 78%) as 
pink solid. 1H NMR (400 MHz, CDCl3) δ 7.59 – 7.48 (m, 1H), 
7.33 (d, J = 8.0 Hz, 1H), 7.27 – 7.08 (m, 5H), 6.86 (d, J = 8.0 Hz, 
1H), 3.73 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 174.2, 163.1 (d, 
J = 246 Hz), 144.6, 136.0 (d, J = 10 Hz), 130.8 (d, J = 10 Hz), 127.9, 124.9, 124.2, 
123.1, 122.2 (d, J = 3 Hz), 115.2 (d, J = 22 Hz), 114.1 (d, J = 22 Hz), 109.4, 36.0; 
mp: 89 – 100 °C; IR (film): 3326, 1691 cm−1; HRMS (ESI) m/z calcd. for C14H11FNO 
[M+H]+ 228.0819; found 228.0831. 
 
 1-benzyl-3-(2-((3-fluorophenyl)amino)phenyl)pyrrolidin-
2-one (30). The titled compound was prepared according to 
the general procedure using 1-(3-fluorophenyl)indolin-2-one 
(29) and N-benzylethanolamine (3). The product was purified 
by flash chromatography (cyclohexane/EtOAc 7:3) to give 30  
(124 mg, 69%) as pink solid. 1H NMR (400 MHz, CDCl3) δ 
7.91 (br s, 1H), 7.49 (dd, J = 8.5 and 1.5 Hz, 1H), 7.35 – 7.31 
(m, 3H), 7.27 – 7.22 (m, 4H), 7.20 – 7.24 (m, 1H), 7.10 – 
7.05 (m, 1H), 6.75 – 6.72 (m, 1H), 6.69 (dt, J = 11.5 and 2.5 Hz, 1H), 6.53 (td, J = 
8.5 and 2.5 Hz, 1H), 4.53 (d, J = 15.0 Hz, 1H), 4.46 (d, J = 15.0 Hz, 1H), 4.13 (t, J = 
8.0 Hz, 1H), 3.51 – 3.45 (m, 1H), 3.41 – 3.35 (m, 1H), 2.46 – 2.40 (m, 2H); 13C NMR 
(101 MHz, CDCl3) δ 175.7, 163.9 (d, J = 242 Hz), 146.7 (d, J = 10 Hz), 141.8, 136.1, 
130.3 (d, J = 10 Hz), 128.8, 128.0, 127.9 (d, J = 22 Hz), 126.6, 123.2, 122.1, 111.9 
(d, J = 2 Hz), 105.7 (d, J = 22 Hz), 102.7 (d, J = 25 Hz), 46.9, 45.5, 43.8, 24.2; mp: 
96-98 °C; IR (film): 3330, 1668, cm−1; HRMS (ESI) m/z calcd for C23H22FN2O 
[M+H]+ 361.1711; found 361.1736.  
 
 1-(3-methoxyphenyl)indolin-2-one (31). The titled compound 
was prepared according to the general procedure 2, using indolin-
2-one (1) and 1-bromo-3-methoxybenzene to give 31 (149 mg, 
62%) as off-white solid. 1H NMR (400 MHz, CDCl3) δ 7.46 – 
7.41 (m, 1H), 7.32 (d, J = 7.5 Hz, 1H), 7.22 (t, J = 8.0 Hz, 1H), 
7.08 (t, J = 7.5 Hz, 1H), 7.03 – 6.95 (m, 3H), 6.83 (d, J = 8.0 Hz, 
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1H), 3.84 (s, 3H), 3.72 (s, 2H); HRMS (ESI) m/z calcd. for C15H14NO2 [M+H]
+ 
240.1092; found 240.1085. The chemical-physical data are in accordance whit the 
literature.96 
 1-benzyl-3-(2-((3-
methoxyphenyl)amino)phenyl)pyrrolidin-2-one (32). The 
titled compound was prepared according to the general 
procedure using 1-(3-methoxyphenyl)indolin-2-one (31) and 
N-benzylethanolamine (3). The product was purified by flash 
chromatography (cyclohexane/EtOAc 7:3) to give 32 (119 
mg, 64%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 
7.74 (br s, 1H), 7.53 – 7.49 (m, 1H), 7.38 – 7.30 (m, 3H), 7.29 
– 7.22 (m, 4H), 7.20 – 7.13 (m, 1H), 7.07 – 7.01 (m, 1H), 6.63 – 6.56 (m, 2H), 6.46 – 
6.42 (m, 1H), 4.52 (d, J = 15.0 Hz, 1H), 4.49 (d, J = 15.0 Hz, 1H), 4.18-4.12 (m, 1H), 
3.79 (s, 3H), 3.51 – 3.45 (m, 1H), 3.40 – 3.34 (m, 1H), 2.46 – 2.41 (m, 2H); 13C NMR 
(101 MHz, CDCl3) δ 175.7, 160.8, 146.1, 142.5, 136.1, 130.5, 130.0, 128.8, 128.0, 
127.9, 127.7, 126.5, 122.6, 121.7, 109.4, 105.2, 102.2, 55.2, 46.9, 45.5, 43.7, 24.0; IR 
(film): 3333, 1683 cm−1; HRMS (ESI) m/z calcd for C24H25N2O2 [M+H]
+ 373.1911; 
found 373.1932. 
 
  1-(3-(dimethylamino)phenyl)indolin-2-one (33). The titled 
compound was prepared according to the general procedure 2, 
using indolin-2-one (1) and 4-bromo-N,N-dimethylaniline to give 
33 (155 mg, 62%) as off-white solid. 1H NMR (400 MHz, CDCl3) δ 
7.34 (d, J = 8.0 Hz, 1H), 7.30 – 7.26 (m, 2H), 7.23 (t, J = 8.0 Hz, 
1H), 7.10 (t, J = 8.0 Hz, 1H), 6.91 – 6.83 (m, 2H), 6.79 (d, J = 7.5 
Hz, 1H), 3.74 (s, 2H), 3.06 (s, 6H); HRMS (ESI) m/z calcd. for 
C16H17N2O [M+H]
+ 253.1335; found 253.1341. The chemical-
physical data are in accordance whit the literature.87 
 1-benzyl-3-(2-((4-
(dimethylamino)phenyl)amino)phenyl)pyrrolidin-2-one 
(35). The titled compound was prepared according to the 
general procedure using 1-(4-(dimethylamino)phenyl)indolin-
2-one (33) and N-benzylethanolamine (3). The product was 
purified by flash chromatography (cyclohexane/EtOAc 7:3) to 
give 35 (115 mg, 60%) as yellowish oil. 1H NMR (400 MHz, 
CDCl3) δ 7.48 (br s, 1H), 7.23 – 7.00 (m, 7H), 6.99 – 6.89 (m, 
2H), 6.79 (d, J = 9.0 Hz, 2H), 6.68-6.59 (m, 1H), 6.60 (d, J = 
9.0 Hz, 2H), 4.41 – 4.25 (m, 2H), 3.93 (dd, J = 9.0 and 6.5 
Hz, 1H), 3.39 – 3.28 (m, 1H), 3.25 – 3.16 (m, 1H), 2.71 (s, 6H), 2.30 – 2.22 (m, 2H); 
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13C NMR (101 MHz, Acetone-d6) δ 175.3, 146.4, 145.5, 137.0, 134.3, 128.6, 128.2, 
127.8, 127.3, 126.5, 121.0, 119.8, 116.5, 114.2, 46.2, 45.2, 43.1, 40.6, 24.4; IR (film): 
3328, 1721 cm−1; HRMS (ESI) m/z calcd for C25H28N3O [M+H]
+ 386.2227; found 
386.2231. 
  1-(pyridin-2-yl)indolin-2-one (36). The titled compound was 
prepared according to the general procedure, using indolin-2-one (1) 
and 2-bromopyridine to give 36 (108 mg, 51%) as off-white solid. 
1H NMR (400 MHz, CDCl3) δ 8.61 (d, J = 5.0 Hz, 1H), 7.88 (t, J = 
8.0 Hz, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.55 (d, J = 8.0 Hz, 1H), 7.32 
– 7.25 (m, 3H), 7.12 (t, J = 8.0 Hz, 1H), 3.75 (s, 2H); mp: 145-147 
°C. HRMS (ESI) m/z calcd. for C13H11N2O [M+H]
+ 211.0866; found 211.0857. The 
chemical-physical data are in accordance whit the literature97. 
 
 1-benzyl-3-(2-(pyridin-2-ylamino)phenyl)pyrrolidin-2-one 
(37). The titled compound was prepared according to the 
general procedure using 1-(pyridin-2-yl)indolin-2-one (36) 
and N-benzylethanolamine (3). The product was purified by 
flash chromatography (cyclohexane/EtOAc 1:9) to give 37 
(83 mg, 49%) as yellowish oil. 1H NMR (400 MHz, CDCl3) δ 
8.37 (d, J = 3.0 Hz, 1H), 8.10 (dd, J = 5.0 and 1.0 Hz, 1H), 
7.98 (s, 1H), 7.41 (d, J = 7.5 Hz, 1H), 7.33 – 7.20 (m, 8H), 
7.15 – 7.12 (m, 1H), 7.07 – 7.03 (m, 1H),  4.53 – 4.44 (m, 2H), 4.17 – 4.13  (m, 1H), 
3.52 – 3.48 (m, 1H), 3.41– 3.36 (m, 1H), 2.48 – 2.43 (m, 2H); 13C NMR (101 MHz, 
CDCl3) δ 175.7, 141.9, 141.0, 140.7, 139.5, 135.9, 128.8, 128.6, 128.4, 128.0, 127.9, 
127.8, 126.5, 123.7, 123.0, 122.7, 120.7, 47.0, 45.6, 43.7, 24.0; IR (film): 3308, 1758 
cm−1; HRMS (ESI) m/z calcd for C22H22N3O [M+H]
+ 344.1757; found 344.1786. 
 
 
 1-(pyridin-3-yl)indolin-2-one (38). The titled compound was 
prepared according to the general procedure 2, using indolin-2-one 
(1) and 3-bromopyridine to give 38 (103 mg, 49%) as off-white solid. 
1H NMR (400 MHz, CDCl3) δ 8.74 (br d, J = 2.5 Hz, 1H), 8.66 –  
8.65 (m, 1H), 7.82 – 7.79 (m, 1H), 7.49 (dd, J = 8.0 and 5.0 Hz, 1H), 
7.34 (d, J = 7.5 Hz, 1H), 7.24 (d, J = 7.5 Hz, 1H), 7.12 (t, J = 7.5 Hz, 
1H), 6.81 (d, J = 8.0 Hz, 1H), 3.75 (s, 2H); mp: 165-167 °C; HRMS (ESI) m/z calcd. 
for C13H11N2O [M+H]
+ 211.0866; found 211.0859. The chemical-physical data are in 
accordance whit the literature98. 
 
 1-benzyl-3-(2-(pyridin-3-ylamino)phenyl)pyrrolidin-2-one 
(39). The titled compound was prepared according to the 
general procedure using 1-(pyridin-3-yl)indolin-2-one (38) 
and N-benzylethanolamine (3). The product was purified by 
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flash chromatography (cyclohexane/EtOAc 1:9) to give 39 (119 mg, 70%) as 
yellowish oil. 1H NMR (400 MHz, CDCl3) δ 8.26 (br s, 1H), 8.19 (d, J = 4.0 Hz, 1H), 
7.66 (d, J = 8.0 Hz, 1H), 7.46 (t, J = 8.0 Hz, 1H), 7.34 – 7.10 (m, 7H), 7.12 (t, J = 7.5 
Hz, 1H), 6.73 – 6.67 (m, 2H), 4.53 (d, J = 14.5 Hz, 1H), 4.45 (d, J = 14.5 Hz, 1H), 
4.14 (t, J = 8.0 Hz, 1H), 3.46 – 3.40 (m, 1H), 3.36 – 3.30 (m, 1H), 2.41 – 2.32 (m, 
2H); 13C NMR (101 MHz, CDCl3) δ 175.4, 156.9, 148.3, 139.9, 137.5, 136.2, 132.0, 
128.8, 128.1, 127.9, 127.7, 126.7, 124.2, 114.4, 109.0, 47.0, 45.3, 43.9, 24.7; IR 
(film): 3318, 1778 cm−1; HRMS (ESI) m/z calcd for C22H22N3O [M+H]
+ 344.1757; 
found 344.1758. 
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5.3.3 Iron-Catalyzed Direct C3-Benzylaion of Indoles with Benzyl Alcohols 
through Borrowing Hydrogen 
 
General Procedure for C3-Alkylation of Indole with Benzyl Alcohol. A vial was 
charged with the appropriate indole (0.5 mmol), the appropriate alcohol (1 mmol), 
iron(II) phthalocyanine (Fe(II)Pc) (3 mg, 0.005 mmol), and Cs2CO3 (179 mg, 0.55 
mmol). The vial was immersed in a preheated (140 °C) oil bath and stirred at this 
temperature for 16 h. The reaction mixture was diluted with ethyl acetate and filtered 
over a plug of Celite. The solvent was evaporated under reduced pressure, and the 
residue obtained was purified by flash chromatography.  
 3-Benzyl-1H-indole (3a). The title compound was prepared 
according to the general procedure using 1H-indole and benzyl 
alcohol. The product was purified by flash chromatography 
(cyclo- hexane/EtOAc 8:2) to give (3a) (102 mg, 99%) as white 
solid. 1H NMR (400 MHz, CDCl3): δ 7.92 (br s, 1H), 7.57 (d, J = 
8.0 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.33−7.30 (m, 4H), 
7.24−7.14 (m, 2H), 7.12 (t, J = 7.0 Hz, 1H), 6.93 (s, 1H), 4.16 (s, 2H); HRMS (ESI) 
m/z calcd for C15H13NNa (M+Na)
+  230.0940; found 230.0946. The chemical- 
physical data are in accordance with literature99. 
 3-(4-Methylbenzyl)-1H-indole (3b). The title compound was 
prepared according to the general procedure using 1H-indole 
and p-tolylmethanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 9:1) to give (3b) (78 
mg, 71%) as pinkish solid. 1H NMR (400 MHz, CDCl3) δ 7.87 
(br s, 1H), 7.59 (d, J = 8.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 
7.26−7.22 (m, 3H), 7.16−7.12 (m, 3H), 6.92−6.91 (m, 1H), 4.14 (s, 2H), 2.38 (s, 3H); 
HRMS (ESI) m/ z calcd for C16H16N (M+H)
+ 222.1277; found 222.1286. The 
chemical-physical data are in accordance with literature100. 
 3-(3-Methylbenzyl)-1H-indole (3c). The title compound was 
prepared according to the general procedure using 1H-indole 
and m-tolylmethanol. The product was purified by flash 
chromatography(cyclohexane/EtOAc 8:2) to give (3c) (108 mg, 
98%) as brown solid. 1H NMR (400 MHz, CDCl3): δ 7.76 (br s, 
1H), 7.70 (d, J = 8.0 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.33 (t, J 
= 8.0 Hz, 2H), 7.27−7.23 (m, 3H), 7.17 (d, J = 7.0 Hz, 1H), 6.92 (s, 1H), 4.22 (s, 2H), 
2.46 (s, 3H); HRMS (ESI) m/z calcd for C16H16N (M+H)
+ 222.1277; found 222.1283. 
The chemical-physical data are in accordance with literature86.  
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 3-(2-Methylbenzyl)-1H-indole (3d). The title compound was 
prepared according to the general procedure using 1H-indole and 
o-tolylmethanol. The product was purified by flash 
chromatography (gradient from cyclohexane/EtOAc 8:2 to 
cyclohexane/EtOAc 7:3) to give (3d) (83 mg, 75%) as pinkish 
solid. 1H NMR (400 MHz, CDCl3): δ 7.85 (br s, 1H), 7.65 (d, J = 
8.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 1H), 7.30−7.15 (m, 6H), 6.74 (s, 1H), 4.15 (s, 2H), 
2.41 (s, 3H); HRMS (ESI) m/z calcd for C16H16N (M+H)
+ 222.1277; found 222.1274. 
The chemical-physical data are in accordance with literature86.  
 3-(Biphenyl-3-ylmethyl)-1H-indole (3e). The title 
compound was prepared according to the general procedure 
using 1H-indole and biphenyl-3-ylmethanol. The product was 
purified by flash chromatography (cyclohexane/EtOAc 9:1) to 
give (3e) (65 mg, 46%) as orange solid. 1H NMR (400 MHz, 
CDCl3) δ 7.99 (br s, 1H), 7.61−7.57 (m, 3H), 7.53 (d, J = 8.0 
Hz, 3H), 7.44 (t, J = 8.0 Hz, 2H), 7.40−7.32 (m, 3H), 
7.24−7.20 (m, 1H), 7.14−7.10 (m, 1H), 6.98 (br s, 1H), 4.18 
(s, 2H); 13C NMR (101 MHz, CDCl3) δ 141.1, 140.4, 138.8, 
136.4, 129.1, 128.7, 127.5, 127.1, 127.0, 122.4, 122.1, 119.4, 119.2, 115.7, 111.1, 
31.2; mp 194−196 °C; IR (film): 3412, 3056 cm−1; HRMS (ESI) m/z calcd for 
C21H18N (M+H)
+ 284.1434; found 284.1439.  
 3-(4-Methoxybenzyl)-1H-indole (3f). The title compound 
was prepared according to the general procedure using 1H-
indole and (4-methoxyphenyl)methanol. The product was 
purified by flash chromatography (gradient from 
cyclohexane/EtOAc 95:5 to cyclo- hexane/EtOAc 90:10) to 
give (3f) (89 mg, 75%) as brown solid. 1H NMR (400 MHz, 
CDCl3) δ 7.96 (br s, 1H), 7.58 (d, J = 8.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 1H), 
7.29−7.22 (m, 3H), 7.14 (t, J = 8.0 Hz, 1H), 6.93 (s, 1H), 6.88 (d, J = 8.0 Hz, 2H), 
4.11 (s, 2H), 3.83 (s, 3H); HRMS (ESI) m/z calcd for C16H16NO (M + H)+ 
238.1226; found 238.1221. The chemical-physical data are in accordance with 
literature101. 
 2-((1H-Indol-3-yl)methyl)aniline (3g). The title compound was 
prepared according to the general procedure using 1H-indole and 
(2- aminophenyl)methanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give (3g) (62 mg, 
56%) as off-white solid. 1H NMR (400 MHz, acetone-d6) δ 
10.05 (br s, 1H), 7.53−7.51 (m, 1H), 7.40 (dt, J = 8.0, 1.0 Hz, 
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1H), 7.13−7.05 (m, 3H), 7.01−6.95 (m, 2H), 6.72 (dd, J = 8.0, 1.5 Hz, 1H), 6.59 (dt, J 
= 7.5, 1.5 Hz, 1H), 4.40 (br s, 2H), 3.99 (s, 2H). 13C NMR (101 MHz, Acetone-d6) δ 
146.0, 137.1, 129.7, 127.7, 126.8, 125.0, 122.9, 121.3, 118.8, 118.5, 117.1, 115.1, 
113.0, 111.3, 27.4; HRMS (ESI) m/z calcd for C15H15N2 (M+H)+ 223.1230; found 
223.1241. The chemical-physical data are in accordance with literature102.  
 2-((1H-Indol-3-yl)-methyl)phenol (3h). The title compound 
was prepared according to the general procedure using 1H-indole 
and 2- (hydroxymethyl)phenol. The product was purified by 
flash chromatography (cyclohexane/EtOAc 1:1) to give (3h) (47 
mg, 42%) as pale yellow solid. 1H NMR (400 MHz, acetone-d6) 
δ 9.99 (br s, 1H), 8.28 (s, 1H), 7.57−7.54 (m, 1H), 7.38 (dt, J = 
8.0, 1.0 Hz, 1H), 7.12−7.06 (m, 3H), 7.04−6.96 (m, 2H), 6.88 
(dd, J = 8.0, 1.0 Hz, 1H), 6.71 (dt, J = 7.5, 1.0 Hz, 1H), 4.10 (s, 2H); HRMS (ESI) 
m/z calcd for C15H14NO (M+H)
+ 224.1070; found 224.1079. The chemical-physical 
data are in accordance with literature103.  
 3-(4-Chlorobenzyl)-1H-indole (3i). The title compound 
was prepared according to the general procedure using 1H-
indole and (4-chlorophenyl)methanol. The product was 
purified by flash chromatography (cyclohexane/EtOAc 8:2) 
to give (3i) (54 mg, 45%) as off-white solid. 1H NMR (400 
MHz, CDCl3) δ 7.95 (br s, 1H), 7.51 (d, J = 8.0 Hz, 1H), 
7.38 (d, J = 8.0 Hz, 1H), 7.33−7.22 (m, 5H), 7.12 (t, J = 7.0 Hz, 1H), 6.93 (s, 1H), 
4.12 (s, 2H); HRMS (ESI) m/z calcd for C15H13ClN (M+H)
+ 242.0731; found 
242.0726. The chemical- physical data are in accordance with literature89. 
 3-(2-Chlorobenzyl)-1H-indole (3j). The title compound was 
prepared in according to the general procedure using 1H-indole 
and (2-chlorophenyl)methanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give (3j) (44 mg, 
37%) as white solid. 1H NMR (400 MHz, CDCl3): δ 7.98 (br s, 
1H), 7.58 (d, J = 8.0 Hz, 1H), 7.43−7.38 (m, 2H), 7.25−7.11 (m, 
5H), 6.96 (s,1H), 4.25 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 138.7, 136.4, 134.0, 
130.6, 129.4, 127.4, 127.3, 126.7, 122.7, 122.1, 119.5, 119.1, 114.0, 111.1, 29.1; 
HRMS (ESI) m/z calcd for C15H13ClN (M+ H)
+ 242.0731; found 242.0742. 
  3-(4-Fluorobenzyl)-1H-indole (3k). The title compound 
was prepared according to the general procedure using 1H-
indole and (4-fluorophenyl)methanol. The product was 
purified by flash chromatography (cyclohexane/EtOAc 8:2) 
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to give (3k) (76 mg, 68%) as white solid. 1H NMR (400 MHz, CDCl3) δ 7.99 (br s, 
1H), 7.58 (d, J = 8.0 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.23−7.14 (m, 3H), 7.13− 6.99 
(m, 4H), 4.15 (s, 2H); HRMS (ESI) m/z calcd for C15H13FN (M+H)
+ 226.1027; found 
226.1036. The chemical-physical data are in accordance with literature86. 
 
 
 3-(4-(Trifluoromethyl)benzyl)-1H-indole (3l). The title 
compound was prepared according to the general 
procedure using 1H-indole and(4 
(trifluoromethyl)phenyl)methanol. The product was 
purified by flash chromatography (cyclohexane/EtOAc 
9:1) to give (3l) (97 mg, 71%) as off-white solid. 1H NMR 
(400 MHz, CDCl3) δ 8.01 (br s, 1H), 7.54 (d, J = 8.0 Hz, 2H), 7.49 (d, J = 8.0 Hz, 
1H), 7.41−7.39 (m, 3H), 7.23 (t, J = 7.5 Hz, 1H), 7.11 (t, J = 7.5 Hz, 1H), 7.02−6.93 
(m, 1H), 4.19 (s, 2H); HRMS (ESI) m/z calcd for C16H13F3N (M+H)
+ 276.0995; 
found 275.0988. The chemical-physical data are in accordance with literature86. 
 4-((1H-Indol-3-yl)methyl)benzonitrile (3m). The title 
compound was prepared according to the general 
procedure using 1H-indole and 4-
(hydroxymethyl)benzonitrile. The product was purified by 
flash chromatography (from cyclohexane/EtOAc 1:1 to 
cyclohexane/ EtOAc 1:9) to give (3m) (83 mg, 72%) as 
off-white solid. 1H NMR (400 MHz, acetone-d6) δ 10.11 (br s, 1H), 7.86 (d, J = 8.0 
Hz, 2H), 7.46 (d, J = 7.5 Hz, 1H), 7.46 (d, J = 8.0 Hz, 2H), 7.19−7.18 (m,1H), 
7.11−7.07 (m,1H), 6.99−6.95 (m,1H), 4.18 (s, 2H); HRMS (ESI) m/ z calcd for 
C16H13N2 (M+H)
+ 233.1073; found 233.1068. The chemical-physical data are in 
accordance with literature104. 
 3-(3,4,5-Trimethoxybenzyl)-1H-indole (3n). The title 
compound was prepared according to the general procedure 
using 1H-indole and (3,4,5-trimethoxyphenyl)methanol. 
The product was purified by flash chromatography 
(cyclohexane/EtOAc 8:2) to give (3n) (92 mg, 62%) as 
orange solid. 1H NMR (400 MHz, CDCl3) δ 8.01 (br s, 1H), 
7.57 (d, J = 8.0 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.21 (t, J 
= 8.0 Hz, 1H), 7.11 (t, J = 8.0 Hz, 1H), 6.95 (s, 1H), 6.54 (s, 2H), 4.07 (s, 2H), 3.84 
(s, 3H), 3.81 (s, 6H); HRMS (ESI) m/z calcd for C18H20NO3 (M+H)
+ 298.1438; found 
298.1435. The chemical-physical data are in accordance with literature85. 
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 3-(Naphthalen-2-ylmethyl)-1H-indole (3o). The title 
compound was prepared according to the general 
procedure using 1H-indole and naphthalen-2-ylmethanol. 
The product was purified by flash chromatography 
(cyclohexane/EtOAc 8:2) to give (3o) (91 mg, 71%) as off-
white solid. 1H NMR (400 MHz, CDCl3) δ 7.98 (br s, 1H), 
7.83−7.74 (m, 4H), 7.56 (dd, J = 8.0, 1.0 Hz, 1H), 7.46−7.41 (m, 3H), 7.39 (dt, J = 
8.0, 1.0 Hz, 1H), 7.21 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 7.09 (ddd, J = 8.0, 7.0, 1.0 Hz, 
1H), 6.96−6.95 (m, 1H), 4.30 (s, 2H); HRMS (ESI) m/z calcd for C19H16N (M+H)+ 
258.1277; found 258.1271. The chemical-physical data are in accordance with 
literature105. 
 3-(3,5-Dichlorobenzyl)-1H-indole (3p). The title compound 
was prepared according to the general procedure using 1H-
indole and (3,5- dichlorophenyl)methanol. The product was 
purified by flash chromatography (cyclohexane/EtOAc 98:2) 
to give (3p) (53 mg, 39%) as brown oil. 1H NMR (400 MHz, 
CDCl3) δ 8.02 (br s, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.40 (d, J = 
8.0 Hz, 1H), 7.29−7.12 (m, 5H), 6.98 (s, 1H), 4.08 (s, 2H); 13C 
NMR (101 MHz, CDCl3) δ 144.8, 136.4, 134.7, 127.14, 127.08, 126.2, 122.6, 122.4, 
119.7, 118.9, 114.0, 111.2, 31.1; IR (film): 3170, 2949, 2824, 1555 cm−1; HRMS 
(ESI) m/ z calcd for C15H12Cl2N (M+H)
+ 276.0341; found 276.0334. 
 3-(Benzo[d][1,3]dioxol-5-ylmethyl)-1H-indole (3q). The 
title comound was prepared according to the general 
procedure using 1H- indole and benzo[d][1,3]dioxol-5-
ylmethanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give (3q) (105 
mg, 84%) as brown solid. 1H NMR (400 MHz, CDCl3) δ 
7.95 (br s, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.23 (t, J = 8.0 Hz, 
1H), 7.13 (t, J = 8.0 Hz, 1H), 6.94 (s, 1H), 6.82−6.76 (m, 3H), 5.93 (s, 2H), 4.07 (s, 
2H); HRMS (ESI) m/z calcd for C16H14NO2 (M+H)
+ 252.1019; found 252.1013. The 
chemical- physical data are in accordance with literature87. 
 3-(Thiophen-2-ylmethyl)-1H-indole (3r). The title compound 
was prepared according to the general procedure using 1H-indole 
and thiophen-2-ylmethanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 8:2) to give (3r) (101 mg, 
95%) as brown solid. 1H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 
7.60 (d, J = 8.0 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.25−7.21 (m, 1H), 7.16−7.11 (m, 
2H), 7.06−7.05 (m, 1H), 6.95 (dd, J = 5.0, 4.0 Hz, 1H), 6.91−6.90 (m, 1H), 4.35 (s, 
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2H); HRMS (ESI) m/z calcd for: C13H12NS (M+H)
+ 214.0685; found 214.0677. The 
chemical-physical data are in accordance with literature87.  
 3-(Furan-2-ylmethyl)-1H-indole (3s). The title compound was 
prepared according to the general procedure using 1H-indole and 
furan-2-ylmethanol. The product was purified by flash 
chromatography (cyclohexane/EtOAc 95:5) to give (3s) (76 mg, 
78%) as brown solid. 1H NMR (400 MHz, CDCl3) δ 7.80 (br s, 
1H), 7.71 (d, J = 8.0 Hz, 1H), 7.45 (s, 1H), 7.34 (dt, J = 8.0, 7.6 Hz, 2H), 7.27−7.21 
(m, 1H), 7.02 (s, 1H), 6.41 (dd, J = 3.0, 2.0 Hz, 1H), 6.16 (d, J = 3.0 Hz, 1H), 4.24 (s, 
2H); HRMS (ESI) m/z calcd for C13H11NONa (M+Na)
+ 220.0733; found 220.0737. 
The chemical-physical data are in accordance with literature87. 
 1,3-Bis((1H-indol-3-yl)methyl)benzene (3t). The title 
compound was prepared according to the general 
procedure using 1H-indole (234 mg, 2 mmol) and 1,3-
phenylenedimethanol (138 mg, 1 mmol). The product 
was purified by flash chromatography 
(cyclohexane/EtOAc 8:2) to give (3t) (97 mg, 58%) as 
brown oil. 1H NMR (400 MHz, CDCl3): δ 7.88 (br s, 
2H), 7.53 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 
7.28 (br s, 1H), 7.23−7.19 (m, 3H), 7.15−7.04 (m, 4H), 6.87 (s, 2H), 4.09 (s, 4H); 13C 
NMR (101 MHz, CDCl3): δ 141.2, 136.4, 129.2, 128.3, 127.5, 126.3, 122.3, 122.0, 
119.3, 119.2, 116.0, 111.1, 31.6; IR (film): 3165, 2929, 2820, 1556 cm−1; HRMS 
(ESI) m/z calcd for C24H21N2 (M+H)
+ 337.1699; found 337.1691.  
 3-(3-((1H-Indol-3-yl)methyl)benzyl)-6-fluoro-
1H-indole (3u). A vial was charged with 1H-
indole (59 mg, 0.5 mmol), 1,4-phenyl- 
enedimethanol (69 mg, 1 mmol), iron(II) 
phthalocyanine (2.5 mg, 0.005 mmol), and 
Cs2CO3 (179 mg, 0.55 mmol). The vial was 
immersed in a preheated (140 °C) oil bath and stirred at this temperature for 16 h. 
Than the vial was removed from oil bath, and 6-fluoro-1H-indole (67 mg, 0.5 mmol) 
was added to the reaction mixture and stirred again for 16 h at 140 °C. The reaction 
mixture was diluted with ethyl acetate and filtered over a plug of silica gel. The 
solvent was evaporated under reduced pressure, and the residue obtained was purified 
by flash chromatography (cyclohexane/EtOAc 7:3) to give (3u) (93 mg, 52%) as off-
white solid. 1H NMR (400 MHz, CDCl3): δ 7.93 (br s, 1H), 7.94 (br s, 1H), 7.49 (d, J 
= 8.0 Hz, 1H), 7.23−7.18 (m, 3H), 7.14−7.01 (m, 5H), 6.88−6.78 (m, 3H), 4.08 (s, 
2H), 4.04 (s, 2H); 13C NMR (101 MHz, CDCl3): δ 159.9 (d, J = 236 Hz), 141.0 (d, J = 
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39 Hz), 136.43, 136.39, 136.3, 129.1, 128.3, 127.4, 126.4, 126.3, 126.2, 124.1, 122.5 
(d, J = 3 Hz), 122.2, 122.0, 120.0, 119.9 (d, J = 10 Hz), 119.2 (d, J = 10 Hz), 116.0 
(d, J = 12 Hz), 111.0, 108.0 (d, J = 25 Hz), 97.3 (d, J = 25 Hz), 31.59, 31.57; mp 
166−168 °C; IR (film): 3161, 2932, 2816, 1549 cm−1; HRMS (ESI) m/z calcd for 
C24H20FN2 (M+H)
+ 355.1605; found 355.1611.  
 3-(1-Phenylethyl)-1H-indole (3v). The title compound was prepared 
according to the general procedure using 1H-indole and 1-
phenylethanol. The product was purified by flash chromatography 
(cyclohexane/EtOAc 8:2) to give (3v) (79 mg, 72%) as yellowish solid. 
1H NMR (400 MHz, CDCl3) δ 7.88 (br s, 1H), 7.45 (dd, J = 8.0, 2.5 
Hz, 1H), 7.38−7.35 (m, 4H), 7.26−7.21 (m, 2H), 7.11−7.07 (m, 1H), 
7.02 (s, 1H), 4.45 (q, J = 7.0 Hz, 1H), 1.78 (d, J = 7.0 Hz, 3H); HRMS 
(ESI) m/z calcd for C16H16N (M+H)
+ 222.1277; found 222.1269. The chemical-
physical data are in accordance with literature86.  
3-Benzhydryl-1H-indole (3w). The title compound was 
prepared according to the general procedure using 1H-indole and 
diphenylmethanol. The product was purified by flash 
chromatography (cyclo- hexane/EtOAc 9:1) to give (3w) (52 mg, 
37%) as yellowish solid. 1H NMR (400 MHz, CDCl3) δ 7.89 (s, 
1H), 7.38−7.19 (m, 13H), 7.04 (dt, J = 7.5, 1.0 Hz, 1H), 6.57 (t, J     
= 2.0, 1.0 Hz, 1H), 5.73 (s, 1H); HRMS (ESI) m/z calcd for 
C21H18N (M+H)
+ 284.1434; found 284.1439. The chemical-physical data are in 
accordance with literature86. 
 N-(2-(1H-indol-3-yl)-2-phenylethyl)acetamide (3x). The title 
compound was prepared according to the general procedure 
using 1H-indole and N-(2-hydroxy-2-phenylethyl)acetamide. 
The product was purified by flash chromatography (EtOAc) to 
give (3x) (62 mg, 45%) as yellowish solid. 1H NMR (400 MHz, 
CDCl3) δ 8.23 (br s, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.37 (d, J = 
8.0 Hz, 1H), 7.32−7.31 (m, 4H), 7.24 (dd, J = 5.0, 4.0 Hz, 1H), 
7.21−7.16 (m, 1H), 7.09 (br s, 1H), 7.07−7.03 (m, 1H), 5.51 (br s, 1H), 4.44 (t, J = 
8.0 Hz, 1H), 4.11−4.04 (m, 1H), 3.86−3.79 (m, 1H), 1.91 (s, 3H); HRMS (ESI) m/z 
calcd for C18H19N2O (M+H)
+ 279.1492; found 279.1486. The chemical-physical data 
are in accordance with literature106. 
 4-Methoxy-3-(4-methoxybenzyl)-1H-indole (3y). The 
title compound was prepared according to the general 
procedure using 4- methoxy-1H-indole and (3-((1H-indol-3-
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yl)methyl)phenyl)methanol. The product was purified by flash chromatography 
(gradient from cyclohexane/EtOAc 8:2 to cyclohexane/EtOAc 6:4) to give (3y) (117 
mg, 88%) as brown oil. 1H NMR (400 MHz, CDCl3): δ 7.88 (br s, 1H), 7.25 (d, J = 
8.0 Hz, 2H), 7.11 (t, J = 8.0 Hz, 1H), 6.95 (d, J = 8.0, 1H), 6.87−6.85 (m, 2H), 6.64 
(br s, 1H), 6.51 (d, J = 8.0 Hz, 1H), 4.26 (s, 2H), 3.90 (s, 3H), 3.82 (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ 157.6, 155.1, 138.1, 134.7, 129.8, 122.8, 120.9, 117.4, 
117.2, 113.6, 104.4, 99.5, 55.3, 55.1, 32.2; IR (film): 3397, 2848,1387 cm−1; HRMS 
(ESI) m/z calcd for: C17H18NO2 (M+H)+ 268.1332; found 268.1338.  
 3-(4-Methoxybenzyl)-6-methyl-1H-indole (3z). The 
title compound was prepared according to the general 
procedure using 6-methyl-1H-indole and (3-((1H-indol-
3-yl)methyl)phenyl)methanol. The product was purified 
by flash chromatography (cyclohexane/ EtOAc 8:2) to 
give (3z) (79 mg, 63%) as pinkish solid. 1H NMR (400 
MHz, CDCl3) δ 7.78 (br s, 1H), 7.45 (d, J = 8.0 Hz, 1H), 7.29−7.23 (m, 2H), 7.16 (s, 
1H), 6.98 (d, J = 8.0 Hz, 1H), 6.88 (m, 2H), 6.84 (s, 1H), 4.09 (s, 2H), 3.83 (s, 3H), 
2.51 (s, 3H); HRMS (ESI) m/z calcd for C17H18NO (M+H)
+ 252.1383; found 
252.1379. The chemical- physical data are in accordance with literature107. 
 5-Fluoro-3-(2-methylbenzyl)-1H-indole (3aa). The title 
compound was prepared according to the general procedure 
using 5-fluoro-1H- indole and (3-((1H-indol-3-
yl)methyl)phenyl)methanol. The product was purified by 
flash chromatography (cyclohexane/EtOAc 9:1) to give (3aa) 
(95 mg, 80%) as orange solid. 1H NMR (400 MHz, CDCl3) δ 7.94 (br s, 1H), 
7.30−7.26 (m, 2H), 7.23−7.14 (m, 4H), 6.95 (td, J = 9.0, 2.5 Hz, 1H), 6.80 (s, 1H), 
4.03 (s, 2H), 2.33 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 157.8 (d, J = 234 Hz), 
138.8, 136.5, 133.0, 130.3, 129.4, 128.0 (d, J = 10 Hz), 126.4, 126.1, 124.4, 115.3 (d, 
J = 5 Hz), 111.8 (d, J = 10 Hz), 110.4 (d, J = 26 Hz), 104.0 (d, J = 23 Hz), 29.3, 19.6; 
mp 65−66 °C; IR (film): 3310, 2901,1354 cm−1; HRMS (ESI) m/z calcd for 
C16H15FN (M+H)
+ 240.1183; found 240.1180.  
 
 6-Chloro-3-(4-methylbenzyl)-1H-indole (3ab). The 
title compound was prepared according to the general 
procedure using 6-chloro-1H-indole and (3-((1H-indol-3-
yl)methyl)phenyl)methanol. The product was purified by 
flash chromatography (cyclohexane/ EtOAc 8:2) to give 
(3ab) (82 mg, 64%) as brown solid. 1H NMR (400 MHz, CDCl3) δ 7.93 (br s, 1H), 
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7.41 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 2.0 Hz, 1H), 7.16 (d, J = 8.0 Hz, 2H), 7.10 (d, J 
= 8.0 Hz, 2H), 7.05 (dd, J = 8.0, 2.0 Hz, 1H), 6.92 (d, J = 1.0 Hz, 1H), 4.06 (s, 2H), 
2.33 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 137.7, 136.8, 135.5, 129.1, 128.5, 128.0, 
126.1, 122.8, 120.1, 116.3, 110.9, 31.0, 21.0; mp 98−99 °C; IR (film): 3220, 2965, 
2837, 1601 cm−1; HRMS (ESI) m/z calcd for C16H15ClN (M+H)
+ 256.0888; found 
256.0895. 
 
 3-Benzyl-2-phenyl-1H-indole (3ac). The title compound was 
prepared according to the general procedure using 2-phenyl-1H-
indole and benzyl alcohol. The product was purified by flash 
chromatography (cyclohexane/DCM 1:9) to give (3ac) (69 mg, 
49%) as off-white solid. 1H NMR (400 MHz, CDCl3) δ 8.15 (br 
s, 1H), 7.55−7.52 (m, 2H), 7.46−7.44 (m, 4H), 7.38−7.31 (m, 
2H), 7.26− 7.16 (m, 5H), 7.10−7.06 (m, 1H), 4.29 (s, 2H); HRMS (ESI) m/z calcd for 
C21H18N (M+H)
+ 284.1434; found 284.1438. The chemical-physical data are in 
accordance with literature108. 
Procedure for Large-Scale Synthesis of Compound (3a). A 50 
mL Schlenk flask equipped with a magnetic stir bar was charged 
with indole (1 g, 8.5 mmol), benzyl alcohol (1.8 g, 17 mmol), 
iron(II) phthalocyanine (48 mg, 0.085 mmol), and Cs2CO3 (3 g, 
9.35 mmol). The reaction mixture was immersed in a preheated 
(140 °C) oil bath and stirred at this temperature for 16 h. The 
reaction mixture was diluted with ethyl acetate and filtered over a plug of Celite. The 
solvent was evaporated under reduced pressure, and the residue obtained was purified 
by flash chromatography (cyclohexane/EtOAc 8:2) to give (3a) (1.6 g, 92%) as white 
solid. The chemical-physical data are in accordance as reported above. 
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Peña- López, M.; Piehl, P.; Elangovan, S.; Neumann, H.; Beller, M. Angew. Chem., Int. Ed. 2016, 
55, 14967. 
(66) Rivara, S.; Pala, D.; Bedini, A.; Spadoni, G. Expert Opin. Ther. Pat. 2015, 25, 425. 
(67) By using the chiral *Cp[(R,R)-Tsdpen]Ir (10 mol %), the product 5c was obtained in 81% yield 
with 51:49 e.r. whereas under the conditions of [{Ir(cod)Cl}2] and P, alkene ligand, Carreira ligand, 
the product (5c) was obtained in 69% yield with 48:52 e.r. 
(68) For examples demonstrating similar reactivity, in reversible catalytic dehydrogenation of 
alcohols, see (a) Bonitatibus, P. J.; Chakraborty, S.; Doherty,M. D.; Siclovan, O.; Jones, W. D.; 
Soloveichik, G. L. Proc. Natl. Acad. Sci. U.S.A. 2015, 112, 1687; (b) Tseng, K.-N. T.; Kampf, J. 
W.; Szymczak, N. K. ACS Catal. 2015, 5, 5468. 
(69) Shashikumar, N. D.; Krishnamurthy, G. N.; Rao, K. S. R.; Shridhara, K.; Bhojya Naik, H. S.; 
Nagarajan, K. Org. Process Res. Dev. 2010, 14, 918. 
 88 
 
                                                                                                                                                                                                          
(70) (a) Araujo, A. M.; Carvalho, F.; de Lourdes Bastos, M.; Guedes de Pinho, P.; Carvalho, M. 
Arch. Toxicol. 2015, 89,1151; (b) Vitaku, E.; Smith, D. T.; Njardarson, J. T. J. Med. Chem. 2014, 
57, 10257. 
(71) (a) Berger, M.; Gray, J. A.; Roth, B. L. Annu. Rev. Med. 2009, 60,355e366; (b) Smythies, J. 
Int. Rev. Neurobiol. 2005, 64, 217. 
(72) (a) Park, S.; Kang, K.; Lee, S. W.; Ahn, M.-J.; Bae, J.-M.; Back, K. Appl. Microbiol. Biot. 
2011, 89, 1387; (b) Revial, G.; Jabin, I.; Lim, S.; Pfau, M. J. Org. Chem. 2002, 67, 2252; (c) 
Young, E. H. P. J. Chem. Soc. 1958, 3493; (d) Somei, M.; Yamada, F.; Kurauchi, T.; Nagahama, 
Y.; Hasegawa, M.; Yamada, K.; Teranishi, S.; Sato, H.; Kaneko, C. Chem. Pharm. Bull. 2001, 49, 
87. 
(73) The amide-type compounds (7), (9), (11), and (13) are usually synthesized by N-acylation of 
tryptamine followed by oxidation of the indole ring with DMSO and 3 M HCl (1/9, v/v), 60 °C, 21 
h, in low yields and low compatibility of functional groups. 
(74) (a) Shen, K.; Liu, X.; Lin, L.; Feng, X. Chem. Sci. 2012, 3, 327–334. For an outstanding 
example: (b) Huang, A.; Kodanko, J. J.; Overman, L. E. J. Am. Chem. Soc. 2004, 126, 14043. (c) 
Pinto, A.; Jia, Y.; Neuville, L.; Zhu, J. Chem.—Eur. J. 2007, 13, 961–967. (d) Trost, B. M.; 
Frederiksen, M. U. Angew. Chem. Int. Ed. 2005, 44, 308–310. (e) Trost, B. M.; Malhotra, S.; Chan, 
W. H. J. Am. Chem. Soc. 2011, 133, 7328–7331. (f) Trost, B. M.; Zhang, Y. J. Am. Chem. Soc. 
2006, 128, 4590–4591. (g) Trost, B. M.; Zhang, Y. J. Am. Chem. Soc. 2007, 129, 14548–14549. (h) 
Trost, B. M.; Zhang, Y. Chem. Eur. J. 2010, 16, 296–303. (i) Trost, B. M.; Zhang, Y. Chem. Eur. J. 
2011, 17, 2916–2922. (j) Wang, T.; Yao, W.; Zhong, F.; Pang, G. H.; Lu, Y. Angew. Chem., Int. Ed. 
2014, 53, 2964–2968. (k) Repka, L. M.; Reisman, S. E. J. Org. Chem. 2013, 78, 12314-12320. 
(75) (a) Kong, D.-L.; Cheng, L.; Yue, T.; Wu, H,-R., Feng, W.-C.; Wang, D.; Liu, L. J. Org. Chem. 
2016, 81, 5337–5344. (b) Klare, H.k F. T.; Goldberg, A. F. G.; Duquette, D, C.; Stoltz, B. M. Org. 
Lett. 2017, 19, 988–991.  
(76) Lozinskaya, N. A.; Sosonyuk, S. E.; Volkova, M. S.; Seliverstov, M. Y.; Prokurnina, M. V.; 
Bachurin, S. E.; Zefirov, N. S. Synthesis 2011, 273–276. 
(77) For an application in C−N bond formation, see: Bala, M.; Verma, P. K.; Sharma, U.; Kumar, 
N.; Singh, B. Green Chem. 2013, 15, 1687. 
(78) For a noncatalytic C3 alkylation using activated benzyl alcohol with an excess amount of 
KOH, see: Cano, R.; Yus, M.; Ramón, D. J. Tetrahedron Lett. 2013, 54, 3394. 
(79) Shiri, M.; Zolfigol, M. A.; Kruger, H. G.; Tanbakouchian, Z. Chem. Rev. 2010, 110, 2250. 
(80) (a) Quintard, A.; Rodriguez, J. Angew. Chem., Int. Ed. 2014, 53, 4044. (b) Bauer, I.; Knölker, 
H.-J. Chem. Rev. 2015, 115, 3170. Also, see: (c) Elangovan, S.; Sortais, J. B.; Beller, M.; Darcel, C. 
Angew. Chem., Int. Ed. 2015, 54, 14483. (d) Moulin, S.; Dentel, H.; Pagnoux-Ozherelyeva, A.; 
Gaillard, S.; Poater, A.; Cavallo, L.; Lohier, J. F.; Renaud, J. L. Chem. - Eur. J. 2013, 19, 17881. 
(81) For reviews covering the direct dehydrative Friedel−Crafts reactions of alcohols, see: (a) 
Cozzi, P. G.; Benfatti, F. Angew. Chem., Int. Ed. 2010, 49, 256. (b) Bandini, M. Angew. Chem., Int. 
Ed. 2011, 50, 994. (c) Emer, E.; Sinisi, R.; Capdevila, M. G.; Petruzziello, D.; De Vincentiis, F.; 
Cozzi, P. G. Eur. J. Org. Chem. 2011, 2011, 647. 
(82) (a) Zhu, Y.; Rawal, V. H. J. Am. Chem. Soc. 2012, 134, 111. (b) Mari, M.; Lucarini, S.; 
Bartoccini, F.; Piersanti, G.; Spadoni, G. Beilstein J. Org. Chem. 2014, 10, 1991. 
(83) The hydrogen borrowing catalyst systems, seems to be compromised by substrates containing 
multiple heteroatoms (nitrogen and/or oxygen), particularly when they are separated by two carbon 
atoms. Such substrates can potentially chelate the metal centre of the catalyst, leading to catalyst 
termination, as well as suffering from potential side reactions associated with tautomerization of a- 
heterosubstituted aldehydes and imines. Hamid, M. H. S. A.; Allen, C. L.; Lamb, G.; Maxwell, A. 
C.; Maytum, H. C.;Watson, A. J. A.;Williams, J. M. J. J. Am. Chem. Soc. 2009, 131, 1766. 
(84) Smart, B. P.; Oslund, R. C.; Walsh, L. A.; Gelb, M. H. J. Med. Chem. 2006, 49, 2858-2860. 
 89 
 
                                                                                                                                                                                                          
(85) Pelagalli, R.; Chiarotto, I.; Feroci, M.; Vecchio, S. Green Chem. 2012, 14, 2251e2255. 
(86) Salomè, C.; Salomè-Grosjean, E.; Park, K. D.; Morieux, P.; Swendiman, R.; De- Marco, E.; 
Stables, J. P.; Kohn, H. J. Med. Chem. 2010, 53, 1288. 
(87) Pedras, M.; Soledade, C.; Sarma Mamillapalle, V. K. J. Agr. Food Chem. 2012, 60, 7792. 
(88) (a) Angelini, E.; Balsamini, C.; Bartoccini, F.; Lucarini, S.; Piersanti, G. J. Org. Chem. 2008, 
73, 5654; (b) Mari, M.; Bartoccini, F.; Piersanti, G. J. Org. Chem. 2013, 78, 7727. 
(89) Hanessian, S.; Stoffman, E. J. L. Can. J. Chem. 2013, 91, 13. 
(90 Nowak, W.; Gerlach, H. Liebigs Ann. Chem. 1993, 2, 153. 
(91) Shirota, O.; Hakamata, W.; Goda, Y. J. Nat. Prod. 2003, 66, 885. 
(92) Salmoun, M.; Devijver, C.; Daloze, D.; Braekman, J.-C.; Van Soest, R.W. M. J. Nat. Prod. 
2002, 65, 1173. 
(93) Hasegawa, M.; Nagahama, Y.; Kobayashi, K.; Hayashi, M.; Somei, M. Heterocycles 2000, 52, 483–491 
(94) Kashyap, S.; Sandler, J.; Peters, U.; Martinez, E. J.; Kapoor, T. M. Bioorganic Med. Chem. 
2(014, 22, 2253. 
(95) Lozinskaya, N. A.; Sosonyuk, S. E.; Volkova, M. S.; Seliverstov, M. Y.; Proskurnina, M. V.; 
Bachurin, S. E.; Zefirov N. S. Synthesis 2011, 273-276.   
(96) Altman, R.; Hyde, A.; Huang, X. J. Am. Chem. Soc. 2008, 11, 9613. 
(97) Bai, S.; Chen, X.; Hu, X.; Deng, Y.; Jiang, H.; Zeng, W. Org. Biomol. Chem. 2017, 15, 3638–3647. 
(98) Deng, Q.; Zhang, Y.; Zhu, H.; Tu, T. Chem. Asian J. 2017, 12, 236 –2368. 
(99) Jia, Y.; Zhu, J. J. Org. Chem. 2006, 71, 7826. 
(100) Putra, A. E.; Takigawa, K.; Tanaka, H.; Ito, Y.; Oe, Y.; Ohta, T. Eur. J. Org. Chem. 2013, 
2013, 6344. 
(101) Whitney, S.; Grigg, R.; Derrick, A.; Keep, A. Org. Lett. 2007, 9, 3299. 
(102) Sharma, S. K.; Sharma, S.; Agarwal, P. K.; Kundu, B. Eur. J. Org. Chem. 2009, 2009, 1309. 
(103) Katritzky, A. R.; Zhang, Z.; Lang, H.; Lan, X. J. Org. Chem. 1994, 59, 7209. 
(104) Sharma, R.; Chouhan, M.; Sood, D.; Nair, V. A. Appl. Organomet. Chem. 2011, 25, 305. 
(105) De Rosa, M.; Soriente, A. Eur. J. Org. Chem. 2010, 2010, 1029. 
(106) Bartolucci, S.; Mari, M.; Di Gregorio, G.; Piersanti, G. Tetrahedron 2016, 72, 2233. 
(107) Wu, L.; Jiang, R.; Yang, J.-M.; Wang, S.-Y.; Ji, S.-J. RSC Adv. 2013, 3 , 5459. 
(108) Cao, L. L.; Wang, D. S.; Jiang, G. F.; Zhou, Y. G. Tetrahedron Lett. 2011, 52, 2837. 
 
 
 
 
 
The following work has been done during my period of 
visiting spent abroad at Lund University under the guidance 
of Professor Peter Somfai. 
 
 
 
Asymmetric Lewis Acid Mediated [1,2]-
Rearrangement Approach Towards the Formal 
Synthesis of Cephalotaxine 
 
 
Department of Chemistry                  Centre for Analysis and Synthesis                 
   LUND UNIVERSITY                                    KEMICENTRUM  
 i 
 
 
Contents 
Abbreviations ii 
1.1 Introduction 1 
2. Aim of the thesis 3 
3. Results and Discussion 5 
4. Conclusion 11 
5. Experimental Section 12 
5.1Materials and Methods 12 
5.2 Compounds Characterization and Synthetic Methods 12 
6. Notes and References 21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ii 
 
Abbreviations 
 
Boc              di-tert-butyl dicarbonate 
DBU             1,5-diazabiciclo(5.4.0)undec-5-ene 
DCM             dichloromethane  
DMF                  dimethylformamide  
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1. Introduction 
 
1.1 Introduction 
Cephalotaxine is the most abundant alkaloid isolated form cephalotaxus harringtonii, 
an evergreens conifer species native to Japan, India and China. Cephalotaxine was 
isolated by Paudlar and co-workers1 and was later described and characterized by 
Powell and co-workers.2 The structure has an unique skeleton with an unusual 1-
azaspiro[4,4] moiety fused to a benzazepine system. Cephalotaxine itself does not 
display any biological activity but various esters of cephalotaxine were isolated and 
named harringtonine, homoringtonine, isoharringtonine and deoxyharringtonine. 
These derivatives show significant inhibitor activity against lymphoid leukemia in 
mice3 and clinical trials have reached phase II-III4 and, more recently, 
homoharringtonine has been investigated in the treatment of chloroquine resistant 
malaria (Figure1).5 
 
Figure 1 Cephalotaxine alkaloids. 
 
Cephalotaxine has become an interesting synthetic target, not only because of its 
unique ring skeleton but also for the biological activity shown from the ester 
 2 
 
derivatives aforementioned. Several elegant total syntheses both racemic and 
enantiopure of cephalotaxine have been reported.6  
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2. Aim of the thesis  
 
The goal of the present work is to achieve a short, efficient and novel route to 
cephalotaxine using as a key step an highly selective 1,2-Stevens rearrangement to 
establish the correct stereochemistry of the quaternary stereocenter transforming (S)-
1-allyl-N,N-dimethylpyrrolidine-2-carboxamide (8) in to (R)-2-allyl-N,N-
dimethylpyrrolidine-2-carboxamide (7). A recent work on 1,2-Stevens rearrangement 
was previously developed by P. Somfai and co-workers.7 
 
 
 
Scheme 1 Retrosynthetic analysis of cephalotaxine (1). 
 
Retrosynthesis of (1) lead to compound (2) that was recently reported by Li and co-
worker8 and previously reported by Weinreb9, Dolby10 and Weinstein11 so the 
sequence from (1) to (2) has been already demonstrated. We want to highlight that 
not only it should be possible to prepare the pentacyclic intermediate (2) in seven 
steps against nine steps already reported by Li but also in a stereoselective way. 
Compound (2) come from the hydrogenation of the double bond present in molecule 
(3). The stereocontrol should be guided from the substrate. The molecular model 
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shows us that the hydrogen should approach the double bond form the less hindered 
face to give the desired stereochemistry (substrate control). The seven-carbon ring in 
molecule (3) should be formed starting from bis-ketone (4) under acidic condition. 
Reasonably a kind of Friedel-Crafts acylation should take place with a 
thermodynamic regiocontrol guided from the possible formation ring size and the 
geometry of the starting molecule, that favour the closest carbonyl due to the spatial 
proximity. Molecule (4) should be formed in basic condition promoting the enolate 
formation of ketone (5) and the subsequent addition-elimination steps to the amide to 
from the ring containing the double ketone in molecule (4).12 Ketone (5) should be 
formed form the double bond using the well establish Wacker oxidation process. 
Compound (6) should be made by N-alkylation of the proline amide (7) with the 
homopiperonyl tosylate (2f). The key step involving the asymmetric transformation 
of (8) in (7) among the [1,2]-Stevens rearrangement should be achieved using an 
optimization of the previous reported condition by P. Somfai and co-workers.7 
Finally (8) should be prepared by N- allylation of the commercial available L-proline 
amide. 
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3. Results and Discussion 
 
As shown in the retrosynthesis (Scheme 1) the synthesis commenced from the 
commercial available L-proline amide to form the N-allylated proline amide (8). The 
nucleophilic substitution was carried out as microwaved assisted reaction in 
acetonitrile using allyl bromide as alkylating agent. This reaction proceeds in 30 min 
and in 98% yield. Based on the previously reported work of asymmetric Lewis acid 
mediated [1,2]-rearrangement of N-benzylic proline amides to form quaternary 
proline derivatives with high C-N-C chirality transfer prompt us to try this procedure 
on our compound (8). We have thought to apply that procedure to compound (8) 
where instead to have a transfer of a benzyl group we could have the transfer of allyl 
group. In this transformation the high level of C-N-C chirality transfer can be 
explained by in situ formation of the rigid bicyclic complex (b) (Scheme 2). 
Treatment of amide with BBr3 results in coordination of the Lewis acid cis to the 
amide moiety which is followed by formation of structure (b) (Scheme 2) resulting in 
an efficient transfer of chirality from the -carbon to the nitrogen nucleus. 
Subsequent deprotonation with Et3N provides (c) (Scheme 2), which suffers a 
homolytic cleavage of the C-N bond (see structure (d) in Scheme 2) and then a 
radical recombination occurs to form complex (e) (Scheme 2). Bicyclic structure (d) 
(Scheme 2) is chiral because of is non-planar so, efficient N-C chirality transfer is 
secured by selective migration of the benzyl radical on the α-face. Finally, hydrolysis 
of (e) (Scheme 2) gives (f) (Scheme 2), the absolute stereochemistry of which is 
identical to the starting material (a) (Scheme 2). 
 
 
Scheme 2 Proposed Mechanism for the Stevens Rearrangement. 
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The goal of the aforementioned publication was to study the transfer of different 
substituted aryl groups. Herein we have studied if it was possible to maintain the 
efficiencies in term of yield and the sterocontrol transferring the N-allyl group. First 
of all was tried the previous reported condition used for the benzyl group (Table 1, 
entry 1), isolating only traces of the desired product.  We believed that the product 
was formed but not completely recovered from the aqueous phase. For this reason  
the reaction was repeated changing the work up using NaOH instead NaHCO3 to 
have an higher pH that should ensure the neutral form of the secondary amine. 
Nevertheless in this case we had the consume of the starting material without any 
formation of the desired product. We also increased the temperature considering the 
possible higher energy barrier for the formation of complex (b) (Scheme 1) in the 
case of allyl compared to the benzyl. As shown in (Table 1, entry 3 and 4) 
temperature was increased, respectively refluxing in dichloromethane at 50°C and 
toluene at 110°C but we obtained the consume of the starting material without 
formation of the product. Finally, we change the base believing that the problem was 
the passages from (b) to (c) (Scheme 2) that was blocked due to the base that was not 
able to deprotonate the complex (b) (Scheme 2). LDA was used without success 
causing a mess reaction, probably it is too strong as base (Table 1, entry 5). Instead  
using 1,5-diazabiciclo(5.4.0)undec-5-ene (DBU) (Table 1, entry 6) right condition 
was found allowing the rearrangement to give product (7) in 73 % yield.  
 
Entry T (°C) Solvent Base Work Up Comments 
1 r.t. DCM TEA NaHCO3 traces 
2 rt DCM TEA NaOH - 
3 50 DCM TEA NaHCO3 - 
4 110 toluene TEA NaHCO3 - 
5 r.t. DCM LDA NaHCO3 messy 
6 r.t. DCM DBU NaHCO3 Yield 73% 
 
Table 1 Reaction Conditions: BBr3 2eq (1.98 M in DCM), 5eq of Base, 2,5h. 
 
With the rearrangement conditions in hand, it was consequently possible to evaluate 
the enantiomeric ratio. The sequence was repeated for the formation of (7), starting 
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from the commercially available DL-proline amide. Dissolving 5mg in 1 mL of 
isopropanol of the racemic form of (7) were run different chiral-hplc using a variety 
of chiral stationary phases (AI, AB, AC, ODH, ABH, ADH, OJ) and a variable 
elution system made of hexane: isopropanol with a ratio variable in the range of 
90:10 to 99:1 and a flow in the range  of 1ml/min to 0.5ml/min. It was not possible to 
find the HPLC condition for the separation of the racemate (7). As alternative, a 
derivatization of the secondary amine was done, making the protection of the 
secondary ammine (7) as Boc, and all the condition aforementioned were tried again 
without any result. The doubtful results convinced us to check if the initial 
commercial reagent was actually racemic. Using a polarimeter to evaluate the angle 
of rotation caused by passing polarized light through an optically active substance 
were compared the two commercial available racemic and enantiopure prolineamides 
(9) and was found that the racemic form of (9) actually was enantiopure measuring an 
 of -44° (c 1.00, CHCl3). Conscious of this inconvenient we decided to prepare 
the racemate by ourselves. First, we tried to racemize the enantiopure proline amide 
using a different base that should promote the enolization of the amide and the 
consequence racemization, but without satisfactory results. LDA (1 eq) was tired but 
the proline amide was degraded, while NaOEt (10%) was used the enantiopure form 
was recoverd (Scheme 3), so it was decided to prepare the raceme proline amide 
starting from the DL-proline.  
 
 
Scheme 3 Racemization Attempts.  
 
After many efforts, a practical route to produce DL-proline was found (Scheme 3). 
  
Scheme 3 Racemic Proline Amide Synthetic Route. 
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DL-proline (1a) was converted in N-Boc-DL-proline (1b) in quantitative yield using 
the classical Shotten-Baumann conditions.13 Then the coupling with the 
dimethylamine was realized through the activation of acid employing HBTU, OHBt, 
running the reaction in DCM and diisopropylamine as base at room temperature for 
24h, giving (1c) in 89% yield. Due to the water solubility of (1d) the Boc 
deprotection cannot be performed using TFA because of the basic/water extraction 
needed to remove the excess of acid (TFA) and also to restore the neutral form of the 
proline amide (1d). So, to this end the extraction with basic aqueous solution was 
avoided by using hexafluoroisopropanol (HFIP) as deprotecting reagent. The reaction 
was performed in a microwave at 150°C for 1h using only HFIP both as reagent and 
solvent. In this case, there is no need to extract with water solutions because the work 
up is simply the removal of the solvent under reduced pressure to afford the racemic 
proline amide rac-(9) in 84% yield. Finally, rac-(9) was used in the aforementioned 
discussed sequence for the formation of racemic compound (7).  Once more, all the 
analysis aforementioned for the chiral-hplc were repeated without obtaing a 
separation of the two enantiomers of (7). Moreover, 1% of dimethylamine was added  
as additive in the HPLC elution systems describe before and both the racemates (7) 
and (7)-boc-protected, were not separated with these conditions, highlighting the 
difficulty to separate the two enantiomers via chiral-HPLC. As last resorts to evaluate 
the enantiomeric ratio diastereoisomer of (7) with the (R)-Mosher acid chloride were 
made and finally the diasteromeric ratio was evaluated, as 4(RR):6(RS). Considering 
that the rearrangement reaction of (8) is performed only starting from the S form 
(99,9% purity) and for the racemate there is no preferential reaction on of the two 
enantiomers with the R-Mosher acid chloride is possible to transfer the d.r. to e.r. so 
 = 94(R):6(S). An assumption was done: the retention of chirality is maintained as 
reported in the precedent work for the transfer of benzyl group. Finally, to assign the 
stereochemistry of (7) should be transformed in a known compound, for example (1) 
and check the alfa rotation to assign the stereo descriptor. Afterwards moving on in 
the synthesis the preparation of homopiperonyl tosylate was considered (Scheme 4). 
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Scheme 4 Homopiperonyl Tosylate Synthetic Route. 
The acid (2a) was quantitatively transformed in the corresponding ester (2b) using 
the Fischer esterification, then the protection of catechol (2b) was achieved in 50% 
yield refluxing in DMF/ dichloromethane, which undergo a double substitution 
reaction. (2c) was reduced to the correspondent alcohol (2d) with LiALH4, refluxing 
in THF for 2h. The 1,3-dioxolane moiety is unstable to acid condition, so the chosen 
work up for this reaction was Fieser work up, consisting in a basic washing with and 
aqueous solution of NaOH at 15%. (2d) was obtained in 87% yield. Finally, the 
homopiperonyl tosylate (2f) was simply obtained from tosyl chloride in 91% yield. 
Compound (2f) and (7) were allowed to react together in a nucleophilic substitution, 
using acetonitrile as solvent, potassium carbonate as base and KI as catalyst, 
producing (6) in 98% yield. Working on compound (6) different variants of Wacker 
process to achieve the ketone were tried (5). 
 
entry T (°C) solvent catalyst  equivalents comments 
1 r.t. DMF/H2O PdCl2/Cul 0.25/1.50 SM recover 
2 60°C DMF/H2O PdCl2/Cul 0.25/1.50 SM recover 
3 60°C DMF/H2O PdCl2/Cul 3/1.5 SM recover 
5 60°C DMF/H2O/H
+ PdCl2/Cul 3/1.5 
Traces of 
TM 
 
Table 2 Wacker Process, Screening Conditions. O2 (1atm) ,24h for all the reaction runs. 
The first condition tested (Table 2, entry 1) was the classical Wacker reaction with 
PdCl2/CuCl where PdCl2 is used in catalytic amount. In this case, we recovered only 
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the starting material, then we repeated the same reaction conditions heating at 60°C 
for 24h (Table 2, entry 2), nevertheless continuing to recover starting material.  In 
literature, it was found that the nitrogen bond can influence the course of the Wacker 
oxidation due to the affinity to coordinate palladium.14 To avoid this inconvenient 
and to allow the reaction to continue to work, two possibilities were taken in 
consideration: 1) overloading of catalysts using an excess of it; 2) protonation of 
amine. In (Table 2, entry 3) it was tried the super-stochiometric conditions without 
good results. In the conditions of (Table 2, entry 4) the amine (6) was protonated with 
one equivalent of hydrochloric acid and it was used also a super-stochiometric 
condition of catalyst load and traces of product were obtained. Another issue is that 
compound (6) contain the methylenedioxy moiety that is not stable in acid conditions, 
influencing the yield of the process.  
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4. Conclusion 
 
The formal synthesis of Cephalotaxine was taken in consideration. The condition of 
1,2-stevens rearrangement for the allyl group transfer was found and I supposed to 
have the correct stereochemistry of the quaternary stereocenter.  Indeed, based on the 
previous reported work of Somfai and co-workers7 , there was a retention of chirality.  
In the present case we transfor (S)-1-allyl-N,N-dimethylpyrrolidine-2-carboxamide in 
to (R)-2-allyl-N,N-dimethylpyrrolidine-2-carboxamide in the presence of  BBr3 as 
Lewis acid DBU as base and DCM as solvent at room temperature in 3h with 89 % 
yields and almost complete transfer of chirality. Starting from 99,9 % (S) proline 
amide (9) we obtain (7) e.r. = 94(R):6(S). Finally, I worked on the transformation of 
double bond on compound (6) to ketone (5) furnishing for now only traces of 
product, that means the reaction works, but remain to be optimized. The planned 
synthesis is almost of half of the way. 
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5. Experimental Section 
5.1 Materials and Methods 
Unless stated specifically, all reactions were performed under argon atmosphere. 
Analytical thin-layer chromatography was performed with Merck Silica gel 60. Flash 
silica gel column chromatography was performed with Acros silica gel 40- 60. 1 H 
NMR spectra were recorded on a Bruker Avance II at 400 MHz and Bruker Avance 
III HD at 500 MHz. Chemical shifts are reported relative to Me4Si. 
13C NMR spectra 
were recorded on a Bruker Avance II at 100 MHz and Bruker Avance III HD at 125 
MHz. Chemical shifts are reported relative to CDCl3 (δ 77.0). Infrared spectra were 
recorded on a Bruker Alpha-P FT/IR instrument with a Diamond ATR sensor for 
detection in the range from ῦ = 4500 cm–1 to ῦ = 500 cm–1. Samples were prepared 
as a film for liquid or neat for solid substances. High resolution mass spectra (HRMS) 
were recorded on Waters XEVO-G2 QTOF with electrospray ionization (ESI). 
Melting points were measured on a BÜCHI B-540 melting point apparatus and are 
uncorrected. 
5.2 Compound Characterization and Synthetic Methods    
 
 (S)-1-allyl-N,N-dimethylpyrrolidine-2-carboxamide (8) To the cold 
(0°) solution of proline amide (9) (90mg, 0.632 mmol) in CH3CN (330 
l) was added allyl bromide (10) (82µL, 0.949 mmol) and resulting 
mixture was heated in micro-wave reactor at 120 °C (100W) for 30 
min. The resulting mixture was poured into the aqueous saturated 
NaHCO3 (2.5 mL) and extracted with CH2Cl2 (3x5 mL). The 
combined organic phases were washed with brine, dried over K2CO3 and 
concentrated. The residue was purified by column flash chromatography (SiOx, 20% 
of EtOAc in Heptane containing 1% iPrNH2) to afford (5) (114 mg, 98%). 1H NMR 
(CDCl3, 400 MHz) δ 5.98-5.89 (m, 1H), 5.12 (dd, J = 17.0, 1.0 Hz, 2H), 5.03 (dd, J = 
10.0, 1.0 Hz, 2H), 3.36 - 3.26 (m, 2H), 3.18 (t, J = 8.5 Hz, 1H), 3.03 (s, 3H), 3.01 - 
2.95 (m, 1H), 2.92 (s, 3H), 2.35- 2.27 (m, 1H), 2.13 – 2.02 (m, 1H), 1.96 – 1.88 (m, 
1H), 1.84 – 1.73 (m, 1H). 13C NMR (CDCl3, 101 MHz) δ 173.0, 135.9 , 116.6 , 63.7, 
57.4 , 53.1 , 36.7 , 35.9 , 28.7 , 22.8 . IR (film): 1671 cm−1; HRMS (ESI) m/z calcd. 
for C10H19N2O (M+H)
+ 183.1492; found 2183.1489. Rf:0,20 using heptane: ethyl 
acetate (80:20 + 1% iPrNH2). Yellow spot is obtained staining with permanganate 
solution 
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 (R)-2-allyl-N,N-dimethylpyrrolidine-2-carboxamide (7) A solution 
of 5 (160 mg, 0.877 mmol, 1.0 equiv.) in dry CH2Cl2 (4 mL) under a 
nitrogen atmosphere was cooled to -78 °C and BBr3 (880 µL, 1.76 
mmol, 2 M solution in CH2Cl2, 2.0 equiv) was added dropwise. 
Cooling bath was removed and resulting solution was stirred for 1 h (-
78 °C → rt). To the resultant mixture DBU (655 µL, 4.39 mmol, 5.0 equiv) was 
added drop wise at 0°C and the reaction mixture was stirred for 1h at room 
temperature. Reaction was then quenched at 0°C by addition of 1 M HCl (1.0 mL) 
and stirred for 1h then poured into the saturated NaHCO3 (5 mL) until basic pH 
solution and extracted with CH2Cl2 (3x5 mL). Organic phases were combined and 
washed with brine (1x10 mL) and dried over K2CO3, then evaporated. Purification of 
the residue by column chromatography, silica gel heptane:acetone (50:50 + 1% 
iPrNH2) afforded amide 6 (90mg, 56%) as colourless oil. 
1H NMR (CDCl3, 400 
MHz) δ 5.81-5.71 (m, 1H), 5.05-5.03 (m, 1H), 5.02-4.99 (m, 1H), 3.09-2.88 (m, 1H), 
2.78-2.72 (m, 1H), 1.87-1.81 (m, 1H), 1.80-1.65 (m, 2H).  13C NMR (CDCl3, 101 
MHz) δ 175.5, 134.2, 117.5, 68.4, 46.5, 44.7, 35.2, 26.5. IR (film): 1697 cm−1; 
HRMS (ESI) m/z calcd. for C10H19N2O (M+H)
+ 183.1492; found 183.1499 Rf:0,52 
using heptane:acetone (50:50 + 1% iPrNH2). Brown spot is obtained staining with 
ninhydrin solution.  
Preparation sequence of racemic prolineamide rac-(9): 
 (tert-butoxycarbonyl)-proline (1b) A solution of 729 mg (6.33 
mmol) of DL-proline (1a) in 9 mL of saturated NaHCO3 solution (= 
0.7 mol/l) was cooled in an ice bath, treated dropwise with a 
solution of Boc2O in THF (2 mol/l) and stirred for 19 h at room 
temp. In the following THF was removed under reduced pressure, 
the residue cooled to 0 °C, then acidified by the addition of 2 mL of 
3 M HCl solution and other 10 mL of 3 N HCl solution from pH = 8 to 2 and 
extracted three times with 20 mL of EtOAc. After drying of the combined organic 
phases over MgSO4, concentration under reduced pressure and drying in oil pump 
vacuum 805 mg of the acid 7 were obtained as a colorless solid. Purification of the 
residue by column chromatography is also possible when necessary using, silica gel 
ethyl acetate:methanol (90:10) afforded amide 6 (90mg, 56%) as colourless oil. 1H 
NMR (CDCl3, 400 MHz, mixture of rotamers) δ 8.16 (bs, 1H), 4.15 (bs, 1H), 3.51-
3.30 (m, 2H), 2.08-1.92 (m, 3H), 1.83-1.79 (m, 1H), 1.42 (s, 1H). Rf:0,25 using ethyl 
acetate:methanol (90:10 + 1% iPrNH2). Yellow elongated spot is obtained staining 
with permanganate solution. The chemical-physical data are in accordance with 
literature15. 
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 Tert-butyl-2-(dimethylcarbamoyl)pyrrolidine-1-carboxylate 
(1c) To a solution of (1b) (650 mg, 3.02 mmol), 1-
hydroxybenzotriazole (448.8 mg, 3.32 mmol) and N,N-
diisopropylethylamine (1.05 mL, 7.55 mmol) in CH2Cl2 (6 mL) was 
added HBTU (1.15 g, 3.02 mmol), and the reaction mixture was 
then stirred for 30 min. Dimethylamine solution in THF (1.05 mL, 
2M) was then added portionwise over 15 min. After stirring at room temperature for 
24 h, the solvent was removed under vacuum and then the residue was diluted with 
CH2Cl2 (10 mL), washed with saturated sodium hydrogen carbonate solution (8 mL), 
saturated aqueous ammonium chloride solution (8 mL) and brine (8 mL). The organic 
layer was dried over anhydrous Na2SO4, and the solvent was evaporated under 
reduced pressure. The residue obtained was purified by flash chromatography (ethyl 
acetate:methanol 90:10) to give 719 mg (89%) of coupled product 8 as yellow oil.1H 
NMR (CDCl3, 400 MHz, mixture of rotamers)  δ 7.00 (s, 1H), 4.63 (dd, 8.5, 3.0 Hz 
1H), 4.53 (dd, J = 8.5, 4.5 Hz, 1H), 3.55 – 3.37 (m, 3H), 3.06 (d, J = 8.0 Hz, 3H), 
2.94 (d, J = 7.0 Hz, 3H), 2.20-2.11 (m, 1H), 2.04-2.98 (m, 1H), 1.88-1.79 (m, 2H). 
1.38-1.36 (m, 9H). 13C NMR (CDCl3, 101 MHz, mixture of rotamers)  δ 173.0 , 172.4 
, 154.59 , 154.1 , 79.8 , 79.6 , 56.6, 56.5, 46.8, 46.6, 45.5, 36.9, 36.0, 30.2, 29.5, 28.5, 
28.3, 24.2, 23.7. Note: 1,1,3,3-tetramethylurea signals are detected as impurity. At the 
moment no way found to remove it. Rf:0,70 using ethyl acetate:methanol (90:10 + 
1% iPrNH2). Yellow spot is obtained staining with permanganate solution. The 
chemical-physical data are in accordance with literature16. 
 N,N-dimethylpyrrolidine-2-carboxamide (1d) A solution of the N-
Boc protected prolineamine (1c) (350mg, 1.44mmol) in 
hexafluoroisopropanol (15 mL) was placed in a sealed microwave vial. 
The reaction mixture was heated (150°C) in a Biotage–microwave 
instrument stirring for 1h.. After cooling to room temperature, the mixture was 
evaporated to dryness under reduced pressure. The crude product was purified by 
flash-column chromatography using (ethyl acetate:methanol 90:1 + 1% iPrNH2) to 
give 174mg (84%) of deprotected product 9 as transparent oil. 1H NMR (CDCl3 400 
MHz) δ 4.11 (dd, J = 8., 6.0 Hz, 1H), 3.70 (bs, 2H), 3.24 – 3.18 (m, 1H), 3.03 (s, 3H), 
2.97 (s, 3H), 2.24 – 2.14 (m, 1H), 1.91 – 1.84 (m, 1H), 1.80 – 1.64 (m, 2H). 13C NMR 
(CDCl3, 101 MHz) δ 172.8 , 58.1, 47.4, 36.6, 35.9, 30.4, 26.1. IR (film): 1850 cm−1; 
HRMS (ESI) m/z calcd. for C7H15N2O (M+H)
+ 143.1179; found 143.1188. Rf:0,25 
using ethyl acetate:methanol (90:10 + 1% iPrNH2). Yellow spot is obtained staining 
with permanganate solution or brown spot staining with ninhydrin.  
Procedure for the Boc protection of (7) and rac-(7) 
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 Tert-butyl 2-allyl-2-(dimethylcarbamoyl)pyrrolidine-1-
carboxylate. Et3N (43 l, 0,30 mmol) and Boc2O (67 mg, 0,30 
mmol) were added sequentially to a solution of compound 7 or rac-
(7) (40 mg, 0.22 mmol) in CH2Cl2 (450 L) at room temperature. 
The reaction mixture was stirred overnight and then saturated 
aqueous NaHCO3 (2.5 mL) was carefully added. The mixture was 
extracted with CH2Cl2 (3×5 mL). The combined extracts were dried 
on MgSO4 and concentrated under vacuo. The crude was purified by flash-column 
chromatography using (ethyl acetate 100%) to give 80 mg (100%) of protected 
product 10 as yellow-transparent oil.1H NMR (CDCl3 400 MHz) δ 5-94-5.84 (m, 
1H), 5.11-5-04 (m, 2H), 3.64-3.58 (1H, m), 3.50-3.45 (m, 1H), 2.96 (s, 6H), 2.79 (dd, 
J = 7.0, 1.0 Hz, 1H), 3.22 – 3.08 (m, 2H), 2.05-1.90 (m, 2H), 1.44 (s, 3H), 1.41 (s, 
6H). 13C NMR (CDCl3, 101 MHz) δ 172.86, 153.24, 146.71, 135.11, 118.18, 85.13, 
80.09, 68.16, 47.16, 42.60, 35.63, 28.27, 27.38, 21.80. IR (film): 1787 cm−1; HRMS 
(ESI) m/z calcd. for C12H23N2O3 (M+H)
+ 243.1703; found 243.1714. Rf:0,85 using 
ethyl acetate (100%).Yellow spot is obtained staining with permanganate solution or 
brown spot staining with ninhydrin.  
Sequence for the preparation of the homopiperonyl moiety: 
 methyl 2-(3,4-dihydroxyphenyl)acetate (2b) 
Dihydroxyphenylacetic acid (2a) (100 mg, 0.60 mmol) was 
treated by MeOH (2 mL) in acid medium with concentrated 
H2SO4 (25 L), stirred and refluxed for 3 h. Then, the MeOH 
was evaporated off under reduced pressure to afford a residue of 3,4-
dihydroxyphenylacetyl methyl ester. The crude was purified by flash-column 
chromatography using (heptane:ethyl acetate 50:50) to give 100 mg (98%) of 11 as 
oil.1H NMR (CDCl3 400 MHz) δ 6.74 (s, 0H), 6.73 (d, J = 8.9 Hz, 1H), 6.62 (dd, J = 
8.1, 2.1 Hz, 1H), 6.42 (s, 1H), 6.21 (s, 1H), 3.71 (s, 2H), 3.51 (s, 1H). 13C NMR 
(CDCl3, 101 MHz) δ 173.9, 143.9, 143.2, 125.9, 121.7, 116.4, 115.5, 52.5, 40.5. 
Rf:0,55 using (heptane:ethyl acetate 50:50).Yellow spot is obtained staining with 
permanganate solution. The chemical-physical data are in accordance with 
literature17.  
 methyl 2-(benzo[d][1,3]dioxol-5-yl)acetate (2c) 
Dichloromethane (140 L, 2.2 mmol) and CsF (400 mg, 2.64 
mmol) were added to a solution of (2b) (100mg, 0.55 mmol) in 
anhydrous DMF (2 mL), and the mixture was refluxed for 3 h with stirring. After 
cooling, the reaction mixture was extracted with CH2Cl2 and the organic layer was 
 16 
 
washed with 5% aq NaHCO3 and water, dried over Na2SO4 and concentrated in 
vacuo to dryness. The residue was purified by flash chromatography using as eluent 
CH2Cl2:hexane (60:40) furnishing 30 mg (43%) of 3,4-methylenedioxyphenylacetyl 
methyl ester 12 as a pale yellow oil. 1H NMR (CDCl3 400 MHz) δ 6.76 (d, J = 8.0 
Hz, 1H), 6.72 (d, J = 2.0 Hz, 1H), 6.68 (d, J = 2.0 Hz, 1H), 6.66 (d, J = 2.0 Hz, 0H), 
3.81 (t, J = 6.5 Hz, 2H), 2.78 (t, J = 6.5 Hz, 2H). 13C NMR (CDCl3, 101 MHz) δ 
147.8, 146.2, 132.2, 121.9, 109.3, 108.4, 100.9, 63.8, 38.9. Rf:0,35 using 
(CH2Cl2:hexane 60:40). Yellow spot is obtained staining with permanganate solution. 
The chemical-physical data are in accordance with literature17.  
 2-(benzo[d][1,3]dioxol-5-yl)ethan-1-ol (2d) A 0.2 M solution 
of 3,4-dihydroxyphenylacetic acid (2c) (10mg, 0.05 mmol) in 
dry tetrahydrofuran was added to a suspension (1.95 mg, 0.05 
mmol) of LiAlH4 in the same solvent (1 mL) dropwise, under magnetic stirring and at 
0°C. Soon after, the mixture was heated until reflux and left under reflux for 2 h. 
Afterward, the reaction mixture was cooled (0°C) and treated with ethyl acetate (2 
mL), water (2ml), 15 % of aqueous sodium hydroxide (2 mL), and was stirred for 15 
min, and then was add anhydrous magnesium sulphate and stirred other 15 min, 
finally the mixture was filtered and then concentrated under reduced pressure. The 
residue was purified by flash chromatography using as eluent ethyl heptane:ethyl 
acetate (20:80) furnishing 7.7 mg (87%) of 13 as a pale yellow oil. 1H NMR (CDCl3 
400 MHz) δ 6.76 (d, J = 7.8 Hz, 1H), 6.72 (d, J = 1.7 Hz, 1H), 6.68 (dd, J = 7.8, 1.7 
Hz, 1H), 3.81 (t, J = 6.5 Hz, 2H), 2.79 (t, J = 6.5 Hz, 2H), 1.48 (s, 2H).13C NMR 
(CDCl3, 101 MHz) δ 147.8, 146.2, 132.2, 121.9, 109.3, 108.4, 100.9, 63.8, 38.9. 
Rf:0,45 using (heptane:ethyl acetate 20:80). Yellow spot is obtained staining with 
permanganate solution. The chemical-physical data are in accordance with 
literature18.  
 2-(benzo[d][1,3]dioxol-5-yl)ethyl 4-
methylbenzenesulfonate (2f) To a dry round-
bottom flask equipped with a stirbar under N2 were 
added of TsCl (9.5 mg 0.50 mmol), DMAP (0.55 
mg, 0,05 mmol), NEt3 (12 L, 0.90 mmol), and 0.5 mL of DCM. The resulting 
mixture was cooled to 0° C, and a solution of (2d) (7.50 mg, 0.45 mmol) in 0.5 mL of 
DCM was added dropwise. The mixture was allowed to warm to room temperature 
and was stirred overnight. The solution was then washed with sat. aq. NaHCO3 (1 × 1 
mL) and H2O (1 × 1 mL). The combined aqueous layers were extracted with DCM (1 
× 5 mL) and the combined organic layers were dried over Na2SO4, decanted, and 
concentrated in vacuo. The residue was purified by flash chromatography using as 
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eluent ethyl heptane:ethyl acetate (20:80) furnishing 15 mg (48%) of 14 as a white 
solid. 1H NMR (CDCl3 400 MHz) δ 7.70 (d, J = 8.5 Hz, 1H), 7.31 – 7.28 (m, 1H), 
6.68 (d, J = 8.5 Hz, 1H), 6.58 – 6.54 (m, 1H), 5.92 (s, 1H), 4.15 (t, J = 7.0 Hz, 1H), 
2.86 (t, J = 7.0 Hz, 1H), 2.44 (s, 2H). 13C NMR (CDCl3, 101 MHz) δ 147.7, 146.5, 
144.7, 132.9, 129.9, 129.8, 127.9, 127.0, 121.9, 109.2, 108.3, 100.9, 70.8, 35.1, 21.7. 
IR (film): 1507 cm−1; HRMS (ESI) m/z calcd. for C16H17O5S (M+H)+ 321.0791; 
found 321.0798. Rf:0,85 using (heptane:ethyl acetate 20:80). Yellow spot is obtained 
staining with permanganate solution. 
 (R)-2-allyl-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)-N,N-
dimethylpyrrolidine-2-carboxamide (6) Tosylate 14 (130mg, 
0,71mmol) was added to a mixture of a secondary amine, NaI 
(106mg, 0.71mmol), and K2CO3 (295mg, 2.14mmol) in CH3CN 
(0.5 M). The reaction was heated to reflux for 16 h and then 
cooled to room temperature. The reaction mixture was diluted 
with CH2Cl2 (5 mL), and the solid was filtered off. The filtrate 
was concentrated under vacuum, and the residue was dissolved in 
CH2Cl2. The resulting solution was washed with 5 % of aqueous 
NaOH, brine, dried with anhydrous MgSO4, and concentrated under vacuum. The 
residue was purified through silica gel flash chromatography using as eluent ethyl 
heptane:ethyl acetate (50:50) furnishing 146 mg (62%) of 15 as a yellowish-
transparent oil. 1H NMR (CDCl3 400 MHz) δ 6.68 (d, J = 8.0 Hz, 1H), 6.61 (d, J = 
2.0 Hz, 1H), 6.57 (dd, J = 8.0, 2.0 Hz, 1H), 6.99 – 5.90 (m, 1H), 5.87 (dd, J = 2.0, 1.5 
Hz, 2H), 5.01 – 4.99 (m, 1H), 4.98 – 4.96 (m, 1H), 3.20 (ddd, J = 9.0, 8.0, 4.0 Hz, 
1H), 2.86 (s, 6H), 2.82 – 2.74 (m, 1H), 2.75 – 2.60 (m, 3H), 2.57 – 2.49 (m, 2H), 2.08 
– 1.94 (m, 3H), 1.88 – 1.78 (m, 2H). 13C NMR (CDCl3, 101 MHz) δ 174.1, 147.4, 
145.6, 137.4, 134.7, 121.4, 116.9, 109.0, 107.9, 100.7, 71.6, 50.5, 49.9, 37.7, 36.4, 
35.1, 31.2, 22.0. IR (film): 1787 cm−1; HRMS (ESI) m/z calcd. for C19H26N2O3 
(M+H)+ 330.1938; found 330.1944. Rf:0,50 using (heptane:ethyl acetate 50:50). 
Yellow spot is obtained staining with permanganate solution.  
Evaluation of enantiomeric ratio by means NMR study of the diasteromeric 
mosher amide derivatives.   
 
 2-allyl-N,N-dimethyl-1-((R)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoyl)pyrrolidine-2-carboxamide rac-(7) In a 
vial under argon were added the prolineamide 9 (30 mg, 
0,21mmol, racemate) 0,5 ml of anhydrous DCM, (45 L, 
 18 
 
0.26mmol) of DIPEA and finally (R)-Mosher’s acid chloride (40, L, 0.21mmol). 
The reaction was heated at 40°C over night and after the complete consuming of 
starting material, NaHCO3 (1ml) was added and extracted with DCM (3 x 1mL), the 
combined organic phases was dried on Na2SO4, and reduced under high vacuum, 
furnishing 65 mg (100%) of (7) as a light yellow transparent oil.   1H NMR 1H NMR 
(CDCl3 400 MHz, racemate) δ 7.75 – 7.72 (m, 1H), 7.64 – 7.66 (m, 2H), 7.40 – 7.36 
(m, 6H), 5.97 – 5.90 (m, 1H), 5.70 – 5.61 (m, 1H), 5.16 – 5.02 (m, 4H), 3.94 (q, J = 
2.0 Hz, 3H), 3.73 (q, J = 2.0 Hz, 3H), 3.63 (ddd, J = 11.5, 8.0, 5.5 Hz, 1H), 3.50 
(ddd, J = 11.5, 8.5, 7.0 Hz, 1H), 3.38 (ddt, J = 14.0, 6.5, 1.5 Hz, 1H), 3.09 ddt, J = 
14.0, 7.5, 1.0 Hz, 1H)), 3.03 (s, 3H), 3.02 – 2.96 (m, 1H), 2.94 (s, 3H), 2.93 – 2.82 
(m, 2H), 2.78 (dt, J = 11.5, 7.5 Hz, 1H), 2.07-1.93 (m, 2H), 1.96-1.98 (m, 2H), 1.86 – 
1.77 (m, 1H), 1.73 – 1.64 (m, 3H), 1.57 – 1.50 (m, 1H), 1.29 – 1.22 (m, 3H). 13C 
NMR (101 MHz, CDCl3, racemate) δ 171.4, 170.9, 165.2, 164.2, 134.6, 134.2, 133.6, 
132.8, 129.3, 129.2, 127.9, 127.9, 127.6, 127.2, 125.2, 122.3, 118.8, 118.5, 77.4, 
77.3, 77.1, 76.7, 72.3, 72.1, 56.0, 55.6, 47.4, 47.3, 39.9, 39.1, 38.4, 38.3, 33.5, 32.4, 
31.9, 29.0, 24.1, 23.8, 22.7, 14.1. IR (film): 1757 cm−1; HRMS (ESI) m/z calcd. for 
C20H26F3N2O3 (M+H)+ 399.1890; found 399.1878. Rf:0,60 using (heptane:actone 
(50:50) + 1% iPNH2). Yellow spot is obtained staining with permanganate solution.  
 
 (R)-2-allyl-N,N-dimethyl-1-((R)-3,3,3-trifluoro-2-
methoxy-2-phenylpropanoyl)pyrrolidine-2-carboxamide 
(7) In a vial under argon were added the prolineamide 6 (30 
mg, 0,21mmol, enatipure) 0,5 ml of anhydrous DCM, (45 L, 
0.26mmol) of DIPEA and finally  (R)-Mosher’s acid chloride 
(40, L, 0.21mmol). The reaction was heated at 40°C over 
night and after the complete consuming of starting material, NaHCO3 (1ml) was 
added and extracted with DCM (3 x 1mL), the combined organic phases was dried on 
Na2SO4, and reduced under high vacuum, furnishing 65 mg (100%) of (7) as a light 
yellow transparent oil.  1H NMR (400 MHz, CDCl3, enantiopure) δ 7.63 – 7.60 (m, 
2H), 7.39 – 7.37 (m, 3H), 5.71 – 5.62 (m, 1H), 5.12 – 5.03 (m, 2H), 3.94 (q, J = 2.0 
Hz, 3H), 3.50 (ddd, J = 11.5, 8.5, 7.0 Hz, 1H), 3.38 (ddt, J = 14.0, 6.5, 1.5 Hz, 1H), 
3.03 (s, 6H), 2.93 – 2.83 (m, 3H), 2.04 – 1.98 (m, 1H), 1.96 – 1.91 (m, 1H), 1.72 – 
1.66 (m, 1H), 1.55 – 1.48 (m, 1H), 1.28 – 1.22 (m, 1H). 13C NMR (101 MHz, CDCl3, 
enantiopure) δ 171.35, 165.22, 134.17, 133.55, 129.27, 129.17, 128.02, 127.96, 
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127.93, 127.21, 125.13, 122.25, 118.47, 72.31, 56.02, 47.35, 39.10, 38.41, 33.49, 
31.89, 29.03, 24.10, 22.70, 14.13. ): 1758 cm−1; HRMS (ESI) m/z calcd. for 
C20H26F3N2O3 (M+H)
+ 399.1890; found 399.1876. Rf:0,60 using (heptane:actone 
(50:50) + 1% iPNH2). Yellow spot is obtained staining with permanganate solution.  
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  = 94(RR):6(RS) Considering the rearrangement reaction 
of (8) is performed only starting from the S form (99,9% purity), and for the racemate 
there is no preferential reaction on of the two enantiomers with the R-Mosher 
chloride is possible to transfer the d.r. to e.r.  =>  = 94(R):6(S).  
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